data_2mrm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mrm _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 3' ' ' LEU . 4.0 pp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.827 0.346 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -116.83 144.17 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -78.16 145.13 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.466 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -136.32 166.06 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.824 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 9' ' ' HIS . 1.7 t -102.46 142.58 24.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.935 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -42.06 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.369 2.046 . . . . 0.0 112.063 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -80.89 -27.94 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.11 -52.68 6.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.367 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.11 -32.33 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.424 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 15' ' ' ILE . 1.7 tt0 -66.24 -56.66 10.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -45.48 -26.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 17' ' ' ARG . 27.8 mt -82.94 -39.9 20.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 12' ' ' GLN . 67.0 mt -49.2 -24.85 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.83 -20.72 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.958 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 14' ' ' LEU . 6.0 ttt180 -84.14 -41.04 17.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.504 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 139.01 -7.37 3.21 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 18' ' ' GLY . . . -31.29 151.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 0.0 110.601 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.772 ' HZ3' ' HE ' ' A' ' 56' ' ' ARG . 1.4 mtpt -109.42 99.72 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.23 134.7 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.959 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.429 HD13 ' CE2' ' A' ' 62' ' ' PHE . 14.4 mt -130.85 141.18 46.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 0.0 111.096 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.581 ' OD2' ' NH2' ' A' ' 25' ' ' ARG . 5.2 t0 -111.71 135.6 52.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.135 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 pt -130.12 81.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.243 0.544 . . . . 0.0 110.197 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.581 ' NH2' ' OD2' ' A' ' 23' ' ' ASP . 11.8 ptt180 -154.73 -145.54 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.285 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 11.2 m-20 -101.8 116.21 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.316 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -45.61 -36.01 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.189 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -48.34 -34.35 10.49 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -85.18 -32.4 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.806 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.759 ' CZ ' ' ND1' ' A' ' 34' ' ' HIS . 10.0 t80 -73.08 -31.0 64.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 4.0 tp -65.06 -59.24 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.572 ' C ' ' HE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -53.63 -25.55 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.144 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 32' ' ' ARG . 19.0 tt0 -152.76 117.78 5.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.185 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.77 ' ND1' ' N ' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -140.77 152.13 44.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.513 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.77 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 5.9 mt -110.62 94.18 18.73 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.662 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.37 66.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.871 2.38 . . . . 0.0 112.4 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.71 ' N ' ' O ' ' A' ' 35' ' ' ILE . 14.5 pt-20 -179.46 27.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 153.49 30.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.337 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -84.77 143.53 29.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.71 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.37 114.55 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.84 96.59 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.555 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' VAL . 82.9 Cg_exo -44.94 124.41 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.372 2.048 . . . . 0.0 111.875 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 42' ' ' PRO . 1.7 tt -36.6 -60.29 0.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.137 0.494 . . . . 0.0 110.565 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -44.09 -25.93 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.974 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -73.9 -39.02 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.926 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.467 ' N ' HG11 ' A' ' 45' ' ' VAL . 6.5 tt -83.39 -42.97 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.825 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.88 -29.89 71.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.847 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.487 ' CG ' ' N ' ' A' ' 49' ' ' SER . 7.7 pt20 -97.18 -40.61 8.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.935 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 2.1 t -87.47 -55.36 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.756 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 83.11 0.8 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.674 ' O ' ' N ' ' A' ' 53' ' ' ALA . 14.1 tp -107.58 97.92 21.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.87 67.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.564 2.176 . . . . 0.0 112.194 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -51.71 -19.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.275 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' HIS . 5.4 tttp -63.3 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mp -77.91 -13.56 59.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.793 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.772 ' HE ' ' HZ3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.1 19.95 8.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 166.17 -167.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.786 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -113.38 -39.58 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.3 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -112.31 133.47 54.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.156 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.704 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -136.33 144.35 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -127.02 146.51 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.169 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.457 ' CD2' HD11 ' A' ' 77' ' ' LEU . 96.6 m-85 -126.62 137.36 53.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.74 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 1.0 OUTLIER -140.75 136.32 32.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.519 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.6 t -115.7 153.22 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.455 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.519 ' C ' ' O ' ' A' ' 64' ' ' CYS . 2.8 tt0 -30.08 -53.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.65 54.08 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.621 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 42.7 49.57 5.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -112.24 -42.62 3.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HG2' ' SG ' ' A' ' 64' ' ' CYS . 2.9 mmt180 -83.39 -31.9 26.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.611 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -65.37 -43.34 91.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.531 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -24.7 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.37 -43.96 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 76' ' ' LYS . 9.2 t30 -88.46 -16.44 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.636 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -44.32 -38.22 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.387 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.47 -27.06 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.577 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ASN . 15.6 mmtm -78.96 -26.15 43.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 81' ' ' ALA . 80.4 mt -77.9 -56.81 4.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.33 -33.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.16 -48.32 17.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.5 mt -75.8 -17.7 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -96.27 8.18 44.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.731 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.617 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 42.98 -179.47 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 110.626 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 84' ' ' ALA . 18.1 Cg_exo -62.49 15.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.658 2.239 . . . . 0.0 112.018 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -53.1 -152.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -122.31 98.7 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.382 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.04 146.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.47 177.9 4.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.188 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.95 129.28 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.775 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.459 ' C ' ' CD1' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -87.54 101.33 13.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 15.4 tt0 -54.36 121.24 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER 82.22 -50.26 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.568 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.92 -133.87 9.9 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -77.05 -30.83 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 50.1 t0 -48.22 -30.69 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.81 -54.79 4.76 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.443 ' CZ3' HG23 ' A' ' 35' ' ' ILE . 2.3 t90 -47.09 -32.19 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.914 0.387 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -73.87 -53.05 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.586 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 100' ' ' GLY . 3.3 ttt180 -66.2 -29.54 69.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.534 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.52 -12.26 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.742 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 98' ' ' ARG . . . 101.24 24.19 9.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.4 mt -116.46 138.09 24.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.25 161.66 40.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.349 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.96 172.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.211 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.78 121.15 22.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.691 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 32' ' ' ARG . 15.0 t -96.75 144.02 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.3 108.6 4.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.295 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 tttt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.55 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.814 0.34 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -122.4 158.41 29.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.581 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -87.9 144.25 26.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -136.7 164.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.458 . . . . 0.0 110.931 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 9' ' ' HIS . 17.2 t -104.07 138.99 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.796 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.23 -16.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.578 2.185 . . . . 0.0 111.854 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.645 ' N ' ' O ' ' A' ' 7' ' ' SER . 23.6 m170 -75.92 -35.98 59.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.947 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.2 t0 -76.22 -54.19 7.15 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.506 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.13 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -49.73 -46.77 50.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.27 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -59.01 -42.0 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.189 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 17' ' ' ARG . 6.9 mt -68.3 -43.85 76.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.6 mt -48.14 -23.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.855 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.61 25.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.483 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.0 ttm-85 -81.12 -40.5 23.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.87 -11.81 0.95 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -27.07 144.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.69 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' HZ2' ' CE1' ' A' ' 57' ' ' HIS . 4.8 mmtm -102.24 98.38 8.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.727 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 63' ' ' HIS . 0.5 OUTLIER -84.48 131.78 34.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.105 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.43 140.79 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.511 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.568 ' CG ' ' CE1' ' A' ' 30' ' ' TYR . 1.4 t70 -101.89 136.72 41.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 pp -136.98 84.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 0.0 110.736 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -160.81 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.93 111.23 23.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -41.86 -33.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.276 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.16 -34.67 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -83.84 -31.89 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.538 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.568 ' CE1' ' CG ' ' A' ' 23' ' ' ASP . 1.5 t80 -77.67 -25.37 49.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.412 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' ALA . 1.4 tp -70.32 -47.94 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.171 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.0 -10.2 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.237 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.5 tt0 -172.83 137.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CE1' ' OD1' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -160.63 161.28 32.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 110.796 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 37' ' ' GLU . 1.7 mt -106.27 105.33 53.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.33 19.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.576 2.184 . . . . 0.0 113.046 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.692 ' H ' ' C ' ' A' ' 35' ' ' ILE . 56.1 mm-40 -135.12 24.15 3.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.487 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.51 149.09 42.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.81 133.59 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD11 ' CD2' ' A' ' 30' ' ' TYR . 61.0 tp -92.79 118.0 30.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.291 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.44 93.36 4.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.6 Cg_exo -45.49 120.48 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.497 2.132 . . . . 0.0 111.954 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.558 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -41.23 -25.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.987 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.25 -26.73 32.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.51 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG1' ' N ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -78.34 -48.75 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.077 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.596 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 13.5 tp -54.91 -27.13 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -84.38 -49.47 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -67.0 -52.87 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.6 t -82.99 -77.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.07 91.47 1.28 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 17.0 tp -124.46 79.2 61.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.778 0.323 . . . . 0.0 110.579 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 54' ' ' LYS . 7.6 Cg_exo -69.33 78.12 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.987 2.458 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.52 -21.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 52' ' ' PRO . 14.5 tttm -57.35 -13.81 3.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.074 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.7 mt -77.55 -10.7 59.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.519 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.7 mtt180 -125.01 22.88 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.299 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -170.14 -169.04 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.167 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.7 -34.68 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.023 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -112.77 133.26 54.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.76 118.53 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 mt -110.5 141.74 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.15 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -123.85 143.3 50.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.051 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.726 ' H ' ' HD1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -143.22 135.94 27.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.346 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.671 ' SG ' ' OG1' ' A' ' 70' ' ' THR . 1.3 m -116.48 153.07 32.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.477 ' CG ' ' N ' ' A' ' 66' ' ' ALA . 6.9 pt20 -34.91 -39.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.477 ' N ' ' CG ' ' A' ' 65' ' ' GLN . . . -128.06 -4.96 5.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 85.32 -28.78 4.58 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -42.56 -26.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.459 ' HB3' ' SG ' ' A' ' 64' ' ' CYS . 2.7 tpm_? -83.59 -25.45 30.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.068 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.671 ' OG1' ' SG ' ' A' ' 64' ' ' CYS . 0.2 OUTLIER -65.88 -54.61 24.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.765 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -65.17 -23.66 67.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -86.4 -47.5 9.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.539 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.601 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 t30 -84.28 -16.29 43.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.361 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -41.34 -33.87 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.113 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.18 -31.32 67.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 73' ' ' ASN . 33.8 mmtt -81.79 -22.08 37.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.904 0.383 . . . . 0.0 110.532 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.9 mt -80.62 -57.19 3.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.654 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.99 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.48 -54.59 34.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -18.46 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.221 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.03 2.17 50.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.841 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 52.63 -179.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.735 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 22.9 Cg_exo -60.54 7.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.878 2.386 . . . . 0.0 112.448 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -46.48 169.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.279 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.9 102.67 4.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.217 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.78 133.13 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.4 ' CD1' HD12 ' A' ' 6' ' ' ILE . 46.7 m-85 -125.54 153.56 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.609 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 23.1 mt -122.39 137.03 55.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.195 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.507 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.6 tt -89.04 91.34 8.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.34 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' C ' ' H ' ' A' ' 92' ' ' GLY . 12.2 tt0 -40.66 147.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 68.35 -47.44 0.54 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 101.9 -145.76 16.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mm -51.0 -41.93 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.477 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.29 -35.26 59.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.02 -47.11 39.88 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.471 ' CD1' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.95 -37.04 81.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.45 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -80.76 -25.79 37.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.376 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -73.86 -44.75 54.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.45 63.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.76 45.34 0.24 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.471 HD12 ' CD1' ' A' ' 96' ' ' TRP . 9.6 mt -123.5 106.27 32.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -45.62 152.09 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.455 2.103 . . . . 0.0 112.174 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.37 169.06 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.436 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.65 144.12 51.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.454 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.96 130.57 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.663 ' OD1' ' CE1' ' A' ' 34' ' ' HIS . 1.7 m-20 -67.59 109.69 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 106' ' ' ASN . 17.6 tttt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.852 0.358 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 m -132.72 151.97 51.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.49 33.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.548 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -144.8 163.28 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.728 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.599 ' O ' ' N ' ' A' ' 9' ' ' HIS . 4.9 m -108.62 142.98 26.59 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.46 -17.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.477 2.118 . . . . 0.0 111.722 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.599 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -73.06 -35.81 66.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.754 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 -56.11 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.209 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.61 -23.44 0.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -70.99 -44.41 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -68.07 -26.06 65.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.776 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' ARG . 14.7 mt -79.74 -45.13 19.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.5 mt -47.76 -23.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.447 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -27.46 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.118 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 14' ' ' LEU . 9.9 mtt180 -84.43 -41.54 16.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.416 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.74 28.08 0.41 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.82 149.09 32.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.4 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.61 102.51 13.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.673 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 5.2 mp -92.56 129.22 38.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.445 HD13 ' CE1' ' A' ' 62' ' ' PHE . 7.3 mt -127.44 142.43 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.032 0.444 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -103.75 153.43 20.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.555 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.447 ' O ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 pp -147.73 90.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.334 0.588 . . . . 0.0 110.789 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.441 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 24.4 ttt-85 -173.91 -141.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.9 119.69 30.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.271 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.71 97.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.534 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.66 -26.28 3.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.006 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.56 -44.95 11.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.301 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.8 t80 -70.37 -31.03 68.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.195 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.56 -58.21 8.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.463 ' HB3' HH11 ' A' ' 32' ' ' ARG . 0.5 OUTLIER -52.63 -28.66 22.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.27 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.9 tt0 -152.51 123.58 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.607 ' CD2' ' ND2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -150.55 175.55 11.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.011 0.434 . . . . 0.0 111.034 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.707 ' C ' ' H ' ' A' ' 37' ' ' GLU . 43.8 mt -109.2 106.07 58.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.253 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -54.44 19.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.573 2.182 . . . . 0.0 112.981 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.707 ' H ' ' C ' ' A' ' 35' ' ' ILE . 41.4 mm-40 -137.82 38.51 2.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.342 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.2 150.33 25.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.53 126.41 35.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.1 tp -85.19 117.14 23.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.177 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.36 93.75 6.34 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.569 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.3 Cg_exo -45.99 122.5 5.3 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.498 2.132 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.602 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -39.79 -29.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -75.49 -30.7 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -68.4 -38.77 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.112 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 50' ' ' GLY . 2.4 tt -73.41 -41.81 62.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -64.99 -31.03 72.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.195 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -96.14 -32.73 12.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.145 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 10.0 t -92.07 -44.44 8.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 110.809 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 68.37 64.26 3.18 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -98.68 110.55 57.54 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' LYS . 58.6 Cg_endo -77.44 63.09 7.83 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.376 2.05 . . . . 0.0 112.353 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.62 -21.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.961 0.41 . . . . 0.0 110.046 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HZ1' ' HB2' ' A' ' 84' ' ' ALA . 30.9 tttp -54.34 -21.43 9.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.454 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.59 -6.31 53.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.72 14.86 30.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.412 . . . . 0.0 110.472 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.412 ' CG ' ' H ' ' A' ' 58' ' ' GLU . 5.6 t60 177.97 -164.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.736 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.412 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 58.8 tt0 -121.92 -26.46 4.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.089 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -113.82 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.601 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -134.56 142.16 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.795 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.27 144.85 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.431 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.445 ' CE1' HD13 ' A' ' 22' ' ' ILE . 47.7 m-85 -123.96 141.19 52.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.861 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -149.15 133.84 17.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.657 ' SG ' ' OG1' ' A' ' 70' ' ' THR . 3.5 m -117.54 153.73 32.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.536 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.5 OUTLIER -28.23 -41.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.593 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -126.27 -60.45 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.537 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 154.7 -37.16 0.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 24.6 tttt -45.14 -29.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HB3' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -75.22 -36.49 61.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.657 ' OG1' ' SG ' ' A' ' 64' ' ' CYS . 0.3 OUTLIER -65.66 -42.98 90.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.423 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -66.31 -21.17 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.633 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 68' ' ' LYS . 3.0 m120 -82.75 -41.74 18.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 76' ' ' LYS . 2.0 t-20 -98.72 -13.81 20.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.635 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -47.16 -29.97 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.53 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -80.81 -31.37 35.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.528 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 73' ' ' ASN . 36.7 mmtm -76.76 -41.29 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.655 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 HD23 ' CZ ' ' A' ' 62' ' ' PHE . 10.1 mt -67.81 -57.8 5.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.17 -29.8 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.454 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.5 -56.38 20.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.38 -20.51 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.55 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -77.27 -2.76 36.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.655 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 44.95 -179.27 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 110.472 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 22.7 Cg_exo -60.23 26.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.764 2.309 . . . . 0.0 112.09 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.655 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -69.11 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.506 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -110.31 99.09 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.464 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.83 133.24 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.411 ' CD1' HD13 ' A' ' 6' ' ' ILE . 57.1 m-85 -111.87 163.38 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.851 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.454 HD11 ' N ' ' A' ' 89' ' ' LEU . 10.1 tp -131.92 132.32 43.46 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.876 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.454 ' N ' HD11 ' A' ' 88' ' ' LEU . 7.2 tt -99.24 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' O ' ' OD2' ' A' ' 91' ' ' ASP . 2.7 tm-20 -63.28 158.55 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.424 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.591 ' OD2' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER 69.34 -40.21 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.664 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 90' ' ' GLU . . . 94.2 -160.86 24.08 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.86 -26.6 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.265 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -23.05 6.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.346 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . -86.56 -52.49 3.16 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.01 -28.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HZ3' HG12 ' A' ' 103' ' ' VAL . 3.5 ttmm -76.53 -51.45 11.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 99' ' ' ALA . 5.9 mmt180 -61.27 -44.37 97.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 98' ' ' ARG . . . -39.26 -33.89 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.448 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.11 1.53 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mt -123.53 137.19 28.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.421 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -72.85 174.01 12.56 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.444 2.096 . . . . 0.0 112.379 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.463 HG12 ' HZ3' ' A' ' 97' ' ' LYS . 35.1 m -112.09 172.12 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' O ' ' ND1' ' A' ' 34' ' ' HIS . . . -141.08 135.21 30.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.62 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.5 t -97.13 158.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.607 ' ND2' ' CD2' ' A' ' 34' ' ' HIS . 2.3 m-20 -84.8 109.04 17.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 tptp . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.444 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.775 0.322 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 147.87 45.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.603 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -78.75 151.32 32.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -137.51 166.4 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.442 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.4 OUTLIER -109.21 140.31 21.87 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.514 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.06 -18.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.278 1.985 . . . . 0.0 111.585 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.9 m170 -73.87 -30.63 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.37 -52.73 7.33 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.782 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.01 -32.08 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.708 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -68.89 -44.11 73.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.631 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -66.36 -42.18 88.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 17' ' ' ARG . 22.5 mt -63.73 -42.76 97.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.0 mt -48.22 -24.37 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.65 -28.2 45.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.86 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 14' ' ' LEU . 3.4 mtp180 -84.33 -30.5 25.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.098 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.8 23.9 2.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.35 153.94 5.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.364 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -104.83 97.7 7.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.548 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 131.98 40.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.864 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 mt -135.79 141.08 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.601 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 25' ' ' ARG . 11.1 t0 -110.8 145.12 38.71 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -112.89 -73.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.891 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 24' ' ' ILE . 8.5 ptm180 20.57 -143.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.156 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -116.15 109.64 17.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.046 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.0 -42.1 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -43.08 -38.43 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.44 -22.84 26.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.382 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.555 ' O ' ' O ' ' A' ' 33' ' ' GLU . 4.5 t80 -82.32 -29.16 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -43.77 93.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.449 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.4 mtp85 -74.59 -13.84 60.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.065 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.615 ' CD ' ' HZ2' ' A' ' 97' ' ' LYS . 5.9 tt0 -157.48 122.01 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.279 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.591 ' ND1' ' O ' ' A' ' 104' ' ' ALA . 39.0 p-80 -145.21 147.57 32.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 37' ' ' GLU . 10.4 mt -90.95 130.96 38.62 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.365 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.7 24.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.511 2.141 . . . . 0.0 112.444 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 35' ' ' ILE . 44.3 mm-40 -146.18 35.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.778 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -162.89 147.33 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -84.57 161.22 20.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.454 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.458 HD13 ' CD2' ' A' ' 30' ' ' TYR . 56.5 tp -115.33 122.01 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.68 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.474 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -160.25 95.57 1.53 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.065 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -46.85 147.46 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.578 2.185 . . . . 0.0 112.034 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.477 ' N ' HG21 ' A' ' 24' ' ' ILE . 1.1 pp -71.72 -24.13 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.249 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 46.8 p -76.81 -35.53 57.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.966 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.8 -30.36 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.34 -40.42 89.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.53 -50.13 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -69.47 -34.16 73.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 t -72.8 -78.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.16 75.91 1.0 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 53' ' ' ALA . 32.5 tp -117.7 89.1 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 110.701 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.1 73.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.802 2.335 . . . . 0.0 112.136 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -57.35 -28.13 62.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.389 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -51.94 -24.7 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.387 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.88 -13.6 59.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.565 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 54.9 mtp180 -91.77 16.82 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 169.51 -163.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.902 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.26 -31.15 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.916 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -112.46 132.92 54.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.425 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.655 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -142.27 148.16 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -136.86 144.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.435 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.469 ' CG ' HD13 ' A' ' 77' ' ' LEU . 49.5 m-85 -124.64 151.04 45.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' A' ' 23' ' ' ASP . 48.3 p-80 -159.98 144.36 14.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 111.656 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.643 ' N ' ' HG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -116.74 154.1 31.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.171 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.583 ' C ' ' O ' ' A' ' 64' ' ' CYS . 5.0 tm0? -21.66 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.783 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -109.22 -22.4 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.457 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 113.29 -33.58 5.48 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HG3' ' H ' ' A' ' 69' ' ' ARG . 2.6 pttp -35.49 -64.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.708 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.48 ' H ' ' HG3' ' A' ' 68' ' ' LYS . 19.6 mtt85 -52.12 -38.62 57.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.682 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.643 ' HG1' ' N ' ' A' ' 64' ' ' CYS . 2.1 m -58.74 -47.83 83.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.685 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -70.4 -18.86 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.786 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.04 -47.77 10.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -84.55 -14.18 49.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.718 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.89 -26.75 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.517 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -37.25 76.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.62 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -74.89 -26.91 59.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 79' ' ' ALA . 75.2 mt -74.86 -56.89 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.31 -22.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.671 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -76.83 -53.06 8.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -75.99 -17.75 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.533 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -87.14 -2.95 59.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.643 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 45.71 179.53 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 25.0 Cg_exo -58.25 9.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.596 2.197 . . . . 0.0 111.93 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -55.26 -167.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.332 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 3.8 mm-40 -105.42 106.21 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.34 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.462 ' CD1' HD11 ' A' ' 6' ' ' ILE . 13.3 m-85 -116.32 169.48 9.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 6' ' ' ILE . 7.9 tp -137.85 128.73 27.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 tt -88.17 108.78 19.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.627 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 92' ' ' GLY . 8.1 tt0 -66.16 147.85 52.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 66' ' ' ALA . 19.7 t0 77.7 -35.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.748 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 90' ' ' GLU . . . 92.84 -164.57 27.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.3 -21.41 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.482 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -61.8 -25.65 67.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.33 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.74 -35.3 25.55 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -30.8 70.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.934 0.397 . . . . 0.0 110.134 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.615 ' HZ2' ' CD ' ' A' ' 33' ' ' GLU . 15.4 mtpt -72.12 -38.13 69.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.355 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -75.57 -33.67 60.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.293 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.54 -15.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.548 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.92 32.31 7.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.6 mt -120.0 104.11 44.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.87 160.17 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.571 2.18 . . . . 0.0 112.4 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.76 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.591 ' O ' ' ND1' ' A' ' 34' ' ' HIS . . . -125.41 126.24 44.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.306 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.3 t -96.01 133.74 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.472 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 107' ' ' LYS . 63.3 t-20 -87.17 109.6 19.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 106' ' ' ASN . 75.5 tttt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.567 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 5' ' ' THR . 54.6 m -105.87 147.05 29.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.764 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.462 ' N ' HG22 ' A' ' 4' ' ' THR . 0.6 OUTLIER -77.77 150.63 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -140.28 163.3 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.421 0.629 . . . . 0.0 111.547 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.469 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -109.12 145.33 31.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.318 178.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -39.64 -26.25 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.374 2.05 . . . . 0.0 111.897 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' SER . 78.3 m80 -65.99 -33.37 75.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.413 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.8 t0 -77.85 -55.66 5.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.141 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.88 5.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.284 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -38.88 87.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -74.52 -44.9 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.536 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 17' ' ' ARG . 3.3 mt -65.28 -47.36 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt -47.69 -25.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.795 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.11 -24.69 26.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.215 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -81.35 -41.2 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.703 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 151.43 -15.85 0.85 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -28.41 137.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.425 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.21 98.28 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mt -81.39 136.27 35.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.796 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mt -128.9 139.58 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.109 0.481 . . . . 0.0 111.3 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' OD2' ' CD1' ' A' ' 30' ' ' TYR . 14.9 t70 -103.57 132.36 49.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.61 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -133.65 82.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 110.83 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 3.5 ptt180 -156.63 -150.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.358 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -92.15 116.87 29.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.584 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -47.67 -31.73 4.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.083 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 2.5 m-20 -52.71 -44.41 66.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -74.71 -32.6 62.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . 4.5 t80 -72.19 -25.79 61.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.961 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -67.85 -55.66 12.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp85 -52.17 -18.69 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.18 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 30' ' ' TYR . 2.3 mt-10 -172.03 139.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.475 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.672 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 15.6 p80 -153.64 150.81 29.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.483 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 122.59 52.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.548 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.45 51.27 3.67 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -158.74 18.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.688 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.21 151.48 38.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -85.05 124.05 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.424 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.1 tp -83.31 117.81 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.643 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.5 90.68 4.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.344 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 81.4 Cg_exo -45.79 124.29 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.827 2.351 . . . . 0.0 112.617 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -34.0 -62.58 0.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.441 0.638 . . . . 0.0 110.444 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -43.13 -29.8 0.4 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.307 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -76.73 -42.59 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.774 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.47 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 7.3 tp -78.06 -20.16 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.797 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -39.08 30.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.755 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -90.59 -38.68 12.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.801 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 11.7 t -73.14 -77.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.77 75.97 1.09 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.6 89.36 52.35 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.473 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 54' ' ' LYS . 25.0 Cg_exo -58.67 83.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.844 2.363 . . . . 0.0 112.294 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.64 -20.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.001 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.608 ' HZ1' ' N ' ' A' ' 82' ' ' ALA . 9.4 tttt -60.57 -14.73 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.029 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.1 mt -77.09 -13.34 59.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.615 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -113.76 23.04 13.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.83 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.077 0.465 . . . . 0.0 110.985 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -119.65 -34.09 3.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.156 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -112.13 133.32 54.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.936 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -133.42 120.5 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.435 HG22 HD13 ' A' ' 61' ' ' ILE . 6.4 mt -115.43 149.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.459 ' CE2' HD23 ' A' ' 77' ' ' LEU . 23.1 m-85 -130.07 151.35 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.559 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' A' ' 63' ' ' HIS . 3.4 p-80 -154.59 134.03 12.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.768 ' SG ' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -116.46 155.15 29.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.561 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -22.86 -59.96 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.138 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.31 20.69 14.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.98 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.768 ' N ' ' SG ' ' A' ' 64' ' ' CYS . . . 63.47 6.28 14.94 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.764 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -70.4 -57.46 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.424 ' NH1' ' HA ' ' A' ' 25' ' ' ARG . 3.1 ttm180 -61.24 -23.21 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.556 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -64.15 -59.8 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -57.08 -18.88 16.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.752 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -80.03 -44.23 20.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.493 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -84.93 -17.01 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.411 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.64 -26.75 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.427 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -85.2 -37.74 19.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.689 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.72 -28.22 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.61 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 HD23 ' CE2' ' A' ' 62' ' ' PHE . 95.0 mt -68.47 -53.86 20.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.664 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.04 -56.68 4.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.321 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.6 55.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.968 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -78.01 -18.18 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.146 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -122.99 101.09 7.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.017 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 84' ' ' ALA . . . -39.43 170.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -50.36 65.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.751 2.3 . . . . 0.0 112.433 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.73 -167.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.78 98.44 11.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.24 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.67 135.84 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.54 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.439 ' CD1' HD11 ' A' ' 6' ' ' ILE . 69.2 m-85 -124.52 168.73 12.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -137.47 133.32 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -89.09 100.69 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.587 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 79.1 tt0 -60.84 149.59 35.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.423 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 12.2 t0 77.79 -46.07 0.45 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.618 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.37 -167.97 16.13 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 tt -50.92 -20.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 110.31 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.32 -31.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.268 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.94 -49.67 8.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.672 ' NE1' ' O ' ' A' ' 101' ' ' LEU . 2.4 t-105 -51.97 -38.86 58.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.189 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -70.27 -38.1 75.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.309 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -77.58 -26.22 50.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.63 4.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.53 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.07 18.01 33.0 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.672 ' O ' ' NE1' ' A' ' 96' ' ' TRP . 50.9 mt -118.4 96.52 49.93 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 0.0 110.53 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.37 177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.649 2.233 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.412 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -121.41 172.11 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.541 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -115.68 128.73 56.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.416 ' C ' ' NE2' ' A' ' 34' ' ' HIS . 6.0 t -96.45 133.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.421 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.672 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 1.4 t30 -67.5 108.81 2.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 106' ' ' ASN . 24.2 tptt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.578 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.833 0.349 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.444 ' CG2' ' N ' ' A' ' 5' ' ' THR . 24.2 m -128.93 158.47 38.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.444 ' N ' ' CG2' ' A' ' 4' ' ' THR . 0.8 OUTLIER -88.05 148.65 24.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.177 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.466 HD11 ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -137.26 166.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.191 0.519 . . . . 0.0 110.953 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -106.83 142.13 24.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.889 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.74 -19.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.498 2.132 . . . . 0.0 112.058 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 7' ' ' SER . 7.8 m-70 -76.12 -28.03 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.426 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -84.19 -52.45 6.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.97 -32.94 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -68.31 -51.12 48.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.66 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -56.23 -27.91 56.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 17' ' ' ARG . 25.9 mt -76.18 -42.33 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.2 mt -47.91 -22.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -85.6 -24.23 27.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.151 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -79.39 -51.25 9.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.419 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.608 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 136.81 32.47 0.24 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.0 -177.46 3.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -125.36 111.04 14.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.474 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.11 125.27 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.461 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.557 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 18.6 mt -136.31 138.31 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 111.397 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.657 ' OD1' ' NE ' ' A' ' 25' ' ' ARG . 10.9 t0 -108.83 146.31 33.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.608 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.617 ' O ' ' O ' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -114.78 -73.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.911 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.657 ' NE ' ' OD1' ' A' ' 23' ' ' ASP . 8.4 ptp180 16.42 -139.61 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.555 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -117.01 113.74 22.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' ASP . . . -38.32 -23.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 26' ' ' ASP . 45.1 m-20 -58.82 -33.11 70.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 15.3 mm-40 -86.37 -30.18 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.821 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -75.22 -39.11 60.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.256 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.44 -53.19 60.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.238 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.441 ' CG ' ' O ' ' A' ' 29' ' ' GLU . 7.6 ptp180 -56.83 -26.68 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 30' ' ' TYR . 15.9 tt0 -164.87 129.76 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.128 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 20.4 p80 -143.88 169.81 17.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 37' ' ' GLU . 2.7 mt -109.1 126.65 28.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.185 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.49 24.87 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.287 1.991 . . . . 0.0 111.963 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 35' ' ' ILE . 80.5 mm-40 -138.73 25.94 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.766 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.95 146.75 23.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.672 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -86.61 153.79 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.448 HD12 ' CD2' ' A' ' 30' ' ' TYR . 45.2 tp -108.39 124.43 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -162.71 96.53 1.13 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.614 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.455 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 39.7 Cg_exo -50.56 146.66 19.18 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.497 2.131 . . . . 0.0 112.082 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.481 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.2 pp -65.93 -23.62 66.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.782 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.446 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -74.93 -29.24 60.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.511 ' O ' ' OG ' ' A' ' 49' ' ' SER . 23.6 m -84.92 -25.27 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.72 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.45 ' N ' HG23 ' A' ' 45' ' ' VAL . 3.0 tp -84.93 -46.61 11.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.571 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.61 -31.41 72.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.704 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -85.12 -30.17 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 6.7 m -94.95 -71.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 94.83 87.1 1.7 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -112.31 82.53 4.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.794 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' LEU . 74.8 Cg_exo -45.2 -7.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.796 2.331 . . . . 0.0 112.555 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 51' ' ' LEU . . . -43.43 -29.53 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.736 ' HZ1' ' CA ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -57.11 -5.75 0.3 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 109.834 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.658 ' C ' ' H ' ' A' ' 57' ' ' HIS . 9.7 mp -94.41 -9.97 33.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.479 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.64 8.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.251 0.548 . . . . 0.0 110.271 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.658 ' H ' ' C ' ' A' ' 55' ' ' LEU . 2.0 t60 -134.88 -145.38 0.23 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.231 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 24.7 tt0 -144.4 -43.89 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.032 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.68 133.1 54.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.4 mp -139.19 147.75 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.139 0.495 . . . . 0.0 111.389 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.4 139.59 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.908 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -121.95 137.1 54.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.668 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.2 OUTLIER -129.8 134.07 47.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.104 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.553 ' O ' ' C ' ' A' ' 65' ' ' GLN . 67.3 m -116.37 153.47 31.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.336 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 32.7 tt0 -26.74 -70.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.85 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 91' ' ' ASP . . . -100.95 -51.31 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.602 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.09 -17.39 1.93 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -59.15 -36.78 75.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.562 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -65.71 -46.77 77.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.236 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -49.15 -50.99 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.518 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -24.13 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.522 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 29.9 m120 -86.18 -46.54 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.17 -16.2 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -46.16 -30.9 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.594 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.9 -38.05 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -73.93 -26.92 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.76 -57.83 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.86 -24.0 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.35 -40.86 64.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.653 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 80' ' ' ILE . 50.5 mt -85.71 -47.12 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.736 ' CA ' ' HZ1' ' A' ' 54' ' ' LYS . . . -45.78 -27.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.608 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 84' ' ' ALA . . . 67.91 173.79 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 34.3 Cg_exo -53.57 65.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.699 2.266 . . . . 0.0 112.006 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.17 -172.29 2.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.536 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -102.03 117.42 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 86' ' ' ILE . 2.6 mp -128.47 142.2 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.466 ' CD1' HD11 ' A' ' 6' ' ' ILE . 81.6 m-85 -121.58 169.03 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.028 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' ILE . 18.8 mt -135.6 138.35 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 tt -89.92 107.95 19.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.57 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.6 tp10 -64.13 155.65 30.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.6 OUTLIER 69.52 -34.77 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 90' ' ' GLU . . . 91.4 -160.92 27.17 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.403 ' HB ' HH12 ' A' ' 25' ' ' ARG . 1.0 OUTLIER -50.3 -27.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.344 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.13 -52.39 64.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.151 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.0 -24.34 62.75 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.485 ' C ' ' CD1' ' A' ' 96' ' ' TRP . 9.6 t-105 -82.5 -35.2 27.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -77.26 -30.62 54.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.483 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -78.45 -35.07 47.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.485 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.93 4.45 3.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.48 65.94 3.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 96' ' ' TRP . 59.7 mt -119.96 149.66 49.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.122 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -35.49 146.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 123.006 2.471 . . . . 0.0 112.468 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.8 p -151.51 154.85 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -146.96 139.04 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.595 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 t -98.47 137.31 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.378 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.51 111.35 21.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.619 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.478 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.872 0.368 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.459 HG23 ' N ' ' A' ' 5' ' ' THR . 10.8 m -116.36 156.19 27.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.013 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.459 ' N ' HG23 ' A' ' 4' ' ' THR . 25.1 p -85.41 149.48 25.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.229 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.507 ' N ' ' O ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -139.09 164.2 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.061 0.458 . . . . 0.0 110.816 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -103.32 139.79 20.44 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.24 -16.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.559 2.173 . . . . 0.0 111.898 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' SER . 35.2 t60 -78.47 -35.27 46.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.944 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -75.66 -49.62 17.85 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.089 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -43.29 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.338 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.98 -50.32 58.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.27 -30.8 60.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 17' ' ' ARG . 9.1 mt -75.3 -43.87 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.497 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.4 mt -48.27 -22.72 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.412 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -81.01 -26.67 36.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 7.4 mtt180 -85.46 -38.06 19.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.462 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.54 30.62 0.96 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.42 175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 110.519 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.442 ' NZ ' ' HB2' ' A' ' 57' ' ' HIS . 4.6 mttp -118.61 98.05 6.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.487 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -89.39 126.67 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.991 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.654 ' C ' ' CE1' ' A' ' 63' ' ' HIS . 6.9 mt -131.62 140.79 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.984 0.421 . . . . 0.0 111.421 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 24' ' ' ILE . 64.2 t0 -99.7 149.07 23.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.598 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -150.56 91.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.762 0.792 . . . . 0.0 110.582 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 23' ' ' ASP . 7.3 ptt-85 -169.04 -143.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.091 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -96.92 107.35 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.234 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -40.74 -26.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.457 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' ASP . 41.4 t0 -57.52 -38.07 74.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.09 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' OE1' ' OE1' ' A' ' 65' ' ' GLN . 10.9 mt-10 -80.68 -32.04 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.335 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 33' ' ' GLU . 12.3 t80 -78.92 -32.0 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 7.4 tp -60.27 -55.47 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.298 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -55.0 -20.14 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.302 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 30' ' ' TYR . 22.4 tt0 -163.29 120.7 1.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.696 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 15.0 p80 -138.24 160.85 38.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.591 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 37' ' ' GLU . 17.6 mt -98.7 128.13 33.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.53 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.68 21.32 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.49 2.126 . . . . 0.0 111.91 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 35' ' ' ILE . 24.2 mt-10 -141.96 26.49 1.87 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.522 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.34 33.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.793 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -87.64 145.68 26.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' CD2' ' A' ' 30' ' ' TYR . 62.7 tp -101.99 116.91 33.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.478 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.91 93.81 6.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 52.6 Cg_exo -47.47 118.01 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.505 2.137 . . . . 0.0 111.875 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.614 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -38.26 -34.68 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.12 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.467 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 1.8 t -71.53 -29.77 65.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.357 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -73.28 -43.3 57.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.206 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.523 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 17.6 tp -75.82 -21.65 57.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.207 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.48 -39.72 31.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -92.79 -40.99 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 8.3 t -65.71 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.44 79.95 1.49 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.672 ' C ' ' H ' ' A' ' 53' ' ' ALA . 16.0 tp -118.28 91.43 40.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.785 0.326 . . . . 0.0 110.657 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 54' ' ' LYS . 27.4 Cg_exo -58.76 21.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.739 2.293 . . . . 0.0 112.168 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.672 ' H ' ' C ' ' A' ' 51' ' ' LEU . . . -47.19 -21.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' N ' ' C ' ' A' ' 52' ' ' PRO . 1.4 ttpm? -63.68 -27.17 69.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.414 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.86 -9.12 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.39 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -80.66 10.91 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 110.156 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.442 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 2.0 t60 -148.87 -146.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.421 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -150.15 -36.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.346 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.68 133.13 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.619 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.86 153.34 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.321 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.5 mt -141.9 125.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.137 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.403 ' CE2' ' CD1' ' A' ' 77' ' ' LEU . 80.1 m-85 -107.7 149.23 28.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.956 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.654 ' CE1' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -138.68 133.43 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.794 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.593 ' SG ' ' CB ' ' A' ' 69' ' ' ARG . 1.4 t -116.73 153.77 31.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.519 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 6.7 pt20 -36.03 -33.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.872 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -140.09 -37.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.915 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.71 -4.66 3.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -45.71 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.667 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.593 ' CB ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -59.26 -33.99 71.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.628 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.621 ' O ' ' N ' ' A' ' 74' ' ' ALA . 52.4 m -73.13 -46.22 52.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.722 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 p -62.94 -26.96 69.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.19 -27.72 24.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -102.57 -12.89 17.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.568 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -55.44 -35.26 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.657 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.3 -34.81 78.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.552 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -73.19 -34.21 65.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.544 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 80' ' ' ILE . 28.0 mt -75.66 -56.06 5.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.409 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.04 -30.82 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.14 81.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.346 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 77' ' ' LEU . 89.3 mt -81.46 -30.52 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.563 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -55.69 -43.98 76.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 84' ' ' ALA . . . 75.62 177.02 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.028 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 32.7 Cg_exo -54.55 65.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.089 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.89 -151.44 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.513 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.83 121.06 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.399 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 86' ' ' ILE . 1.6 mp -125.56 126.88 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.87 161.3 18.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.445 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 6' ' ' ILE . 9.1 mt -130.33 140.44 50.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.558 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -85.84 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.098 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 92' ' ' GLY . 1.5 tt0 -59.56 146.03 42.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.915 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.402 ' N ' ' HG2' ' A' ' 90' ' ' GLU . 33.1 t0 69.19 -12.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.717 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 68.83 -158.31 52.98 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -30.58 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 110.576 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -31.1 67.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.388 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 99' ' ' ALA . . . -72.39 -59.38 4.56 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.54 ' C ' ' CD1' ' A' ' 96' ' ' TRP . 4.5 t-105 -48.38 -40.43 25.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.047 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.98 -47.08 87.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.461 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.45 ' C ' ' H ' ' A' ' 100' ' ' GLY . 26.8 ttm180 -83.31 -17.82 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -60.22 -5.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.574 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 98' ' ' ARG . . . 88.39 33.96 9.93 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.468 HD13 ' CZ3' ' A' ' 96' ' ' TRP . 23.0 mt -125.79 144.01 47.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 148.37 42.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.586 2.191 . . . . 0.0 112.466 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.32 171.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.696 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -127.47 125.12 39.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.7 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.46 137.72 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.127 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -71.4 108.54 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.202 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.622 -179.841 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 5' ' ' THR . 89.0 m -90.03 156.26 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.889 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.452 ' N ' HG23 ' A' ' 4' ' ' THR . 1.1 p -85.87 150.6 24.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.164 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -143.59 164.05 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.277 0.56 . . . . 0.0 111.052 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.468 ' N ' HG22 ' A' ' 6' ' ' ILE . 32.1 m -112.45 149.47 41.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.832 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -41.18 -22.59 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.501 2.134 . . . . 0.0 111.856 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.466 ' N ' ' O ' ' A' ' 7' ' ' SER . 3.4 t-80 -67.21 -38.68 85.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.159 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.79 -54.79 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.434 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.58 -39.51 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -61.38 -44.61 96.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.81 -36.84 84.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 17' ' ' ARG . 29.5 mt -72.79 -42.99 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.705 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.0 mt -50.54 -22.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.15 -20.32 38.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.123 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 14' ' ' LEU . 4.7 mtt180 -93.94 -51.28 4.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.46 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 149.15 33.85 0.05 OUTLIER Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 179.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.227 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 98.15 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.898 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.59 133.71 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.972 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.473 HD13 ' CE1' ' A' ' 62' ' ' PHE . 12.1 mt -132.34 142.58 42.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.96 142.13 35.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.432 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.602 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -147.21 88.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.799 0.809 . . . . 0.0 110.769 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.51 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 2.6 ptp180 -165.42 -144.45 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.619 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 38.1 t0 -97.17 107.39 19.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -37.81 -42.27 0.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.66 -38.61 2.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 109.979 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' ASP . 5.4 mm-40 -80.09 -35.09 37.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.067 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 34' ' ' HIS . 4.4 t80 -71.48 -26.98 62.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tp -62.74 -50.42 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -56.76 -27.12 58.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.372 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 30' ' ' TYR . 31.8 tt0 -159.6 128.85 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.644 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 13.2 p80 -145.61 155.35 42.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 110.767 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 37' ' ' GLU . 8.7 mm -91.9 121.56 66.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.5 23.79 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.278 1.986 . . . . 0.0 112.091 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 35' ' ' ILE . 26.0 mt-10 -146.71 30.6 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.545 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.86 157.89 43.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.556 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.37 153.08 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.602 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.7 tp -113.46 110.57 20.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.263 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.64 95.35 6.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.649 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 45' ' ' VAL . 71.2 Cg_exo -44.83 120.32 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.565 2.177 . . . . 0.0 112.079 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.536 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -43.12 -25.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.422 ' H ' ' HG ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -79.94 -30.63 39.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.393 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -81.79 -31.38 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.972 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.47 -20.18 57.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.819 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.65 -40.15 19.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.534 ' CG ' ' N ' ' A' ' 49' ' ' SER . 4.6 pt20 -87.86 -45.2 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.012 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.534 ' N ' ' CG ' ' A' ' 48' ' ' GLN . 5.6 t -66.55 -59.01 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.59 82.19 1.39 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 53' ' ' ALA . 13.4 tp -116.08 89.52 25.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.651 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.01 64.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.774 2.316 . . . . 0.0 112.045 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -50.13 -20.0 0.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.492 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.406 ' NZ ' ' HB1' ' A' ' 82' ' ' ALA . 19.7 tttm -57.6 -26.41 61.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.612 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -80.83 -13.98 58.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -90.15 13.25 15.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.033 0.444 . . . . 0.0 109.937 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.763 ' CG ' ' H ' ' A' ' 58' ' ' GLU . 13.7 t-80 179.3 -150.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.763 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 54.7 tt0 -137.38 -41.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.946 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.679 ' H ' ' HD1' ' A' ' 57' ' ' HIS . 5.3 mt-30 -111.95 132.98 54.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.53 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -132.41 150.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.001 0.429 . . . . 0.0 111.215 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.2 mt -133.58 129.69 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.967 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' CE1' HD13 ' A' ' 22' ' ' ILE . 97.9 m-85 -112.04 145.87 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.529 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -152.26 135.47 15.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.708 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.53 ' SG ' ' OG1' ' A' ' 70' ' ' THR . 1.8 m -115.19 153.09 31.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.51 ' H ' ' NE ' ' A' ' 25' ' ' ARG . 38.1 tp60 -29.69 -47.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.662 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.87 -11.33 8.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.469 ' HA2' ' HG1' ' A' ' 70' ' ' THR . . . 91.57 2.66 69.81 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -64.56 -30.16 71.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.357 . . . . 0.0 110.523 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 73' ' ' ASN . 9.7 mpt_? -81.38 -24.72 36.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.534 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.53 ' OG1' ' SG ' ' A' ' 64' ' ' CYS . 0.4 OUTLIER -59.82 -55.4 34.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -27.59 67.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' OD2' ' A' ' 75' ' ' ASP . 6.5 m120 -86.69 -37.83 17.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.739 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 69' ' ' ARG . 3.7 t30 -84.9 -17.08 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -48.31 -26.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.169 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -80.78 -51.8 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -65.35 -26.22 67.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.502 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.465 HD22 ' CE1' ' A' ' 62' ' ' PHE . 48.1 mt -65.56 -61.16 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.71 -53.31 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.3 68.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.29 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mm -71.39 -17.85 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.182 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -121.62 100.03 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.7 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 84' ' ' ALA . . . -44.02 178.93 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.448 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 29.2 Cg_exo -57.36 64.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.7 2.267 . . . . 0.0 112.34 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.8 -149.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.253 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.576 ' OE1' ' O ' ' A' ' 84' ' ' ALA . 3.1 mm-40 -115.58 103.01 10.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.07 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -115.1 139.1 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 6' ' ' ILE . 54.4 m-85 -120.97 166.92 13.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.184 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 6' ' ' ILE . 17.1 mt -135.58 142.19 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 110.753 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.623 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -97.91 109.71 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.319 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.59 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.7 tm-20 -60.12 143.51 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.755 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.22 -27.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.623 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 87.09 -155.6 27.61 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.8 tt -50.66 -32.45 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.66 -37.34 8.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -57.24 7.26 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.626 ' C ' ' CD1' ' A' ' 96' ' ' TRP . 1.7 t-105 -45.45 -39.28 6.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 110.437 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -56.18 -62.35 1.77 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' A' ' 100' ' ' GLY . 14.3 ptp180 -70.54 -29.6 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.3 -15.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.491 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 98' ' ' ARG . . . 93.51 38.12 5.38 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.472 ' HB2' ' CE2' ' A' ' 96' ' ' TRP . 24.9 mt -125.13 141.05 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.539 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.53 145.98 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.525 2.15 . . . . 0.0 112.073 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 m -112.3 172.08 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.548 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.644 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -132.52 128.93 38.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.8 t -96.77 136.1 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.436 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.543 ' N ' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -82.79 110.68 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.535 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 tttm . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.426 179.93 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.858 0.361 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 88' ' ' LEU . 71.5 m -118.87 151.98 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.544 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.405 ' N ' HG22 ' A' ' 4' ' ' THR . 0.2 OUTLIER -78.31 149.18 33.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.662 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -136.3 161.55 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 110.437 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 9' ' ' HIS . 96.0 p -98.17 135.85 21.19 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.533 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -40.85 -16.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.151 1.901 . . . . 0.0 111.565 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.598 ' N ' ' O ' ' A' ' 7' ' ' SER . 2.1 t60 -79.6 -30.79 41.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.896 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.8 OUTLIER -76.81 -52.07 10.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.241 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.36 -31.08 3.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.28 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -68.66 -52.02 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.375 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.35 -37.64 70.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 17' ' ' ARG . 65.2 mt -70.34 -40.98 73.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.552 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 mt -48.4 -24.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.46 -23.61 32.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.02 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 14' ' ' LEU . 10.8 mmt180 -82.13 -44.94 15.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 143.5 -6.96 1.97 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 18' ' ' GLY . . . -28.71 149.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.848 0.356 . . . . 0.0 110.653 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 39' ' ' ASP . 7.1 mtpp -104.13 98.91 8.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 21' ' ' LEU . 6.3 mp -83.24 124.32 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.969 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mt -122.96 136.67 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 111.475 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' ALA . 34.8 t70 -105.47 136.54 44.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.691 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.47 86.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.47 0.653 . . . . 0.0 110.877 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.542 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 3.1 ptp180 -157.27 -146.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.956 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 27' ' ' ALA . 48.3 m-20 -102.98 114.82 29.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.16 -39.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.503 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -42.46 -33.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.341 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 2.6 mt-10 -86.5 -33.6 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.125 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.2 t80 -73.54 -40.55 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tp -55.88 -56.04 25.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.419 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 29' ' ' GLU . 10.5 ptp180 -49.19 -28.06 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 30' ' ' TYR . 1.4 tm-20 -169.24 136.66 1.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.116 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -150.38 176.54 10.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 110.744 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.711 ' C ' ' H ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -119.68 98.31 49.81 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.444 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.425 ' C ' ' OE1' ' A' ' 37' ' ' GLU . 31.9 Cg_exo -54.23 18.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.89 2.393 . . . . 0.0 113.005 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.711 ' H ' ' C ' ' A' ' 35' ' ' ILE . 1.9 pm0 -126.96 9.73 6.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.047 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.41 149.34 52.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -84.78 124.48 31.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.467 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 tp -84.47 119.95 25.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 23' ' ' ASP . . . -148.88 89.65 4.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -40.46 146.78 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.555 ' CD1' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -72.61 -25.42 61.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.213 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -30.82 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.4 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 49' ' ' SER . 3.4 m -85.54 -30.11 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.576 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.591 ' CD2' ' C ' ' A' ' 46' ' ' LEU . 5.7 tt -60.5 -50.9 71.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.684 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.4 -52.88 62.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -70.97 -44.98 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 41.7 t -61.68 -70.17 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.06 68.48 1.18 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -118.21 86.19 26.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.512 ' C ' ' N ' ' A' ' 54' ' ' LYS . 14.5 Cg_exo -64.97 79.23 0.2 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.906 2.404 . . . . 0.0 112.336 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.72 -21.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.512 ' N ' ' C ' ' A' ' 52' ' ' PRO . 24.9 tttp -56.71 -15.35 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.114 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.49 -10.0 59.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.93 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 -118.3 17.53 13.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.252 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.38 -166.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.45 -31.54 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.18 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -112.12 133.03 54.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.702 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.58 138.84 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 111.07 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mt -116.91 133.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.236 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.457 ' CG ' HD13 ' A' ' 77' ' ' LEU . 95.1 m-85 -116.9 138.01 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.603 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 15.3 p80 -160.65 137.32 8.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -116.27 154.08 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.354 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.542 ' H ' ' NE ' ' A' ' 25' ' ' ARG . 1.9 tp-100 -27.4 -54.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.56 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -108.01 -3.44 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' A' ' 69' ' ' ARG . . . 79.46 -43.05 2.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 67' ' ' GLY . 13.6 mttt -31.56 -33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.552 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -63.32 -59.96 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.553 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.682 ' O ' ' N ' ' A' ' 74' ' ' ALA . 17.5 m -43.83 -49.57 8.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -27.16 63.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.95 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -86.69 -47.48 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.096 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' A' ' 76' ' ' LYS . 2.3 t30 -89.96 -10.41 45.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.998 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.682 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -48.84 -29.44 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.214 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -29.32 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.762 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HB2' ' ND2' ' A' ' 73' ' ' ASN . 52.5 mmtt -83.95 -23.45 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.879 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 80' ' ' ILE . 11.7 mt -80.09 -57.59 3.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.849 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.98 -34.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.46 -29.23 46.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' LEU . 97.0 mt -86.37 -17.89 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -97.67 4.99 49.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.768 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 45.44 179.59 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.989 0.423 . . . . 0.0 110.538 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 23.1 Cg_exo -60.12 20.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.747 2.298 . . . . 0.0 112.164 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.664 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -66.11 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.586 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.66 94.12 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -110.89 144.07 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.471 ' CD1' HD11 ' A' ' 6' ' ' ILE . 11.6 m-85 -120.56 171.02 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.691 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 89' ' ' LEU . 18.6 tp -137.83 128.66 27.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.508 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.3 tt -87.28 97.41 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.563 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.496 ' C ' ' CG ' ' A' ' 91' ' ' ASP . 1.4 tt0 -46.16 139.53 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 74.15 -47.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 105.98 -156.06 16.55 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.419 HG21 ' HZ1' ' A' ' 97' ' ' LYS . 7.6 tt -50.56 -20.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.829 0.347 . . . . 0.0 110.519 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.96 -33.91 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.465 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.37 -36.93 13.08 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.472 ' CE2' HD11 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -67.09 -29.38 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.31 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.597 ' HZ3' ' CB ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -81.51 -43.27 19.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.493 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -77.04 -24.61 52.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.371 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.36 -41.57 65.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.52 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.78 30.46 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' A' ' 96' ' ' TRP . 14.2 mt -118.86 141.93 30.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.72 169.83 21.44 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.355 2.037 . . . . 0.0 112.09 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.62 166.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -121.57 117.09 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.298 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.8 t -96.64 135.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.671 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.88 109.07 8.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.309 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.648 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.829 0.347 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -113.98 138.52 50.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -77.88 145.17 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -131.81 163.21 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.385 0.612 . . . . 0.0 111.205 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' HIS . 12.4 t -105.06 142.35 24.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.656 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -41.64 -17.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.451 2.101 . . . . 0.0 112.302 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -81.42 -28.56 34.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -79.79 -52.15 8.28 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.345 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.05 -35.26 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.29 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -38.88 92.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' ASP . 21.0 mt-10 -70.66 -41.73 71.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 17' ' ' ARG . 16.1 mt -66.98 -41.94 85.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.685 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.3 mt -48.36 -24.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.89 -23.27 36.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.396 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -86.36 -40.35 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.598 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.99 -10.69 0.9 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -30.96 147.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HG3' ' CG ' ' A' ' 57' ' ' HIS . 11.4 mtpt -112.28 109.91 19.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.563 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 mt -94.37 131.9 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.089 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.607 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 12.4 mt -135.55 141.99 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -98.42 137.94 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.95 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.61 83.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 0.0 110.608 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.438 ' CD ' ' H ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -168.32 -149.1 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.438 ' H ' ' CD ' ' A' ' 25' ' ' ARG . 4.0 m-20 -89.01 114.14 25.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.351 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.593 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -43.34 -43.58 5.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.17 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -42.29 -21.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.763 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' ALA . 3.2 mm-40 -86.84 -38.45 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.859 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -81.6 -24.26 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.17 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -45.0 94.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -68.98 -21.93 64.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG2' ' CG2' ' A' ' 103' ' ' VAL . 2.8 tt0 -164.71 126.45 2.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.375 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 2.7 p80 -139.65 160.17 40.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.423 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 37' ' ' GLU . 10.0 mt -105.35 130.58 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.671 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.34 23.17 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.552 2.168 . . . . 0.0 111.876 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 35' ' ' ILE . 51.7 mm-40 -141.67 34.47 1.62 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.646 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.74 23.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.529 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 40' ' ' LEU . 2.0 t0 -90.32 155.48 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.684 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.649 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.5 tp -110.3 119.46 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.535 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.79 88.21 6.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.312 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' VAL . 88.4 Cg_exo -42.49 126.76 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.747 2.298 . . . . 0.0 112.688 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.607 ' CD1' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -41.99 -24.92 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.717 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' PRO . 5.6 t -79.18 -27.51 42.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.462 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 49' ' ' SER . 33.4 m -84.74 -27.83 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.165 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.466 ' N ' HG23 ' A' ' 45' ' ' VAL . 8.4 tp -70.62 -43.41 69.36 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.704 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -32.27 51.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -87.41 -43.63 11.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.611 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.26 -72.83 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.08 92.55 2.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.8 tp -118.59 83.57 22.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.446 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 54' ' ' LYS . 8.3 Cg_exo -68.79 62.22 1.26 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.885 2.39 . . . . 0.0 112.198 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 52' ' ' PRO . . . -39.72 -27.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -51.22 -18.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.48 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.33 -13.56 54.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.985 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.508 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.5 mtp85 -109.16 18.34 20.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -179.52 -169.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.03 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.542 ' C ' ' OE1' ' A' ' 59' ' ' GLN . 4.2 tt0 -118.94 -30.57 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.542 ' OE1' ' C ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -112.06 133.76 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.6 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -127.32 145.51 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.947 0.403 . . . . 0.0 111.107 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 61' ' ' ILE . 7.7 mt -137.55 136.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CD2' HD11 ' A' ' 77' ' ' LEU . 67.8 m-85 -119.75 132.25 55.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.733 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 1.8 p80 -129.0 134.03 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -116.29 153.39 32.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.745 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 60.1 tp60 -34.15 -36.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.481 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -125.61 -42.66 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.654 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 133.18 -32.0 2.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 67' ' ' GLY . 15.8 mmtm -38.67 -42.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.728 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -64.81 -31.92 73.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -61.13 -45.67 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.011 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.436 ' H ' ' HG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -81.3 -23.14 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.852 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.33 -33.37 20.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 69' ' ' ARG . 52.6 t30 -93.3 -17.0 24.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.4 -29.9 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -29.75 65.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.011 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -21.51 29.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.767 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.467 HD11 ' CD2' ' A' ' 62' ' ' PHE . 87.6 mt -80.92 -56.56 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.945 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' LEU . . . -39.27 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -80.18 -47.31 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.441 HD12 HG23 ' A' ' 80' ' ' ILE . 77.8 mt -80.84 -19.17 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.154 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -95.98 5.71 50.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.941 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.657 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 44.47 -178.86 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 0.0 110.371 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 23.2 Cg_exo -60.45 21.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.732 2.288 . . . . 0.0 112.244 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.657 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -68.2 179.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.27 112.69 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mt -117.27 139.12 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.44 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -120.02 171.98 8.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.604 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.1 mt -137.2 131.73 32.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.993 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.475 ' C ' ' CD1' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -81.66 85.33 6.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.205 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.646 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 46.8 tt0 -57.48 121.03 9.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.646 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 19.1 t0 94.11 -26.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.46 -153.32 38.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.56 -21.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.15 -59.55 3.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.427 ' HA2' ' NH1' ' A' ' 98' ' ' ARG . . . -61.38 -40.35 98.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.533 ' CE2' ' CB ' ' A' ' 101' ' ' LEU . 16.7 t-105 -53.73 -35.44 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.361 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -80.68 -51.11 9.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.637 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' NH1' ' HA2' ' A' ' 95' ' ' GLY . 14.2 ttp-105 -51.48 -18.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.976 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.92 -21.12 15.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.775 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.62 72.68 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.533 ' CB ' ' CE2' ' A' ' 96' ' ' TRP . 15.1 mt -119.68 152.68 53.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.399 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' LEU . 96.3 Cg_exo -30.17 118.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 123.193 2.595 . . . . 0.0 112.446 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 2.4 p -143.64 157.04 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.088 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -143.48 130.03 20.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.076 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.416 ' C ' ' NE2' ' A' ' 34' ' ' HIS . 60.9 t -97.33 142.63 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.234 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.567 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -86.45 108.69 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.314 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.505 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.07 35.19 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.269 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 3' ' ' LEU . 4.0 pp -74.95 128.69 36.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.513 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -116.83 144.17 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -78.16 145.13 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.466 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -136.32 166.06 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.824 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 9' ' ' HIS . 1.7 t -102.46 142.58 24.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.935 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -42.06 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.369 2.046 . . . . 0.0 112.063 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -80.89 -27.94 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.11 -52.68 6.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.367 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.11 -32.33 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.424 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 15' ' ' ILE . 1.7 tt0 -66.24 -56.66 10.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -45.48 -26.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 17' ' ' ARG . 27.8 mt -82.94 -39.9 20.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 12' ' ' GLN . 67.0 mt -49.2 -24.85 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.83 -20.72 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.958 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 14' ' ' LEU . 6.0 ttt180 -84.14 -41.04 17.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.504 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 139.01 -7.37 3.21 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 18' ' ' GLY . . . -31.29 151.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 0.0 110.601 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.772 ' HZ3' ' HE ' ' A' ' 56' ' ' ARG . 1.4 mtpt -109.42 99.72 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.23 134.7 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.959 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.429 HD13 ' CE2' ' A' ' 62' ' ' PHE . 14.4 mt -130.85 141.18 46.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 0.0 111.096 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.581 ' OD2' ' NH2' ' A' ' 25' ' ' ARG . 5.2 t0 -111.71 135.6 52.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.135 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 pt -130.12 81.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.243 0.544 . . . . 0.0 110.197 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.581 ' NH2' ' OD2' ' A' ' 23' ' ' ASP . 11.8 ptt180 -154.73 -145.54 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.285 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 11.2 m-20 -101.8 116.21 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.316 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -45.61 -36.01 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.189 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -48.34 -34.35 10.49 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -85.18 -32.4 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.806 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.759 ' CZ ' ' ND1' ' A' ' 34' ' ' HIS . 10.0 t80 -73.08 -31.0 64.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 4.0 tp -65.06 -59.24 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.572 ' C ' ' HE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -53.63 -25.55 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.144 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 32' ' ' ARG . 19.0 tt0 -152.76 117.78 5.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.185 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.77 ' ND1' ' N ' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -140.77 152.13 44.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.513 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.77 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 5.9 mt -110.62 94.18 18.73 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.662 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.37 66.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.871 2.38 . . . . 0.0 112.4 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.71 ' N ' ' O ' ' A' ' 35' ' ' ILE . 14.5 pt-20 -179.46 27.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 153.49 30.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.337 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -84.77 143.53 29.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.71 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.37 114.55 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.84 96.59 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.555 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' VAL . 82.9 Cg_exo -44.94 124.41 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.372 2.048 . . . . 0.0 111.875 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 42' ' ' PRO . 1.7 tt -36.6 -60.29 0.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.137 0.494 . . . . 0.0 110.565 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -44.09 -25.93 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.974 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -73.9 -39.02 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.926 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.467 ' N ' HG11 ' A' ' 45' ' ' VAL . 6.5 tt -83.39 -42.97 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.825 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.88 -29.89 71.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.847 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.487 ' CG ' ' N ' ' A' ' 49' ' ' SER . 7.7 pt20 -97.18 -40.61 8.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.935 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 2.1 t -87.47 -55.36 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.756 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 83.11 0.8 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.674 ' O ' ' N ' ' A' ' 53' ' ' ALA . 14.1 tp -107.58 97.92 21.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.87 67.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.564 2.176 . . . . 0.0 112.194 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -51.71 -19.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.275 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' HIS . 5.4 tttp -63.3 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mp -77.91 -13.56 59.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.793 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.772 ' HE ' ' HZ3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.1 19.95 8.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 166.17 -167.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.786 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -113.38 -39.58 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.3 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -112.31 133.47 54.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.156 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.704 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -136.33 144.35 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -127.02 146.51 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.169 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.457 ' CD2' HD11 ' A' ' 77' ' ' LEU . 96.6 m-85 -126.62 137.36 53.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.74 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 1.0 OUTLIER -140.75 136.32 32.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.519 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.6 t -115.7 153.22 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.455 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.519 ' C ' ' O ' ' A' ' 64' ' ' CYS . 2.8 tt0 -30.08 -53.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.65 54.08 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.621 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 42.7 49.57 5.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -112.24 -42.62 3.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HG2' ' SG ' ' A' ' 64' ' ' CYS . 2.9 mmt180 -83.39 -31.9 26.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.611 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -65.37 -43.34 91.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.531 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -24.7 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.37 -43.96 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 76' ' ' LYS . 9.2 t30 -88.46 -16.44 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.636 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -44.32 -38.22 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.387 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.47 -27.06 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.577 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ASN . 15.6 mmtm -78.96 -26.15 43.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 81' ' ' ALA . 80.4 mt -77.9 -56.81 4.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.33 -33.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.16 -48.32 17.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.5 mt -75.8 -17.7 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -96.27 8.18 44.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.731 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.617 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 42.98 -179.47 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 110.626 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 84' ' ' ALA . 18.1 Cg_exo -62.49 15.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.658 2.239 . . . . 0.0 112.018 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -53.1 -152.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -122.31 98.7 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.382 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.04 146.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.47 177.9 4.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.188 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.95 129.28 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.775 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.459 ' C ' ' CD1' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -87.54 101.33 13.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 15.4 tt0 -54.36 121.24 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER 82.22 -50.26 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.568 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.92 -133.87 9.9 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -77.05 -30.83 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 50.1 t0 -48.22 -30.69 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.81 -54.79 4.76 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.443 ' CZ3' HG23 ' A' ' 35' ' ' ILE . 2.3 t90 -47.09 -32.19 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.914 0.387 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -73.87 -53.05 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.586 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 100' ' ' GLY . 3.3 ttt180 -66.2 -29.54 69.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.534 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.52 -12.26 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.742 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 98' ' ' ARG . . . 101.24 24.19 9.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.4 mt -116.46 138.09 24.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.25 161.66 40.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.349 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.96 172.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.211 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.78 121.15 22.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.691 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 32' ' ' ARG . 15.0 t -96.75 144.02 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.3 108.6 4.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.295 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 tttt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.55 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.38 12.81 18.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.643 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 pp -44.6 126.7 5.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.427 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -122.4 158.41 29.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.581 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -87.9 144.25 26.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -136.7 164.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.458 . . . . 0.0 110.931 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 9' ' ' HIS . 17.2 t -104.07 138.99 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.796 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.23 -16.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.578 2.185 . . . . 0.0 111.854 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.645 ' N ' ' O ' ' A' ' 7' ' ' SER . 23.6 m170 -75.92 -35.98 59.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.947 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.2 t0 -76.22 -54.19 7.15 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.506 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.13 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -49.73 -46.77 50.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.27 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -59.01 -42.0 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.189 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 17' ' ' ARG . 6.9 mt -68.3 -43.85 76.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.6 mt -48.14 -23.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.855 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.61 25.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.483 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.0 ttm-85 -81.12 -40.5 23.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.87 -11.81 0.95 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -27.07 144.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.69 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' HZ2' ' CE1' ' A' ' 57' ' ' HIS . 4.8 mmtm -102.24 98.38 8.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.727 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 63' ' ' HIS . 0.5 OUTLIER -84.48 131.78 34.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.105 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.43 140.79 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.511 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.568 ' CG ' ' CE1' ' A' ' 30' ' ' TYR . 1.4 t70 -101.89 136.72 41.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 pp -136.98 84.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 0.0 110.736 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -160.81 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.93 111.23 23.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -41.86 -33.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.276 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.16 -34.67 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -83.84 -31.89 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.538 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.568 ' CE1' ' CG ' ' A' ' 23' ' ' ASP . 1.5 t80 -77.67 -25.37 49.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.412 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' ALA . 1.4 tp -70.32 -47.94 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.171 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.0 -10.2 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.237 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.5 tt0 -172.83 137.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CE1' ' OD1' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -160.63 161.28 32.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 110.796 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 37' ' ' GLU . 1.7 mt -106.27 105.33 53.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.33 19.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.576 2.184 . . . . 0.0 113.046 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.692 ' H ' ' C ' ' A' ' 35' ' ' ILE . 56.1 mm-40 -135.12 24.15 3.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.487 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.51 149.09 42.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.81 133.59 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD11 ' CD2' ' A' ' 30' ' ' TYR . 61.0 tp -92.79 118.0 30.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.291 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.44 93.36 4.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.6 Cg_exo -45.49 120.48 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.497 2.132 . . . . 0.0 111.954 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.558 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -41.23 -25.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.987 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.25 -26.73 32.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.51 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG1' ' N ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -78.34 -48.75 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.077 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.596 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 13.5 tp -54.91 -27.13 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -84.38 -49.47 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -67.0 -52.87 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.6 t -82.99 -77.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.07 91.47 1.28 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 17.0 tp -124.46 79.2 61.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.778 0.323 . . . . 0.0 110.579 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 54' ' ' LYS . 7.6 Cg_exo -69.33 78.12 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.987 2.458 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.52 -21.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 52' ' ' PRO . 14.5 tttm -57.35 -13.81 3.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.074 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.7 mt -77.55 -10.7 59.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.519 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.7 mtt180 -125.01 22.88 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.299 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -170.14 -169.04 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.167 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.7 -34.68 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.023 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -112.77 133.26 54.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.76 118.53 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 mt -110.5 141.74 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.15 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -123.85 143.3 50.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.051 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.726 ' H ' ' HD1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -143.22 135.94 27.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.346 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.671 ' SG ' ' OG1' ' A' ' 70' ' ' THR . 1.3 m -116.48 153.07 32.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.477 ' CG ' ' N ' ' A' ' 66' ' ' ALA . 6.9 pt20 -34.91 -39.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.477 ' N ' ' CG ' ' A' ' 65' ' ' GLN . . . -128.06 -4.96 5.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 85.32 -28.78 4.58 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -42.56 -26.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.459 ' HB3' ' SG ' ' A' ' 64' ' ' CYS . 2.7 tpm_? -83.59 -25.45 30.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.068 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.671 ' OG1' ' SG ' ' A' ' 64' ' ' CYS . 0.2 OUTLIER -65.88 -54.61 24.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.765 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -65.17 -23.66 67.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -86.4 -47.5 9.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.539 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.601 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 t30 -84.28 -16.29 43.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.361 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -41.34 -33.87 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.113 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.18 -31.32 67.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 73' ' ' ASN . 33.8 mmtt -81.79 -22.08 37.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.904 0.383 . . . . 0.0 110.532 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.9 mt -80.62 -57.19 3.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.654 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.99 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.48 -54.59 34.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -18.46 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.221 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.03 2.17 50.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.841 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 52.63 -179.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.735 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 22.9 Cg_exo -60.54 7.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.878 2.386 . . . . 0.0 112.448 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -46.48 169.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.279 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.9 102.67 4.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.217 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.78 133.13 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.4 ' CD1' HD12 ' A' ' 6' ' ' ILE . 46.7 m-85 -125.54 153.56 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.609 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 23.1 mt -122.39 137.03 55.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.195 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.507 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.6 tt -89.04 91.34 8.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.34 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' C ' ' H ' ' A' ' 92' ' ' GLY . 12.2 tt0 -40.66 147.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 68.35 -47.44 0.54 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 101.9 -145.76 16.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mm -51.0 -41.93 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.477 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.29 -35.26 59.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.02 -47.11 39.88 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.471 ' CD1' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.95 -37.04 81.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.45 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -80.76 -25.79 37.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.376 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -73.86 -44.75 54.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.45 63.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.76 45.34 0.24 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.471 HD12 ' CD1' ' A' ' 96' ' ' TRP . 9.6 mt -123.5 106.27 32.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -45.62 152.09 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.455 2.103 . . . . 0.0 112.174 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.37 169.06 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.436 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.65 144.12 51.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.454 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.96 130.57 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.663 ' OD1' ' CE1' ' A' ' 34' ' ' HIS . 1.7 m-20 -67.59 109.69 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 106' ' ' ASN . 17.6 tttt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.48 16.87 9.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.594 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pp -69.49 152.06 45.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.536 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 m -132.72 151.97 51.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.49 33.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.548 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -144.8 163.28 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.728 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.599 ' O ' ' N ' ' A' ' 9' ' ' HIS . 4.9 m -108.62 142.98 26.59 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.46 -17.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.477 2.118 . . . . 0.0 111.722 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.599 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -73.06 -35.81 66.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.754 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 -56.11 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.209 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.61 -23.44 0.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -70.99 -44.41 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -68.07 -26.06 65.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.776 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' ARG . 14.7 mt -79.74 -45.13 19.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.5 mt -47.76 -23.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.447 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -27.46 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.118 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 14' ' ' LEU . 9.9 mtt180 -84.43 -41.54 16.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.416 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.74 28.08 0.41 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.82 149.09 32.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.4 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.61 102.51 13.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.673 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 5.2 mp -92.56 129.22 38.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.445 HD13 ' CE1' ' A' ' 62' ' ' PHE . 7.3 mt -127.44 142.43 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.032 0.444 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -103.75 153.43 20.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.555 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.447 ' O ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 pp -147.73 90.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.334 0.588 . . . . 0.0 110.789 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.441 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 24.4 ttt-85 -173.91 -141.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.9 119.69 30.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.271 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.71 97.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.534 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.66 -26.28 3.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.006 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.56 -44.95 11.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.301 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.8 t80 -70.37 -31.03 68.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.195 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.56 -58.21 8.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.463 ' HB3' HH11 ' A' ' 32' ' ' ARG . 0.5 OUTLIER -52.63 -28.66 22.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.27 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.9 tt0 -152.51 123.58 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.607 ' CD2' ' ND2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -150.55 175.55 11.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.011 0.434 . . . . 0.0 111.034 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.707 ' C ' ' H ' ' A' ' 37' ' ' GLU . 43.8 mt -109.2 106.07 58.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.253 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -54.44 19.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.573 2.182 . . . . 0.0 112.981 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.707 ' H ' ' C ' ' A' ' 35' ' ' ILE . 41.4 mm-40 -137.82 38.51 2.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.342 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.2 150.33 25.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.53 126.41 35.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.1 tp -85.19 117.14 23.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.177 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.36 93.75 6.34 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.569 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.3 Cg_exo -45.99 122.5 5.3 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.498 2.132 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.602 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -39.79 -29.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -75.49 -30.7 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -68.4 -38.77 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.112 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 50' ' ' GLY . 2.4 tt -73.41 -41.81 62.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -64.99 -31.03 72.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.195 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -96.14 -32.73 12.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.145 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 10.0 t -92.07 -44.44 8.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 110.809 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 68.37 64.26 3.18 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -98.68 110.55 57.54 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' LYS . 58.6 Cg_endo -77.44 63.09 7.83 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.376 2.05 . . . . 0.0 112.353 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.62 -21.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.961 0.41 . . . . 0.0 110.046 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HZ1' ' HB2' ' A' ' 84' ' ' ALA . 30.9 tttp -54.34 -21.43 9.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.454 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.59 -6.31 53.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.72 14.86 30.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.412 . . . . 0.0 110.472 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.412 ' CG ' ' H ' ' A' ' 58' ' ' GLU . 5.6 t60 177.97 -164.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.736 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.412 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 58.8 tt0 -121.92 -26.46 4.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.089 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -113.82 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.601 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -134.56 142.16 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.795 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.27 144.85 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.431 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.445 ' CE1' HD13 ' A' ' 22' ' ' ILE . 47.7 m-85 -123.96 141.19 52.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.861 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -149.15 133.84 17.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.657 ' SG ' ' OG1' ' A' ' 70' ' ' THR . 3.5 m -117.54 153.73 32.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.536 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.5 OUTLIER -28.23 -41.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.593 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -126.27 -60.45 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.537 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 154.7 -37.16 0.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 24.6 tttt -45.14 -29.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HB3' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -75.22 -36.49 61.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.657 ' OG1' ' SG ' ' A' ' 64' ' ' CYS . 0.3 OUTLIER -65.66 -42.98 90.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.423 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -66.31 -21.17 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.633 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 68' ' ' LYS . 3.0 m120 -82.75 -41.74 18.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 76' ' ' LYS . 2.0 t-20 -98.72 -13.81 20.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.635 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -47.16 -29.97 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.53 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -80.81 -31.37 35.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.528 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 73' ' ' ASN . 36.7 mmtm -76.76 -41.29 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.655 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 HD23 ' CZ ' ' A' ' 62' ' ' PHE . 10.1 mt -67.81 -57.8 5.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.17 -29.8 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.454 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.5 -56.38 20.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.38 -20.51 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.55 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -77.27 -2.76 36.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.655 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 44.95 -179.27 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 110.472 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 22.7 Cg_exo -60.23 26.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.764 2.309 . . . . 0.0 112.09 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.655 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -69.11 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.506 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -110.31 99.09 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.464 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.83 133.24 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.411 ' CD1' HD13 ' A' ' 6' ' ' ILE . 57.1 m-85 -111.87 163.38 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.851 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.454 HD11 ' N ' ' A' ' 89' ' ' LEU . 10.1 tp -131.92 132.32 43.46 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.876 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.454 ' N ' HD11 ' A' ' 88' ' ' LEU . 7.2 tt -99.24 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' O ' ' OD2' ' A' ' 91' ' ' ASP . 2.7 tm-20 -63.28 158.55 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.424 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.591 ' OD2' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER 69.34 -40.21 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.664 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 90' ' ' GLU . . . 94.2 -160.86 24.08 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.86 -26.6 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.265 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -23.05 6.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.346 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . -86.56 -52.49 3.16 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.01 -28.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HZ3' HG12 ' A' ' 103' ' ' VAL . 3.5 ttmm -76.53 -51.45 11.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 99' ' ' ALA . 5.9 mmt180 -61.27 -44.37 97.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 98' ' ' ARG . . . -39.26 -33.89 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.448 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.11 1.53 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mt -123.53 137.19 28.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.421 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -72.85 174.01 12.56 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.444 2.096 . . . . 0.0 112.379 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.463 HG12 ' HZ3' ' A' ' 97' ' ' LYS . 35.1 m -112.09 172.12 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' O ' ' ND1' ' A' ' 34' ' ' HIS . . . -141.08 135.21 30.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.62 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.5 t -97.13 158.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.607 ' ND2' ' CD2' ' A' ' 34' ' ' HIS . 2.3 m-20 -84.8 109.04 17.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 tptp . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.444 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mtp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 3' ' ' LEU . . . -122.13 12.14 10.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.489 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -38.55 143.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.58 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 147.87 45.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.603 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -78.75 151.32 32.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -137.51 166.4 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.442 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.4 OUTLIER -109.21 140.31 21.87 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.514 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.06 -18.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.278 1.985 . . . . 0.0 111.585 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.9 m170 -73.87 -30.63 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.37 -52.73 7.33 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.782 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.01 -32.08 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.708 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -68.89 -44.11 73.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.631 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -66.36 -42.18 88.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 17' ' ' ARG . 22.5 mt -63.73 -42.76 97.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.0 mt -48.22 -24.37 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.65 -28.2 45.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.86 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 14' ' ' LEU . 3.4 mtp180 -84.33 -30.5 25.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.098 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.8 23.9 2.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.35 153.94 5.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.364 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -104.83 97.7 7.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.548 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 131.98 40.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.864 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 mt -135.79 141.08 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.601 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 25' ' ' ARG . 11.1 t0 -110.8 145.12 38.71 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.608 ' O ' ' O ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -112.89 -73.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.891 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 24' ' ' ILE . 8.5 ptm180 20.57 -143.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.156 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -116.15 109.64 17.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.046 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.0 -42.1 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -43.08 -38.43 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.44 -22.84 26.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.382 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.555 ' O ' ' O ' ' A' ' 33' ' ' GLU . 4.5 t80 -82.32 -29.16 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -43.77 93.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.449 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.4 mtp85 -74.59 -13.84 60.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.065 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.615 ' CD ' ' HZ2' ' A' ' 97' ' ' LYS . 5.9 tt0 -157.48 122.01 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.279 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.591 ' ND1' ' O ' ' A' ' 104' ' ' ALA . 39.0 p-80 -145.21 147.57 32.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 37' ' ' GLU . 10.4 mt -90.95 130.96 38.62 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.365 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.7 24.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.511 2.141 . . . . 0.0 112.444 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 35' ' ' ILE . 44.3 mm-40 -146.18 35.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.778 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -162.89 147.33 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -84.57 161.22 20.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.454 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD13 ' CD2' ' A' ' 30' ' ' TYR . 56.5 tp -115.33 122.01 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.68 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.474 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -160.25 95.57 1.53 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.065 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -46.85 147.46 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.578 2.185 . . . . 0.0 112.034 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.477 ' N ' HG21 ' A' ' 24' ' ' ILE . 1.1 pp -71.72 -24.13 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.249 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 46.8 p -76.81 -35.53 57.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.966 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.8 -30.36 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.34 -40.42 89.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.53 -50.13 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -69.47 -34.16 73.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 t -72.8 -78.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.16 75.91 1.0 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 53' ' ' ALA . 32.5 tp -117.7 89.1 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 110.701 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.1 73.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.802 2.335 . . . . 0.0 112.136 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -57.35 -28.13 62.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.389 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -51.94 -24.7 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.387 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.88 -13.6 59.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.565 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 54.9 mtp180 -91.77 16.82 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 169.51 -163.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.902 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.26 -31.15 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.916 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -112.46 132.92 54.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.425 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.655 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -142.27 148.16 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -136.86 144.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.435 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.469 ' CG ' HD13 ' A' ' 77' ' ' LEU . 49.5 m-85 -124.64 151.04 45.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' A' ' 23' ' ' ASP . 48.3 p-80 -159.98 144.36 14.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 111.656 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.643 ' N ' ' HG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -116.74 154.1 31.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.171 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.583 ' C ' ' O ' ' A' ' 64' ' ' CYS . 5.0 tm0? -21.66 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.783 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -109.22 -22.4 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.457 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 113.29 -33.58 5.48 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HG3' ' H ' ' A' ' 69' ' ' ARG . 2.6 pttp -35.49 -64.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.708 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.48 ' H ' ' HG3' ' A' ' 68' ' ' LYS . 19.6 mtt85 -52.12 -38.62 57.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.682 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.643 ' HG1' ' N ' ' A' ' 64' ' ' CYS . 2.1 m -58.74 -47.83 83.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.685 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -70.4 -18.86 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.786 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.04 -47.77 10.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -84.55 -14.18 49.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.718 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.89 -26.75 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.517 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -37.25 76.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.62 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -74.89 -26.91 59.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 79' ' ' ALA . 75.2 mt -74.86 -56.89 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.31 -22.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.671 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -76.83 -53.06 8.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -75.99 -17.75 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.533 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -87.14 -2.95 59.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.643 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 45.71 179.53 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 25.0 Cg_exo -58.25 9.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.596 2.197 . . . . 0.0 111.93 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -55.26 -167.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.332 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 3.8 mm-40 -105.42 106.21 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.34 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.462 ' CD1' HD11 ' A' ' 6' ' ' ILE . 13.3 m-85 -116.32 169.48 9.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 6' ' ' ILE . 7.9 tp -137.85 128.73 27.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 tt -88.17 108.78 19.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.627 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 92' ' ' GLY . 8.1 tt0 -66.16 147.85 52.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 66' ' ' ALA . 19.7 t0 77.7 -35.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.748 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 90' ' ' GLU . . . 92.84 -164.57 27.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.3 -21.41 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.482 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -61.8 -25.65 67.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.33 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.74 -35.3 25.55 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -30.8 70.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.934 0.397 . . . . 0.0 110.134 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.615 ' HZ2' ' CD ' ' A' ' 33' ' ' GLU . 15.4 mtpt -72.12 -38.13 69.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.355 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -75.57 -33.67 60.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.293 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.54 -15.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.548 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.92 32.31 7.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.6 mt -120.0 104.11 44.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.87 160.17 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.571 2.18 . . . . 0.0 112.4 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.76 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.591 ' O ' ' ND1' ' A' ' 34' ' ' HIS . . . -125.41 126.24 44.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.306 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.3 t -96.01 133.74 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.472 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 107' ' ' LYS . 63.3 t-20 -87.17 109.6 19.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 106' ' ' ASN . 75.5 tttt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.567 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 3' ' ' LEU . . . -109.77 22.22 15.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.766 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -38.08 116.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 5' ' ' THR . 54.6 m -105.87 147.05 29.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.764 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.462 ' N ' HG22 ' A' ' 4' ' ' THR . 0.6 OUTLIER -77.77 150.63 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -140.28 163.3 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.421 0.629 . . . . 0.0 111.547 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.469 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -109.12 145.33 31.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.318 178.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -39.64 -26.25 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.374 2.05 . . . . 0.0 111.897 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' SER . 78.3 m80 -65.99 -33.37 75.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.413 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.8 t0 -77.85 -55.66 5.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.141 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.88 5.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.284 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -38.88 87.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -74.52 -44.9 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.536 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 17' ' ' ARG . 3.3 mt -65.28 -47.36 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt -47.69 -25.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.795 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.11 -24.69 26.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.215 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -81.35 -41.2 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.703 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 151.43 -15.85 0.85 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -28.41 137.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.425 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.21 98.28 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mt -81.39 136.27 35.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.796 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mt -128.9 139.58 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.109 0.481 . . . . 0.0 111.3 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' OD2' ' CD1' ' A' ' 30' ' ' TYR . 14.9 t70 -103.57 132.36 49.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.61 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -133.65 82.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 110.83 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 3.5 ptt180 -156.63 -150.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.358 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -92.15 116.87 29.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.584 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -47.67 -31.73 4.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.083 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 2.5 m-20 -52.71 -44.41 66.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -74.71 -32.6 62.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . 4.5 t80 -72.19 -25.79 61.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.961 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -67.85 -55.66 12.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp85 -52.17 -18.69 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.18 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 30' ' ' TYR . 2.3 mt-10 -172.03 139.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.475 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.672 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 15.6 p80 -153.64 150.81 29.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.483 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 122.59 52.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.548 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.45 51.27 3.67 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -158.74 18.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.688 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.21 151.48 38.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -85.05 124.05 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.424 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.1 tp -83.31 117.81 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.643 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.5 90.68 4.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.344 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 81.4 Cg_exo -45.79 124.29 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.827 2.351 . . . . 0.0 112.617 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -34.0 -62.58 0.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.441 0.638 . . . . 0.0 110.444 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -43.13 -29.8 0.4 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.307 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -76.73 -42.59 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.774 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.47 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 7.3 tp -78.06 -20.16 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.797 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -39.08 30.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.755 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -90.59 -38.68 12.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.801 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 11.7 t -73.14 -77.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.77 75.97 1.09 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.6 89.36 52.35 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.473 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 54' ' ' LYS . 25.0 Cg_exo -58.67 83.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.844 2.363 . . . . 0.0 112.294 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.64 -20.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.001 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.608 ' HZ1' ' N ' ' A' ' 82' ' ' ALA . 9.4 tttt -60.57 -14.73 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.029 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.1 mt -77.09 -13.34 59.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.615 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -113.76 23.04 13.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.83 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.077 0.465 . . . . 0.0 110.985 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -119.65 -34.09 3.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.156 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -112.13 133.32 54.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.936 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -133.42 120.5 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.435 HG22 HD13 ' A' ' 61' ' ' ILE . 6.4 mt -115.43 149.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.459 ' CE2' HD23 ' A' ' 77' ' ' LEU . 23.1 m-85 -130.07 151.35 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.559 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' A' ' 63' ' ' HIS . 3.4 p-80 -154.59 134.03 12.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.768 ' SG ' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -116.46 155.15 29.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.561 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -22.86 -59.96 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.138 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.31 20.69 14.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.98 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.768 ' N ' ' SG ' ' A' ' 64' ' ' CYS . . . 63.47 6.28 14.94 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.764 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -70.4 -57.46 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.424 ' NH1' ' HA ' ' A' ' 25' ' ' ARG . 3.1 ttm180 -61.24 -23.21 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.556 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -64.15 -59.8 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -57.08 -18.88 16.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.752 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -80.03 -44.23 20.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.493 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -84.93 -17.01 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.411 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.64 -26.75 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.427 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -85.2 -37.74 19.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.689 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.72 -28.22 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.61 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 HD23 ' CE2' ' A' ' 62' ' ' PHE . 95.0 mt -68.47 -53.86 20.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.664 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.04 -56.68 4.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.321 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.6 55.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.968 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -78.01 -18.18 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.146 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -122.99 101.09 7.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.017 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 84' ' ' ALA . . . -39.43 170.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -50.36 65.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.751 2.3 . . . . 0.0 112.433 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.73 -167.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.78 98.44 11.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.24 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.67 135.84 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.54 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.439 ' CD1' HD11 ' A' ' 6' ' ' ILE . 69.2 m-85 -124.52 168.73 12.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -137.47 133.32 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -89.09 100.69 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.587 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 79.1 tt0 -60.84 149.59 35.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.423 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 12.2 t0 77.79 -46.07 0.45 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.618 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.37 -167.97 16.13 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 tt -50.92 -20.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 110.31 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.32 -31.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.268 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.94 -49.67 8.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.672 ' NE1' ' O ' ' A' ' 101' ' ' LEU . 2.4 t-105 -51.97 -38.86 58.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.189 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -70.27 -38.1 75.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.309 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -77.58 -26.22 50.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.63 4.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.53 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.07 18.01 33.0 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.672 ' O ' ' NE1' ' A' ' 96' ' ' TRP . 50.9 mt -118.4 96.52 49.93 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 0.0 110.53 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.37 177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.649 2.233 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.412 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -121.41 172.11 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.541 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -115.68 128.73 56.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.416 ' C ' ' NE2' ' A' ' 34' ' ' HIS . 6.0 t -96.45 133.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.421 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.672 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 1.4 t30 -67.5 108.81 2.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 106' ' ' ASN . 24.2 tptt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.578 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.81 38.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.558 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pp -42.26 117.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.487 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.444 ' CG2' ' N ' ' A' ' 5' ' ' THR . 24.2 m -128.93 158.47 38.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.444 ' N ' ' CG2' ' A' ' 4' ' ' THR . 0.8 OUTLIER -88.05 148.65 24.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.177 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.466 HD11 ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -137.26 166.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.191 0.519 . . . . 0.0 110.953 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -106.83 142.13 24.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.889 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.74 -19.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.498 2.132 . . . . 0.0 112.058 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 7' ' ' SER . 7.8 m-70 -76.12 -28.03 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.426 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -84.19 -52.45 6.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.97 -32.94 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -68.31 -51.12 48.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.66 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -56.23 -27.91 56.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 17' ' ' ARG . 25.9 mt -76.18 -42.33 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.2 mt -47.91 -22.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -85.6 -24.23 27.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.151 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -79.39 -51.25 9.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.419 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.608 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 136.81 32.47 0.24 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.0 -177.46 3.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -125.36 111.04 14.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.474 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.11 125.27 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.461 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.557 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 18.6 mt -136.31 138.31 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 111.397 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.657 ' OD1' ' NE ' ' A' ' 25' ' ' ARG . 10.9 t0 -108.83 146.31 33.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.608 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.617 ' O ' ' O ' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -114.78 -73.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.911 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.657 ' NE ' ' OD1' ' A' ' 23' ' ' ASP . 8.4 ptp180 16.42 -139.61 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.555 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -117.01 113.74 22.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' ASP . . . -38.32 -23.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 26' ' ' ASP . 45.1 m-20 -58.82 -33.11 70.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 15.3 mm-40 -86.37 -30.18 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.821 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -75.22 -39.11 60.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.256 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.44 -53.19 60.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.238 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' CG ' ' O ' ' A' ' 29' ' ' GLU . 7.6 ptp180 -56.83 -26.68 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 30' ' ' TYR . 15.9 tt0 -164.87 129.76 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.128 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 20.4 p80 -143.88 169.81 17.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 37' ' ' GLU . 2.7 mt -109.1 126.65 28.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.185 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.49 24.87 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.287 1.991 . . . . 0.0 111.963 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 35' ' ' ILE . 80.5 mm-40 -138.73 25.94 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.766 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.95 146.75 23.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.672 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -86.61 153.79 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.448 HD12 ' CD2' ' A' ' 30' ' ' TYR . 45.2 tp -108.39 124.43 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -162.71 96.53 1.13 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.614 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.455 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 39.7 Cg_exo -50.56 146.66 19.18 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.497 2.131 . . . . 0.0 112.082 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.481 ' N ' HG23 ' A' ' 24' ' ' ILE . 1.2 pp -65.93 -23.62 66.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.782 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.446 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -74.93 -29.24 60.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.511 ' O ' ' OG ' ' A' ' 49' ' ' SER . 23.6 m -84.92 -25.27 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.72 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.45 ' N ' HG23 ' A' ' 45' ' ' VAL . 3.0 tp -84.93 -46.61 11.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.571 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.61 -31.41 72.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.704 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -85.12 -30.17 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 6.7 m -94.95 -71.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 94.83 87.1 1.7 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -112.31 82.53 4.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.794 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' LEU . 74.8 Cg_exo -45.2 -7.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.796 2.331 . . . . 0.0 112.555 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 51' ' ' LEU . . . -43.43 -29.53 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.736 ' HZ1' ' CA ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -57.11 -5.75 0.3 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 109.834 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.658 ' C ' ' H ' ' A' ' 57' ' ' HIS . 9.7 mp -94.41 -9.97 33.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.479 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.64 8.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.251 0.548 . . . . 0.0 110.271 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.658 ' H ' ' C ' ' A' ' 55' ' ' LEU . 2.0 t60 -134.88 -145.38 0.23 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.231 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 24.7 tt0 -144.4 -43.89 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.032 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.68 133.1 54.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.4 mp -139.19 147.75 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.139 0.495 . . . . 0.0 111.389 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.4 139.59 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.908 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -121.95 137.1 54.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.668 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.2 OUTLIER -129.8 134.07 47.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.104 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.553 ' O ' ' C ' ' A' ' 65' ' ' GLN . 67.3 m -116.37 153.47 31.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.336 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 32.7 tt0 -26.74 -70.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.85 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 91' ' ' ASP . . . -100.95 -51.31 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.602 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.09 -17.39 1.93 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -59.15 -36.78 75.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.562 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -65.71 -46.77 77.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.236 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -49.15 -50.99 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.518 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -24.13 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 29.9 m120 -86.18 -46.54 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.17 -16.2 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -46.16 -30.9 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.594 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.9 -38.05 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -73.93 -26.92 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.76 -57.83 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.86 -24.0 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.35 -40.86 64.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.653 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 80' ' ' ILE . 50.5 mt -85.71 -47.12 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.736 ' CA ' ' HZ1' ' A' ' 54' ' ' LYS . . . -45.78 -27.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.608 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 84' ' ' ALA . . . 67.91 173.79 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 34.3 Cg_exo -53.57 65.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.699 2.266 . . . . 0.0 112.006 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.17 -172.29 2.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.536 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -102.03 117.42 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 86' ' ' ILE . 2.6 mp -128.47 142.2 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.466 ' CD1' HD11 ' A' ' 6' ' ' ILE . 81.6 m-85 -121.58 169.03 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.028 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' ILE . 18.8 mt -135.6 138.35 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 tt -89.92 107.95 19.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.57 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.6 tp10 -64.13 155.65 30.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.6 OUTLIER 69.52 -34.77 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 90' ' ' GLU . . . 91.4 -160.92 27.17 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.403 ' HB ' HH12 ' A' ' 25' ' ' ARG . 1.0 OUTLIER -50.3 -27.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.344 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.13 -52.39 64.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.151 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.0 -24.34 62.75 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.485 ' C ' ' CD1' ' A' ' 96' ' ' TRP . 9.6 t-105 -82.5 -35.2 27.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -77.26 -30.62 54.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.483 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -78.45 -35.07 47.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.485 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.93 4.45 3.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.48 65.94 3.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 96' ' ' TRP . 59.7 mt -119.96 149.66 49.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.122 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -35.49 146.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 123.006 2.471 . . . . 0.0 112.468 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.8 p -151.51 154.85 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -146.96 139.04 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.595 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 t -98.47 137.31 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.378 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.51 111.35 21.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.619 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.478 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 3' ' ' LEU . . . -100.53 36.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.823 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 2' ' ' ALA . 2.2 pp -39.61 120.81 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.251 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.459 HG23 ' N ' ' A' ' 5' ' ' THR . 10.8 m -116.36 156.19 27.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.013 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.459 ' N ' HG23 ' A' ' 4' ' ' THR . 25.1 p -85.41 149.48 25.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.229 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.507 ' N ' ' O ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -139.09 164.2 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.061 0.458 . . . . 0.0 110.816 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -103.32 139.79 20.44 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.24 -16.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.559 2.173 . . . . 0.0 111.898 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' SER . 35.2 t60 -78.47 -35.27 46.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.944 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -75.66 -49.62 17.85 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.089 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -43.29 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.338 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.98 -50.32 58.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.27 -30.8 60.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 17' ' ' ARG . 9.1 mt -75.3 -43.87 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.497 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.4 mt -48.27 -22.72 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -81.01 -26.67 36.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 7.4 mtt180 -85.46 -38.06 19.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.462 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.54 30.62 0.96 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.42 175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 110.519 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.442 ' NZ ' ' HB2' ' A' ' 57' ' ' HIS . 4.6 mttp -118.61 98.05 6.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.487 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -89.39 126.67 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.991 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.654 ' C ' ' CE1' ' A' ' 63' ' ' HIS . 6.9 mt -131.62 140.79 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.984 0.421 . . . . 0.0 111.421 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 24' ' ' ILE . 64.2 t0 -99.7 149.07 23.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.598 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -150.56 91.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.762 0.792 . . . . 0.0 110.582 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 23' ' ' ASP . 7.3 ptt-85 -169.04 -143.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.091 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -96.92 107.35 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.234 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -40.74 -26.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.457 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' ASP . 41.4 t0 -57.52 -38.07 74.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.09 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' OE1' ' OE1' ' A' ' 65' ' ' GLN . 10.9 mt-10 -80.68 -32.04 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.335 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 33' ' ' GLU . 12.3 t80 -78.92 -32.0 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 7.4 tp -60.27 -55.47 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.298 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -55.0 -20.14 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.302 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 30' ' ' TYR . 22.4 tt0 -163.29 120.7 1.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.696 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 15.0 p80 -138.24 160.85 38.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.591 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 37' ' ' GLU . 17.6 mt -98.7 128.13 33.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.53 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.68 21.32 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.49 2.126 . . . . 0.0 111.91 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 35' ' ' ILE . 24.2 mt-10 -141.96 26.49 1.87 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.522 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.34 33.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.793 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -87.64 145.68 26.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' CD2' ' A' ' 30' ' ' TYR . 62.7 tp -101.99 116.91 33.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.478 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.91 93.81 6.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 52.6 Cg_exo -47.47 118.01 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.505 2.137 . . . . 0.0 111.875 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.614 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -38.26 -34.68 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.12 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.467 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 1.8 t -71.53 -29.77 65.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.357 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -73.28 -43.3 57.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.206 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.523 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 17.6 tp -75.82 -21.65 57.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.207 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.48 -39.72 31.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -92.79 -40.99 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 8.3 t -65.71 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.44 79.95 1.49 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.672 ' C ' ' H ' ' A' ' 53' ' ' ALA . 16.0 tp -118.28 91.43 40.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.785 0.326 . . . . 0.0 110.657 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 54' ' ' LYS . 27.4 Cg_exo -58.76 21.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.739 2.293 . . . . 0.0 112.168 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.672 ' H ' ' C ' ' A' ' 51' ' ' LEU . . . -47.19 -21.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' N ' ' C ' ' A' ' 52' ' ' PRO . 1.4 ttpm? -63.68 -27.17 69.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.414 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.86 -9.12 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.39 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -80.66 10.91 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 110.156 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.442 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 2.0 t60 -148.87 -146.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.421 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -150.15 -36.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.346 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.68 133.13 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.619 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.86 153.34 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.321 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.5 mt -141.9 125.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.137 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.403 ' CE2' ' CD1' ' A' ' 77' ' ' LEU . 80.1 m-85 -107.7 149.23 28.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.956 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.654 ' CE1' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -138.68 133.43 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.794 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.593 ' SG ' ' CB ' ' A' ' 69' ' ' ARG . 1.4 t -116.73 153.77 31.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.519 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 6.7 pt20 -36.03 -33.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.872 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -140.09 -37.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.915 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.71 -4.66 3.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -45.71 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.667 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.593 ' CB ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -59.26 -33.99 71.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.628 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.621 ' O ' ' N ' ' A' ' 74' ' ' ALA . 52.4 m -73.13 -46.22 52.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.722 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 p -62.94 -26.96 69.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.19 -27.72 24.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -102.57 -12.89 17.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.568 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -55.44 -35.26 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.657 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.3 -34.81 78.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.552 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -73.19 -34.21 65.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.544 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 80' ' ' ILE . 28.0 mt -75.66 -56.06 5.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.409 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.04 -30.82 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.14 81.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.346 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 77' ' ' LEU . 89.3 mt -81.46 -30.52 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.563 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -55.69 -43.98 76.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 84' ' ' ALA . . . 75.62 177.02 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.028 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 32.7 Cg_exo -54.55 65.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.089 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.89 -151.44 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.513 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.83 121.06 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.399 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 86' ' ' ILE . 1.6 mp -125.56 126.88 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.87 161.3 18.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.445 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 6' ' ' ILE . 9.1 mt -130.33 140.44 50.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.558 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -85.84 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.098 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 92' ' ' GLY . 1.5 tt0 -59.56 146.03 42.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.915 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.402 ' N ' ' HG2' ' A' ' 90' ' ' GLU . 33.1 t0 69.19 -12.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.717 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 68.83 -158.31 52.98 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -30.58 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 110.576 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -31.1 67.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.388 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 99' ' ' ALA . . . -72.39 -59.38 4.56 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.54 ' C ' ' CD1' ' A' ' 96' ' ' TRP . 4.5 t-105 -48.38 -40.43 25.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.047 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.98 -47.08 87.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.461 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.45 ' C ' ' H ' ' A' ' 100' ' ' GLY . 26.8 ttm180 -83.31 -17.82 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -60.22 -5.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.574 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 98' ' ' ARG . . . 88.39 33.96 9.93 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.468 HD13 ' CZ3' ' A' ' 96' ' ' TRP . 23.0 mt -125.79 144.01 47.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 148.37 42.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.586 2.191 . . . . 0.0 112.466 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.32 171.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.696 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -127.47 125.12 39.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.7 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.46 137.72 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.127 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -71.4 108.54 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.202 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.622 -179.841 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 4' ' ' THR . . . -122.06 33.54 5.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.724 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -39.44 99.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 5' ' ' THR . 89.0 m -90.03 156.26 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.889 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.452 ' N ' HG23 ' A' ' 4' ' ' THR . 1.1 p -85.87 150.6 24.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.164 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -143.59 164.05 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.277 0.56 . . . . 0.0 111.052 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.468 ' N ' HG22 ' A' ' 6' ' ' ILE . 32.1 m -112.45 149.47 41.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.832 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -41.18 -22.59 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.501 2.134 . . . . 0.0 111.856 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.466 ' N ' ' O ' ' A' ' 7' ' ' SER . 3.4 t-80 -67.21 -38.68 85.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.159 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.79 -54.79 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.434 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.58 -39.51 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -61.38 -44.61 96.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.81 -36.84 84.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 17' ' ' ARG . 29.5 mt -72.79 -42.99 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.705 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.0 mt -50.54 -22.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.15 -20.32 38.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.123 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 14' ' ' LEU . 4.7 mtt180 -93.94 -51.28 4.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.46 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 149.15 33.85 0.05 OUTLIER Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 179.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.227 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 98.15 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.898 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.59 133.71 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.972 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.473 HD13 ' CE1' ' A' ' 62' ' ' PHE . 12.1 mt -132.34 142.58 42.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.96 142.13 35.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.432 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.602 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -147.21 88.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.799 0.809 . . . . 0.0 110.769 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.51 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 2.6 ptp180 -165.42 -144.45 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.619 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 38.1 t0 -97.17 107.39 19.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -37.81 -42.27 0.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.66 -38.61 2.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 109.979 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' ASP . 5.4 mm-40 -80.09 -35.09 37.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.067 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 34' ' ' HIS . 4.4 t80 -71.48 -26.98 62.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tp -62.74 -50.42 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -56.76 -27.12 58.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.372 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 30' ' ' TYR . 31.8 tt0 -159.6 128.85 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.644 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 13.2 p80 -145.61 155.35 42.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 110.767 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 37' ' ' GLU . 8.7 mm -91.9 121.56 66.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.5 23.79 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.278 1.986 . . . . 0.0 112.091 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 35' ' ' ILE . 26.0 mt-10 -146.71 30.6 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.545 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.86 157.89 43.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.556 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.37 153.08 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.602 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.7 tp -113.46 110.57 20.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.263 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.64 95.35 6.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.649 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 45' ' ' VAL . 71.2 Cg_exo -44.83 120.32 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.565 2.177 . . . . 0.0 112.079 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.536 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -43.12 -25.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.422 ' H ' ' HG ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -79.94 -30.63 39.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.393 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -81.79 -31.38 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.972 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.47 -20.18 57.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.819 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.65 -40.15 19.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.534 ' CG ' ' N ' ' A' ' 49' ' ' SER . 4.6 pt20 -87.86 -45.2 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.012 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.534 ' N ' ' CG ' ' A' ' 48' ' ' GLN . 5.6 t -66.55 -59.01 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.59 82.19 1.39 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 53' ' ' ALA . 13.4 tp -116.08 89.52 25.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.651 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.01 64.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.774 2.316 . . . . 0.0 112.045 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -50.13 -20.0 0.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.492 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.406 ' NZ ' ' HB1' ' A' ' 82' ' ' ALA . 19.7 tttm -57.6 -26.41 61.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.612 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -80.83 -13.98 58.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -90.15 13.25 15.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.033 0.444 . . . . 0.0 109.937 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.763 ' CG ' ' H ' ' A' ' 58' ' ' GLU . 13.7 t-80 179.3 -150.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.763 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 54.7 tt0 -137.38 -41.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.946 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.679 ' H ' ' HD1' ' A' ' 57' ' ' HIS . 5.3 mt-30 -111.95 132.98 54.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.53 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -132.41 150.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.001 0.429 . . . . 0.0 111.215 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.2 mt -133.58 129.69 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.967 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' CE1' HD13 ' A' ' 22' ' ' ILE . 97.9 m-85 -112.04 145.87 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.529 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -152.26 135.47 15.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.708 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.53 ' SG ' ' OG1' ' A' ' 70' ' ' THR . 1.8 m -115.19 153.09 31.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.51 ' H ' ' NE ' ' A' ' 25' ' ' ARG . 38.1 tp60 -29.69 -47.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.662 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.87 -11.33 8.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.469 ' HA2' ' HG1' ' A' ' 70' ' ' THR . . . 91.57 2.66 69.81 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -64.56 -30.16 71.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.357 . . . . 0.0 110.523 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 73' ' ' ASN . 9.7 mpt_? -81.38 -24.72 36.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.534 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.53 ' OG1' ' SG ' ' A' ' 64' ' ' CYS . 0.4 OUTLIER -59.82 -55.4 34.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -27.59 67.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' OD2' ' A' ' 75' ' ' ASP . 6.5 m120 -86.69 -37.83 17.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.739 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 69' ' ' ARG . 3.7 t30 -84.9 -17.08 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -48.31 -26.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.169 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -80.78 -51.8 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -65.35 -26.22 67.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.502 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD22 ' CE1' ' A' ' 62' ' ' PHE . 48.1 mt -65.56 -61.16 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.71 -53.31 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.3 68.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.29 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mm -71.39 -17.85 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.182 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -121.62 100.03 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.7 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 84' ' ' ALA . . . -44.02 178.93 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.448 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 29.2 Cg_exo -57.36 64.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.7 2.267 . . . . 0.0 112.34 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.8 -149.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.253 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.576 ' OE1' ' O ' ' A' ' 84' ' ' ALA . 3.1 mm-40 -115.58 103.01 10.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.07 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -115.1 139.1 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 6' ' ' ILE . 54.4 m-85 -120.97 166.92 13.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.184 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 6' ' ' ILE . 17.1 mt -135.58 142.19 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 110.753 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.623 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -97.91 109.71 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.319 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.59 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.7 tm-20 -60.12 143.51 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.755 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.22 -27.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.623 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 87.09 -155.6 27.61 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.8 tt -50.66 -32.45 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.66 -37.34 8.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -57.24 7.26 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.626 ' C ' ' CD1' ' A' ' 96' ' ' TRP . 1.7 t-105 -45.45 -39.28 6.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 110.437 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -56.18 -62.35 1.77 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' A' ' 100' ' ' GLY . 14.3 ptp180 -70.54 -29.6 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.3 -15.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.491 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 98' ' ' ARG . . . 93.51 38.12 5.38 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.472 ' HB2' ' CE2' ' A' ' 96' ' ' TRP . 24.9 mt -125.13 141.05 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.539 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.53 145.98 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.525 2.15 . . . . 0.0 112.073 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 m -112.3 172.08 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.548 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.644 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -132.52 128.93 38.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.8 t -96.77 136.1 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.436 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.543 ' N ' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -82.79 110.68 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.535 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 tttm . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.426 179.93 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.83 7.59 14.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.459 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp -94.37 144.54 25.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.617 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 88' ' ' LEU . 71.5 m -118.87 151.98 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.544 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.405 ' N ' HG22 ' A' ' 4' ' ' THR . 0.2 OUTLIER -78.31 149.18 33.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.662 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -136.3 161.55 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 110.437 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 9' ' ' HIS . 96.0 p -98.17 135.85 21.19 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.533 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -40.85 -16.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.151 1.901 . . . . 0.0 111.565 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.598 ' N ' ' O ' ' A' ' 7' ' ' SER . 2.1 t60 -79.6 -30.79 41.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.896 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.8 OUTLIER -76.81 -52.07 10.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.241 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.36 -31.08 3.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.28 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -68.66 -52.02 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.375 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.35 -37.64 70.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 17' ' ' ARG . 65.2 mt -70.34 -40.98 73.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.552 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 mt -48.4 -24.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.46 -23.61 32.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.02 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 14' ' ' LEU . 10.8 mmt180 -82.13 -44.94 15.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 143.5 -6.96 1.97 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 18' ' ' GLY . . . -28.71 149.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.848 0.356 . . . . 0.0 110.653 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 39' ' ' ASP . 7.1 mtpp -104.13 98.91 8.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 21' ' ' LEU . 6.3 mp -83.24 124.32 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.969 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mt -122.96 136.67 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 111.475 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' ALA . 34.8 t70 -105.47 136.54 44.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.691 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.47 86.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.47 0.653 . . . . 0.0 110.877 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.542 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 3.1 ptp180 -157.27 -146.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.956 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 27' ' ' ALA . 48.3 m-20 -102.98 114.82 29.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.16 -39.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.503 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -42.46 -33.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.341 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 2.6 mt-10 -86.5 -33.6 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.125 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.2 t80 -73.54 -40.55 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tp -55.88 -56.04 25.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.419 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 29' ' ' GLU . 10.5 ptp180 -49.19 -28.06 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 30' ' ' TYR . 1.4 tm-20 -169.24 136.66 1.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.116 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -150.38 176.54 10.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 110.744 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.711 ' C ' ' H ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -119.68 98.31 49.81 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.444 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' C ' ' OE1' ' A' ' 37' ' ' GLU . 31.9 Cg_exo -54.23 18.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.89 2.393 . . . . 0.0 113.005 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.711 ' H ' ' C ' ' A' ' 35' ' ' ILE . 1.9 pm0 -126.96 9.73 6.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.047 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.41 149.34 52.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -84.78 124.48 31.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.467 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 tp -84.47 119.95 25.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 23' ' ' ASP . . . -148.88 89.65 4.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -40.46 146.78 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.555 ' CD1' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -72.61 -25.42 61.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.213 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -30.82 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.4 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 49' ' ' SER . 3.4 m -85.54 -30.11 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.576 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.591 ' CD2' ' C ' ' A' ' 46' ' ' LEU . 5.7 tt -60.5 -50.9 71.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.684 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.4 -52.88 62.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -70.97 -44.98 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 41.7 t -61.68 -70.17 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.06 68.48 1.18 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -118.21 86.19 26.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.512 ' C ' ' N ' ' A' ' 54' ' ' LYS . 14.5 Cg_exo -64.97 79.23 0.2 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.906 2.404 . . . . 0.0 112.336 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.72 -21.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.512 ' N ' ' C ' ' A' ' 52' ' ' PRO . 24.9 tttp -56.71 -15.35 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.114 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.49 -10.0 59.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.93 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 -118.3 17.53 13.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.252 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.38 -166.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.45 -31.54 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.18 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -112.12 133.03 54.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.702 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.58 138.84 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 111.07 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mt -116.91 133.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.236 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.457 ' CG ' HD13 ' A' ' 77' ' ' LEU . 95.1 m-85 -116.9 138.01 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.603 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 15.3 p80 -160.65 137.32 8.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -116.27 154.08 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.354 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.542 ' H ' ' NE ' ' A' ' 25' ' ' ARG . 1.9 tp-100 -27.4 -54.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.56 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -108.01 -3.44 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' A' ' 69' ' ' ARG . . . 79.46 -43.05 2.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 67' ' ' GLY . 13.6 mttt -31.56 -33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.552 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -63.32 -59.96 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.553 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.682 ' O ' ' N ' ' A' ' 74' ' ' ALA . 17.5 m -43.83 -49.57 8.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -27.16 63.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.95 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -86.69 -47.48 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.096 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' A' ' 76' ' ' LYS . 2.3 t30 -89.96 -10.41 45.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.998 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.682 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -48.84 -29.44 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.214 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -29.32 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.762 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HB2' ' ND2' ' A' ' 73' ' ' ASN . 52.5 mmtt -83.95 -23.45 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.879 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 80' ' ' ILE . 11.7 mt -80.09 -57.59 3.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.849 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.98 -34.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.46 -29.23 46.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' LEU . 97.0 mt -86.37 -17.89 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -97.67 4.99 49.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.768 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 45.44 179.59 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.989 0.423 . . . . 0.0 110.538 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 23.1 Cg_exo -60.12 20.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.747 2.298 . . . . 0.0 112.164 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.664 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -66.11 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.586 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.66 94.12 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -110.89 144.07 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.471 ' CD1' HD11 ' A' ' 6' ' ' ILE . 11.6 m-85 -120.56 171.02 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.691 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 89' ' ' LEU . 18.6 tp -137.83 128.66 27.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.508 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.3 tt -87.28 97.41 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.563 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.496 ' C ' ' CG ' ' A' ' 91' ' ' ASP . 1.4 tt0 -46.16 139.53 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 74.15 -47.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 105.98 -156.06 16.55 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.419 HG21 ' HZ1' ' A' ' 97' ' ' LYS . 7.6 tt -50.56 -20.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.829 0.347 . . . . 0.0 110.519 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.96 -33.91 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.465 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.37 -36.93 13.08 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.472 ' CE2' HD11 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -67.09 -29.38 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.31 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.597 ' HZ3' ' CB ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -81.51 -43.27 19.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.493 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -77.04 -24.61 52.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.371 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.36 -41.57 65.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.52 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.78 30.46 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' A' ' 96' ' ' TRP . 14.2 mt -118.86 141.93 30.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.72 169.83 21.44 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.355 2.037 . . . . 0.0 112.09 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.62 166.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -121.57 117.09 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.298 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.8 t -96.64 135.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.671 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.88 109.07 8.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.309 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.648 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 174.85 82.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.38 125.67 35.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.634 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -113.98 138.52 50.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -77.88 145.17 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -131.81 163.21 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.385 0.612 . . . . 0.0 111.205 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' HIS . 12.4 t -105.06 142.35 24.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.656 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -41.64 -17.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.451 2.101 . . . . 0.0 112.302 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -81.42 -28.56 34.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -79.79 -52.15 8.28 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.345 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.05 -35.26 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.29 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -38.88 92.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' ASP . 21.0 mt-10 -70.66 -41.73 71.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 17' ' ' ARG . 16.1 mt -66.98 -41.94 85.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.685 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.3 mt -48.36 -24.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.89 -23.27 36.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.396 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -86.36 -40.35 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.598 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.99 -10.69 0.9 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -30.96 147.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HG3' ' CG ' ' A' ' 57' ' ' HIS . 11.4 mtpt -112.28 109.91 19.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.563 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 mt -94.37 131.9 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.089 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.607 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 12.4 mt -135.55 141.99 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -98.42 137.94 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.95 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.61 83.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 0.0 110.608 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.438 ' CD ' ' H ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -168.32 -149.1 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' H ' ' CD ' ' A' ' 25' ' ' ARG . 4.0 m-20 -89.01 114.14 25.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.351 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.593 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -43.34 -43.58 5.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.17 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -42.29 -21.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.763 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' ALA . 3.2 mm-40 -86.84 -38.45 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.859 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -81.6 -24.26 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.17 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -45.0 94.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -68.98 -21.93 64.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG2' ' CG2' ' A' ' 103' ' ' VAL . 2.8 tt0 -164.71 126.45 2.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.375 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 2.7 p80 -139.65 160.17 40.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.423 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 37' ' ' GLU . 10.0 mt -105.35 130.58 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.671 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.34 23.17 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.552 2.168 . . . . 0.0 111.876 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 35' ' ' ILE . 51.7 mm-40 -141.67 34.47 1.62 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.646 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.74 23.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.529 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 40' ' ' LEU . 2.0 t0 -90.32 155.48 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.684 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.649 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.5 tp -110.3 119.46 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.535 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.79 88.21 6.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.312 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' VAL . 88.4 Cg_exo -42.49 126.76 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.747 2.298 . . . . 0.0 112.688 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.607 ' CD1' ' O ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -41.99 -24.92 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.717 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' PRO . 5.6 t -79.18 -27.51 42.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.462 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 49' ' ' SER . 33.4 m -84.74 -27.83 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.165 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.466 ' N ' HG23 ' A' ' 45' ' ' VAL . 8.4 tp -70.62 -43.41 69.36 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.704 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -32.27 51.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -87.41 -43.63 11.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.611 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.26 -72.83 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.08 92.55 2.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.8 tp -118.59 83.57 22.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.446 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 54' ' ' LYS . 8.3 Cg_exo -68.79 62.22 1.26 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.885 2.39 . . . . 0.0 112.198 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 52' ' ' PRO . . . -39.72 -27.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -51.22 -18.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.48 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.33 -13.56 54.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.985 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.508 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.5 mtp85 -109.16 18.34 20.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -179.52 -169.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.03 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.542 ' C ' ' OE1' ' A' ' 59' ' ' GLN . 4.2 tt0 -118.94 -30.57 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.542 ' OE1' ' C ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -112.06 133.76 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.6 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -127.32 145.51 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.947 0.403 . . . . 0.0 111.107 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 61' ' ' ILE . 7.7 mt -137.55 136.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CD2' HD11 ' A' ' 77' ' ' LEU . 67.8 m-85 -119.75 132.25 55.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.733 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 1.8 p80 -129.0 134.03 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -116.29 153.39 32.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.745 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 60.1 tp60 -34.15 -36.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.481 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -125.61 -42.66 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.654 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 133.18 -32.0 2.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 67' ' ' GLY . 15.8 mmtm -38.67 -42.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.728 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -64.81 -31.92 73.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -61.13 -45.67 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.011 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.436 ' H ' ' HG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -81.3 -23.14 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.852 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.33 -33.37 20.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 69' ' ' ARG . 52.6 t30 -93.3 -17.0 24.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.4 -29.9 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -29.75 65.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.011 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -21.51 29.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.767 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.467 HD11 ' CD2' ' A' ' 62' ' ' PHE . 87.6 mt -80.92 -56.56 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.945 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' LEU . . . -39.27 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -80.18 -47.31 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.441 HD12 HG23 ' A' ' 80' ' ' ILE . 77.8 mt -80.84 -19.17 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.154 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -95.98 5.71 50.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.941 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.657 ' C ' ' H ' ' A' ' 84' ' ' ALA . . . 44.47 -178.86 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 0.0 110.371 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 82' ' ' ALA . 23.2 Cg_exo -60.45 21.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.732 2.288 . . . . 0.0 112.244 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.657 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -68.2 179.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.27 112.69 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mt -117.27 139.12 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.44 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -120.02 171.98 8.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.604 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.1 mt -137.2 131.73 32.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.993 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.475 ' C ' ' CD1' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -81.66 85.33 6.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.205 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.646 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 46.8 tt0 -57.48 121.03 9.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.646 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 19.1 t0 94.11 -26.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.46 -153.32 38.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.56 -21.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.15 -59.55 3.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.427 ' HA2' ' NH1' ' A' ' 98' ' ' ARG . . . -61.38 -40.35 98.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.533 ' CE2' ' CB ' ' A' ' 101' ' ' LEU . 16.7 t-105 -53.73 -35.44 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.361 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -80.68 -51.11 9.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.637 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' NH1' ' HA2' ' A' ' 95' ' ' GLY . 14.2 ttp-105 -51.48 -18.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.976 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.92 -21.12 15.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.775 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.62 72.68 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.533 ' CB ' ' CE2' ' A' ' 96' ' ' TRP . 15.1 mt -119.68 152.68 53.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.399 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' LEU . 96.3 Cg_exo -30.17 118.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 123.193 2.595 . . . . 0.0 112.446 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 2.4 p -143.64 157.04 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.088 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -143.48 130.03 20.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.076 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.416 ' C ' ' NE2' ' A' ' 34' ' ' HIS . 60.9 t -97.33 142.63 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.234 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.567 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -86.45 108.69 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.314 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.505 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 3' ' ' LEU . 4.0 pp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.827 0.346 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -116.83 144.17 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.401 HG22 ' HB3' ' A' ' 88' ' ' LEU . 1.4 p -78.16 145.13 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -136.32 166.06 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.824 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 6' ' ' ILE . 1.7 t -102.46 142.58 24.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.935 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -42.06 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.369 2.046 . . . . 0.0 112.063 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -80.89 -27.94 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.11 -52.68 6.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.367 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.11 -32.33 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.424 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.414 ' HA ' HD12 ' A' ' 15' ' ' ILE . 1.7 tt0 -66.24 -56.66 10.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -45.48 -26.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 27.8 mt -82.94 -39.9 20.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 12' ' ' GLN . 67.0 mt -49.2 -24.85 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.83 -20.72 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.958 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.558 ' N ' ' O ' ' A' ' 14' ' ' LEU . 6.0 ttt180 -84.14 -41.04 17.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.504 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 139.01 -7.37 3.21 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -31.29 151.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 0.0 110.601 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.787 ' HZ2' ' HE ' ' A' ' 56' ' ' ARG . 1.4 mtpt -109.42 99.72 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.423 HD23 ' CD2' ' A' ' 63' ' ' HIS . 0.6 OUTLIER -82.23 134.7 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.959 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 22' ' ' ILE . 14.4 mt -130.85 141.18 46.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 0.0 111.096 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.581 ' OD2' ' NH2' ' A' ' 25' ' ' ARG . 5.2 t0 -111.71 135.6 52.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.135 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 70' ' ' THR . 8.2 pt -130.12 81.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.243 0.544 . . . . 0.0 110.197 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.581 ' NH2' ' OD2' ' A' ' 23' ' ' ASP . 11.8 ptt180 -154.73 -145.54 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.285 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 11.2 m-20 -101.8 116.21 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.316 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -45.61 -36.01 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.189 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -48.34 -34.35 10.49 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -85.18 -32.4 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.806 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.759 ' CZ ' ' ND1' ' A' ' 34' ' ' HIS . 10.0 t80 -73.08 -31.0 64.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 4.0 tp -65.06 -59.24 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.694 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -53.63 -25.55 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.144 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.585 ' OE2' HG11 ' A' ' 103' ' ' VAL . 19.0 tt0 -152.76 117.78 5.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.185 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.77 ' ND1' ' N ' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -140.77 152.13 44.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.513 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.77 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 5.9 mt -110.62 94.18 18.73 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.662 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 50.2 Cg_exo -49.37 66.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.871 2.38 . . . . 0.0 112.4 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.71 ' N ' ' O ' ' A' ' 35' ' ' ILE . 14.5 pt-20 -179.46 27.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 153.49 30.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.337 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -84.77 143.53 29.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.71 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.37 114.55 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.84 96.59 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.555 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' VAL . 82.9 Cg_exo -44.94 124.41 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.372 2.048 . . . . 0.0 111.875 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 73' ' ' ASN . 1.7 tt -36.6 -60.29 0.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.137 0.494 . . . . 0.0 110.565 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -44.09 -25.93 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.974 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -73.9 -39.02 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.926 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.436 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 6.5 tt -83.39 -42.97 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.825 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.88 -29.89 71.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.847 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.487 ' CG ' ' N ' ' A' ' 49' ' ' SER . 7.7 pt20 -97.18 -40.61 8.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.935 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 2.1 t -87.47 -55.36 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.756 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 83.11 0.8 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.674 ' O ' ' N ' ' A' ' 53' ' ' ALA . 14.1 tp -107.58 97.92 21.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.87 67.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.564 2.176 . . . . 0.0 112.194 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -51.71 -19.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.275 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' HIS . 5.4 tttp -63.3 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mp -77.91 -13.56 59.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.793 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.787 ' HE ' ' HZ2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.1 19.95 8.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 166.17 -167.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.786 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -113.38 -39.58 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.3 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -112.31 133.47 54.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.156 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.946 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -136.33 144.35 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -127.02 146.51 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.169 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.725 ' CD1' HD13 ' A' ' 77' ' ' LEU . 96.6 m-85 -126.62 137.36 53.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.74 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 1.0 OUTLIER -140.75 136.32 32.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.519 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.6 t -115.7 153.22 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.455 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.519 ' C ' ' O ' ' A' ' 64' ' ' CYS . 2.8 tt0 -30.08 -53.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.65 54.08 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.621 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 42.7 49.57 5.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -112.24 -42.62 3.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.759 ' HB3' HD12 ' A' ' 43' ' ' LEU . 2.9 mmt180 -83.39 -31.9 26.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.611 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.676 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -65.37 -43.34 91.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.531 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -24.7 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.37 -43.96 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.776 ' HB2' HD11 ' A' ' 43' ' ' LEU . 3.4 t-20 -88.46 -16.44 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.636 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -44.32 -38.22 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.387 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.47 -27.06 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.577 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ASN . 15.6 mmtm -78.96 -26.15 43.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.725 HD13 ' CD1' ' A' ' 62' ' ' PHE . 80.4 mt -77.9 -56.81 4.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.33 -33.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.16 -48.32 17.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.5 mt -75.8 -17.7 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -96.27 8.18 44.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.731 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 42.98 -179.47 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 110.626 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.809 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 18.1 Cg_exo -62.49 15.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.658 2.239 . . . . 0.0 112.018 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -53.1 -152.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -122.31 98.7 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.382 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 60' ' ' ILE . 3.0 mp -116.04 146.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.47 177.9 4.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.188 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -135.95 129.28 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.775 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -87.54 101.33 13.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 15.4 tt0 -54.36 121.24 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER 82.22 -50.26 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.568 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.474 ' H ' HD12 ' A' ' 89' ' ' LEU . . . 120.92 -133.87 9.9 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -77.05 -30.83 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 50.1 t0 -48.22 -30.69 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.81 -54.79 4.76 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.457 ' CE2' HD13 ' A' ' 101' ' ' LEU . 2.3 t90 -47.09 -32.19 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.914 0.387 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -73.87 -53.05 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.586 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' C ' ' N ' ' A' ' 100' ' ' GLY . 3.3 ttt180 -66.2 -29.54 69.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.534 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.52 -12.26 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.742 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 98' ' ' ARG . . . 101.24 24.19 9.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.457 HD13 ' CE2' ' A' ' 96' ' ' TRP . 16.4 mt -116.46 138.09 24.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.25 161.66 40.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.349 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.585 HG11 ' OE2' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -111.96 172.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.211 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -132.78 121.15 22.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.691 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 32' ' ' ARG . 15.0 t -96.75 144.02 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.3 108.6 4.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.295 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 tttt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.55 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.8 pp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.814 0.34 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -122.4 158.41 29.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.581 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -87.9 144.25 26.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -136.7 164.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.458 . . . . 0.0 110.931 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 9' ' ' HIS . 17.2 t -104.07 138.99 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.796 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.23 -16.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.578 2.185 . . . . 0.0 111.854 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.645 ' N ' ' O ' ' A' ' 7' ' ' SER . 23.6 m170 -75.92 -35.98 59.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.947 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.2 t0 -76.22 -54.19 7.15 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.506 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.13 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.413 ' HA ' HD12 ' A' ' 15' ' ' ILE . 28.2 tt0 -49.73 -46.77 50.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.27 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -59.01 -42.0 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.189 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.809 HD12 HD11 ' A' ' 61' ' ' ILE . 6.9 mt -68.3 -43.85 76.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 12' ' ' GLN . 58.6 mt -48.14 -23.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.855 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.61 25.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.483 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.0 ttm-85 -81.12 -40.5 23.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.87 -11.81 0.95 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -27.07 144.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.69 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HG3' ' CG ' ' A' ' 57' ' ' HIS . 4.8 mmtm -102.24 98.38 8.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.727 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.588 HD22 ' CE1' ' A' ' 63' ' ' HIS . 0.5 OUTLIER -84.48 131.78 34.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.105 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.43 140.79 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.511 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.568 ' CG ' ' CE1' ' A' ' 30' ' ' TYR . 1.4 t70 -101.89 136.72 41.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 43' ' ' LEU . 1.1 pp -136.98 84.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 0.0 110.736 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -160.81 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.93 111.23 23.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -41.86 -33.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.276 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.16 -34.67 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -83.84 -31.89 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.538 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.862 ' CD2' HD13 ' A' ' 40' ' ' LEU . 1.5 t80 -77.67 -25.37 49.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.412 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' ALA . 1.4 tp -70.32 -47.94 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.171 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.0 -10.2 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.237 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.5 tt0 -172.83 137.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.63 ' CD2' ' OD1' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -160.63 161.28 32.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 110.796 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 37' ' ' GLU . 1.7 mt -106.27 105.33 53.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 32.2 Cg_exo -54.33 19.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.576 2.184 . . . . 0.0 113.046 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.676 ' H ' ' C ' ' A' ' 35' ' ' ILE . 56.1 mm-40 -135.12 24.15 3.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.487 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.51 149.09 42.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.81 133.59 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 30' ' ' TYR . 61.0 tp -92.79 118.0 30.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.291 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.44 93.36 4.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.6 Cg_exo -45.49 120.48 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.497 2.132 . . . . 0.0 111.954 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -41.23 -25.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.987 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.25 -26.73 32.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.51 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG1' ' N ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -78.34 -48.75 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.077 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.848 HD12 ' H ' ' A' ' 51' ' ' LEU . 13.5 tp -54.91 -27.13 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -84.38 -49.47 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -67.0 -52.87 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.6 t -82.99 -77.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.07 91.47 1.28 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 46' ' ' LEU . 17.0 tp -124.46 79.2 61.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.778 0.323 . . . . 0.0 110.579 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 54' ' ' LYS . 7.6 Cg_exo -69.33 78.12 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.987 2.458 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.52 -21.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . 14.5 tttm -57.35 -13.81 3.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.074 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.7 mt -77.55 -10.7 59.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.519 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.7 mtt180 -125.01 22.88 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.299 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -170.14 -169.04 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.167 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.7 -34.68 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.023 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -112.77 133.26 54.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' H ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -129.76 118.53 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.809 HD11 HD12 ' A' ' 14' ' ' LEU . 12.1 mt -110.5 141.74 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.15 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.563 ' CG ' HD13 ' A' ' 77' ' ' LEU . 60.4 m-85 -123.85 143.3 50.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.051 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.588 ' CE1' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -143.22 135.94 27.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.346 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.809 ' HG ' ' HG1' ' A' ' 70' ' ' THR . 1.3 m -116.48 153.07 32.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 66' ' ' ALA . 6.9 pt20 -34.91 -39.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.478 ' N ' ' HG2' ' A' ' 65' ' ' GLN . . . -128.06 -4.96 5.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.568 ' H ' ' HB2' ' A' ' 64' ' ' CYS . . . 85.32 -28.78 4.58 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -42.56 -26.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HB3' ' SG ' ' A' ' 64' ' ' CYS . 2.7 tpm_? -83.59 -25.45 30.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.068 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.809 ' HG1' ' HG ' ' A' ' 64' ' ' CYS . 0.2 OUTLIER -65.88 -54.61 24.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.765 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -65.17 -23.66 67.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -86.4 -47.5 9.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.539 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.601 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 t30 -84.28 -16.29 43.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.361 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -41.34 -33.87 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.113 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.18 -31.32 67.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 73' ' ' ASN . 33.8 mmtt -81.79 -22.08 37.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.904 0.383 . . . . 0.0 110.532 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.563 HD13 ' CG ' ' A' ' 62' ' ' PHE . 60.9 mt -80.62 -57.19 3.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.654 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.99 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.48 -54.59 34.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -18.46 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.221 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.03 2.17 50.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.841 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 52.63 -179.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.735 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 22.9 Cg_exo -60.54 7.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.878 2.386 . . . . 0.0 112.448 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -46.48 169.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.279 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.9 102.67 4.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.217 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.78 133.13 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.425 ' O ' HD23 ' A' ' 88' ' ' LEU . 46.7 m-85 -125.54 153.56 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.609 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.531 HD22 HG22 ' A' ' 70' ' ' THR . 23.1 mt -122.39 137.03 55.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.195 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.507 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.6 tt -89.04 91.34 8.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.34 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -40.66 147.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 68.35 -47.44 0.54 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 101.9 -145.76 16.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mm -51.0 -41.93 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.477 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.29 -35.26 59.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.02 -47.11 39.88 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.529 ' CD1' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.95 -37.04 81.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.45 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -80.76 -25.79 37.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.376 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -73.86 -44.75 54.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.45 63.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.564 ' O ' HD23 ' A' ' 101' ' ' LEU . . . 125.76 45.34 0.24 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 100' ' ' GLY . 9.6 mt -123.5 106.27 32.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -45.62 152.09 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.455 2.103 . . . . 0.0 112.174 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.37 169.06 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.436 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -128.65 144.12 51.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.454 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.96 130.57 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.63 ' OD1' ' CD2' ' A' ' 34' ' ' HIS . 1.7 m-20 -67.59 109.69 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 106' ' ' ASN . 17.6 tttt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.852 0.358 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 m -132.72 151.97 51.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.49 33.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.548 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -144.8 163.28 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.728 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.599 ' O ' ' N ' ' A' ' 9' ' ' HIS . 4.9 m -108.62 142.98 26.59 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.46 -17.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.477 2.118 . . . . 0.0 111.722 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.599 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -73.06 -35.81 66.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.754 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -75.66 -56.11 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.209 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.61 -23.44 0.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -70.99 -44.41 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -68.07 -26.06 65.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.776 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 14.7 mt -79.74 -45.13 19.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.5 mt -47.76 -23.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.447 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -27.46 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.118 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 14' ' ' LEU . 9.9 mtt180 -84.43 -41.54 16.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.416 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.74 28.08 0.41 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -59.82 149.09 32.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.4 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.61 102.51 13.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.673 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 21' ' ' LEU . 5.2 mp -92.56 129.22 38.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.443 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 7.3 mt -127.44 142.43 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.032 0.444 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -103.75 153.43 20.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.555 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.447 ' O ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 pp -147.73 90.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.334 0.588 . . . . 0.0 110.789 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 24.4 ttt-85 -173.91 -141.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.9 119.69 30.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.271 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.71 97.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.534 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.66 -26.28 3.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.006 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.56 -44.95 11.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.301 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.8 t80 -70.37 -31.03 68.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.195 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.56 -58.21 8.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.743 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -52.63 -28.66 22.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.27 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.9 tt0 -152.51 123.58 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -150.55 175.55 11.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.011 0.434 . . . . 0.0 111.034 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.687 ' C ' ' H ' ' A' ' 37' ' ' GLU . 43.8 mt -109.2 106.07 58.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.253 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 32.1 Cg_exo -54.44 19.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.573 2.182 . . . . 0.0 112.981 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.687 ' H ' ' C ' ' A' ' 35' ' ' ILE . 41.4 mm-40 -137.82 38.51 2.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.342 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.2 150.33 25.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.53 126.41 35.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.1 tp -85.19 117.14 23.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.177 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.36 93.75 6.34 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.569 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.3 Cg_exo -45.99 122.5 5.3 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.498 2.132 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.014 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -39.79 -29.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -75.49 -30.7 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -68.4 -38.77 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.112 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD22 HD23 ' A' ' 77' ' ' LEU . 2.4 tt -73.41 -41.81 62.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -64.99 -31.03 72.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.195 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -96.14 -32.73 12.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.145 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 10.0 t -92.07 -44.44 8.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 110.809 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 68.37 64.26 3.18 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -98.68 110.55 57.54 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' LYS . 58.6 Cg_endo -77.44 63.09 7.83 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.376 2.05 . . . . 0.0 112.353 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.62 -21.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.961 0.41 . . . . 0.0 110.046 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HE2' ' HB3' ' A' ' 82' ' ' ALA . 30.9 tttp -54.34 -21.43 9.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.454 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.59 -6.31 53.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.72 14.86 30.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.412 . . . . 0.0 110.472 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 177.97 -164.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.736 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -121.92 -26.46 4.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.089 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -113.82 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.801 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -134.56 142.16 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.795 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.27 144.85 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.431 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 47.7 m-85 -123.96 141.19 52.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.861 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -149.15 133.84 17.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.536 ' O ' ' C ' ' A' ' 65' ' ' GLN . 3.5 m -117.54 153.73 32.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.536 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.5 OUTLIER -28.23 -41.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.593 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -126.27 -60.45 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.537 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 154.7 -37.16 0.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 72' ' ' ASN . 24.6 tttt -45.14 -29.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HE ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -75.22 -36.49 61.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.773 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -65.66 -42.98 90.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.423 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -66.31 -21.17 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.633 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.423 ' CG ' ' O ' ' A' ' 68' ' ' LYS . 24.8 m-20 -82.75 -41.74 18.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 76' ' ' LYS . 13.0 t30 -98.72 -13.81 20.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -47.16 -29.97 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.53 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -80.81 -31.37 35.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.528 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 73' ' ' ASN . 36.7 mmtm -76.76 -41.29 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.655 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.538 HD23 HD22 ' A' ' 46' ' ' LEU . 10.1 mt -67.81 -57.8 5.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.17 -29.8 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.454 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.5 -56.38 20.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.38 -20.51 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.55 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -77.27 -2.76 36.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 44.95 -179.27 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 110.472 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 22.7 Cg_exo -60.23 26.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.764 2.309 . . . . 0.0 112.09 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.623 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -69.11 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.506 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -110.31 99.09 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.464 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.83 133.24 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.87 163.38 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.851 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 89' ' ' LEU . 10.1 tp -131.92 132.32 43.46 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.876 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 88' ' ' LEU . 7.2 tt -99.24 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' O ' ' OD2' ' A' ' 91' ' ' ASP . 2.7 tm-20 -63.28 158.55 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.424 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.591 ' OD2' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER 69.34 -40.21 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.664 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.521 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 94.2 -160.86 24.08 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.86 -26.6 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.265 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -23.05 6.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.346 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . -86.56 -52.49 3.16 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.01 -28.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -76.53 -51.45 11.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 99' ' ' ALA . 5.9 mmt180 -61.27 -44.37 97.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 98' ' ' ARG . . . -39.26 -33.89 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.448 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.11 1.53 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mt -123.53 137.19 28.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.421 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -72.85 174.01 12.56 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.444 2.096 . . . . 0.0 112.379 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.551 HG21 ' OE2' ' A' ' 33' ' ' GLU . 35.1 m -112.09 172.12 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -141.08 135.21 30.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.62 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 32' ' ' ARG . 19.5 t -97.13 158.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.459 ' OD1' ' CD2' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -84.8 109.04 17.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 tptp . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.444 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.435 HD22 ' HB2' ' A' ' 78' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.775 0.322 . . . . 0.0 110.58 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 147.87 45.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.603 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -78.75 151.32 32.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.544 HG23 ' N ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -137.51 166.4 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.442 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.4 OUTLIER -109.21 140.31 21.87 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.514 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.06 -18.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.278 1.985 . . . . 0.0 111.585 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.9 m170 -73.87 -30.63 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.37 -52.73 7.33 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.782 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.01 -32.08 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.708 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.563 ' HA ' HD12 ' A' ' 15' ' ' ILE . 2.9 tt0 -68.89 -44.11 73.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.631 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 7.2 mt-10 -66.36 -42.18 88.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 22.5 mt -63.73 -42.76 97.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 12' ' ' GLN . 22.0 mt -48.22 -24.37 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 13' ' ' GLU . . . -78.65 -28.2 45.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.86 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 14' ' ' LEU . 3.4 mtp180 -84.33 -30.5 25.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.098 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.8 23.9 2.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -54.35 153.94 5.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -104.83 97.7 7.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.548 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 131.98 40.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.864 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.635 HD12 ' CZ ' ' A' ' 62' ' ' PHE . 9.7 mt -135.79 141.08 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.601 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 25' ' ' ARG . 11.1 t0 -110.8 145.12 38.71 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.819 HG22 ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -112.89 -73.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.891 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 24' ' ' ILE . 8.5 ptm180 20.57 -143.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.156 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -116.15 109.64 17.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.046 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.0 -42.1 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -43.08 -38.43 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.44 -22.84 26.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.382 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.818 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.5 t80 -82.32 -29.16 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -43.77 93.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.449 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.755 ' O ' HG13 ' A' ' 105' ' ' VAL . 30.4 mtp85 -74.59 -13.84 60.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.065 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.555 ' O ' ' O ' ' A' ' 30' ' ' TYR . 5.9 tt0 -157.48 122.01 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.279 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.591 ' ND1' ' O ' ' A' ' 104' ' ' ALA . 39.0 p-80 -145.21 147.57 32.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mt -90.95 130.96 38.62 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.365 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.7 24.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.511 2.141 . . . . 0.0 112.444 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -146.18 35.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.778 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -162.89 147.33 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -84.57 161.22 20.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.454 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.818 HD13 ' CD2' ' A' ' 30' ' ' TYR . 56.5 tp -115.33 122.01 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.68 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.819 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -160.25 95.57 1.53 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.065 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -46.85 147.46 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.578 2.185 . . . . 0.0 112.034 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 44' ' ' SER . 1.1 pp -71.72 -24.13 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.249 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 46.8 p -76.81 -35.53 57.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.966 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.8 -30.36 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.34 -40.42 89.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.53 -50.13 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -69.47 -34.16 73.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 t -72.8 -78.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.16 75.91 1.0 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 53' ' ' ALA . 32.5 tp -117.7 89.1 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 110.701 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.1 73.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.802 2.335 . . . . 0.0 112.136 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -57.35 -28.13 62.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.389 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . 8.9 tttm -51.94 -24.7 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.387 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.88 -13.6 59.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.565 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 54.9 mtp180 -91.77 16.82 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 169.51 -163.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.902 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.26 -31.15 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.916 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.494 ' C ' HD12 ' A' ' 60' ' ' ILE . 3.2 mt-30 -112.46 132.92 54.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.425 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.89 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -142.27 148.16 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -136.86 144.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.435 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 49.5 m-85 -124.64 151.04 45.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.425 ' HA ' HG21 ' A' ' 70' ' ' THR . 48.3 p-80 -159.98 144.36 14.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 111.656 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.583 ' O ' ' C ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -116.74 154.1 31.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.171 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.583 ' C ' ' O ' ' A' ' 64' ' ' CYS . 5.0 tm0? -21.66 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.783 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -109.22 -22.4 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.457 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 113.29 -33.58 5.48 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 67' ' ' GLY . 2.6 pttp -35.49 -64.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.708 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 19.6 mtt85 -52.12 -38.62 57.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.682 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.861 HG22 HD11 ' A' ' 88' ' ' LEU . 2.1 m -58.74 -47.83 83.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.685 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -70.4 -18.86 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.786 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.04 -47.77 10.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -84.55 -14.18 49.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.718 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -49.89 -26.75 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.517 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -37.25 76.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.62 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -74.89 -26.91 59.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 79' ' ' ALA . 75.2 mt -74.86 -56.89 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' A' ' 3' ' ' LEU . . . -41.31 -22.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.671 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -76.83 -53.06 8.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -75.99 -17.75 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.533 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -87.14 -2.95 59.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 45.71 179.53 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 25.0 Cg_exo -58.25 9.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.596 2.197 . . . . 0.0 111.93 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -55.26 -167.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.332 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 85' ' ' GLU . 3.8 mm-40 -105.42 106.21 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.34 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -116.32 169.48 9.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.861 HD11 HG22 ' A' ' 70' ' ' THR . 7.9 tp -137.85 128.73 27.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 92' ' ' GLY . 4.9 tt -88.17 108.78 19.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.627 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 8.1 tt0 -66.16 147.85 52.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 66' ' ' ALA . 19.7 t0 77.7 -35.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.748 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.511 ' H ' HD23 ' A' ' 89' ' ' LEU . . . 92.84 -164.57 27.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.3 -21.41 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.482 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -61.8 -25.65 67.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.33 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.74 -35.3 25.55 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -30.8 70.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.934 0.397 . . . . 0.0 110.134 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -72.12 -38.13 69.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.355 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -75.57 -33.67 60.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.293 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.54 -15.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.548 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.92 32.31 7.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.6 mt -120.0 104.11 44.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.87 160.17 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.571 2.18 . . . . 0.0 112.4 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.76 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.591 ' O ' ' ND1' ' A' ' 34' ' ' HIS . . . -125.41 126.24 44.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.306 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 32' ' ' ARG . 18.3 t -96.01 133.74 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.472 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 107' ' ' LYS . 63.3 t-20 -87.17 109.6 19.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 106' ' ' ASN . 75.5 tttt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.567 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -105.87 147.05 29.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.764 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.77 150.63 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -140.28 163.3 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.421 0.629 . . . . 0.0 111.547 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.525 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -109.12 145.33 31.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.318 178.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -39.64 -26.25 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.374 2.05 . . . . 0.0 111.897 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' SER . 78.3 m80 -65.99 -33.37 75.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.416 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.8 t0 -77.85 -55.66 5.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.141 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.88 5.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.284 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.07 -38.88 87.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -74.52 -44.9 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.536 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 3.3 mt -65.28 -47.36 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt -47.69 -25.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.795 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.11 -24.69 26.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.215 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -81.35 -41.2 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.703 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 151.43 -15.85 0.85 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -28.41 137.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.425 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.21 98.28 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.545 HD22 ' CE1' ' A' ' 63' ' ' HIS . 1.8 mt -81.39 136.27 35.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.796 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.503 HD12 ' CZ ' ' A' ' 62' ' ' PHE . 5.7 mt -128.9 139.58 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.109 0.481 . . . . 0.0 111.3 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' OD2' ' CD1' ' A' ' 30' ' ' TYR . 14.9 t70 -103.57 132.36 49.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.61 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.465 HD13 ' HG ' ' A' ' 43' ' ' LEU . 1.1 pt -133.65 82.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 110.83 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 65' ' ' GLN . 3.5 ptt180 -156.63 -150.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.358 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -92.15 116.87 29.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.584 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -47.67 -31.73 4.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.083 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 2.5 m-20 -52.71 -44.41 66.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -74.71 -32.6 62.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.693 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.5 t80 -72.19 -25.79 61.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.961 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -67.85 -55.66 12.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp85 -52.17 -18.69 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.18 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 30' ' ' TYR . 2.3 mt-10 -172.03 139.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.475 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.672 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 15.6 p80 -153.64 150.81 29.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.483 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 122.59 52.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.548 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.45 51.27 3.67 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -158.74 18.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.688 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.21 151.48 38.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -85.05 124.05 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.424 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.693 HD13 ' CD2' ' A' ' 30' ' ' TYR . 50.1 tp -83.31 117.81 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.643 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.5 90.68 4.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.344 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 81.4 Cg_exo -45.79 124.29 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.827 2.351 . . . . 0.0 112.617 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -34.0 -62.58 0.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.441 0.638 . . . . 0.0 110.444 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -43.13 -29.8 0.4 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.307 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -76.73 -42.59 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.774 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.47 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 7.3 tp -78.06 -20.16 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.797 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -39.08 30.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.755 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -90.59 -38.68 12.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.801 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 11.7 t -73.14 -77.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.77 75.97 1.09 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.6 89.36 52.35 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.473 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 54' ' ' LYS . 25.0 Cg_exo -58.67 83.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.844 2.363 . . . . 0.0 112.294 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.64 -20.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.001 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.981 ' HZ3' ' HB3' ' A' ' 82' ' ' ALA . 9.4 tttt -60.57 -14.73 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.029 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.1 mt -77.09 -13.34 59.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.615 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -113.76 23.04 13.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.83 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.077 0.465 . . . . 0.0 110.985 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -119.65 -34.09 3.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.156 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.451 ' OE1' HD11 ' A' ' 61' ' ' ILE . 9.4 tt0 -112.13 133.32 54.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.936 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -133.42 120.5 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.451 HD11 ' OE1' ' A' ' 59' ' ' GLN . 6.4 mt -115.43 149.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 23.1 m-85 -130.07 151.35 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.559 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' A' ' 63' ' ' HIS . 3.4 p-80 -154.59 134.03 12.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.768 ' SG ' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -116.46 155.15 29.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.561 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -22.86 -59.96 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.138 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.31 20.69 14.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.98 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.768 ' N ' ' SG ' ' A' ' 64' ' ' CYS . . . 63.47 6.28 14.94 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.764 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -70.4 -57.46 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.432 ' NH1' ' HA ' ' A' ' 25' ' ' ARG . 3.1 ttm180 -61.24 -23.21 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.556 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -64.15 -59.8 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -57.08 -18.88 16.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.752 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -80.03 -44.23 20.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.493 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.451 ' CG ' HD21 ' A' ' 43' ' ' LEU . 16.9 t30 -84.93 -17.01 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.411 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.64 -26.75 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.427 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -85.2 -37.74 19.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.689 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.72 -28.22 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.61 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.458 HD13 ' CG ' ' A' ' 62' ' ' PHE . 95.0 mt -68.47 -53.86 20.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.664 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.04 -56.68 4.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.321 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.6 55.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.968 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -78.01 -18.18 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.146 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -122.99 101.09 7.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.017 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.981 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . . . -39.43 170.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.755 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 32.8 Cg_exo -50.36 65.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.751 2.3 . . . . 0.0 112.433 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.706 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.73 -167.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.78 98.44 11.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.24 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -111.67 135.84 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.54 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CG ' HD12 ' A' ' 6' ' ' ILE . 69.2 m-85 -124.52 168.73 12.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -137.47 133.32 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 92' ' ' GLY . 5.2 tt -89.09 100.69 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.587 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 79.1 tt0 -60.84 149.59 35.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.423 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 12.2 t0 77.79 -46.07 0.45 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.618 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.522 ' H ' HD23 ' A' ' 89' ' ' LEU . . . 104.37 -167.97 16.13 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.728 HD11 HG11 ' A' ' 103' ' ' VAL . 2.2 tt -50.92 -20.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 110.31 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.32 -31.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.268 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.94 -49.67 8.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.672 ' NE1' ' O ' ' A' ' 101' ' ' LEU . 2.4 t-105 -51.97 -38.86 58.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.189 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -70.27 -38.1 75.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.309 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -77.58 -26.22 50.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.63 4.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.53 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.07 18.01 33.0 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.672 ' O ' ' NE1' ' A' ' 96' ' ' TRP . 50.9 mt -118.4 96.52 49.93 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 0.0 110.53 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.37 177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.649 2.233 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.728 HG11 HD11 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -121.41 172.11 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.541 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -115.68 128.73 56.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 33' ' ' GLU . 6.0 t -96.45 133.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.421 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.672 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 1.4 t30 -67.5 108.81 2.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 106' ' ' ASN . 24.2 tptt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.578 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.1 pp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.833 0.349 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 5' ' ' THR . 24.2 m -128.93 158.47 38.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.509 ' N ' HG22 ' A' ' 4' ' ' THR . 0.8 OUTLIER -88.05 148.65 24.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.177 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -137.26 166.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.191 0.519 . . . . 0.0 110.953 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.555 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -106.83 142.13 24.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.889 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.74 -19.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.498 2.132 . . . . 0.0 112.058 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.9 m80 -76.12 -28.03 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.426 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -84.19 -52.45 6.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.97 -32.94 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -68.31 -51.12 48.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.66 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -56.23 -27.91 56.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 17' ' ' ARG . 25.9 mt -76.18 -42.33 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.2 mt -47.91 -22.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -85.6 -24.23 27.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.151 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -79.39 -51.25 9.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.419 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.578 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 136.81 32.47 0.24 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.0 -177.46 3.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -125.36 111.04 14.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.474 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.11 125.27 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.461 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.557 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 18.6 mt -136.31 138.31 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 111.397 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.657 ' OD1' ' NE ' ' A' ' 25' ' ' ARG . 10.9 t0 -108.83 146.31 33.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.608 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -114.78 -73.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.911 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.657 ' NE ' ' OD1' ' A' ' 23' ' ' ASP . 8.4 ptp180 16.42 -139.61 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.555 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -117.01 113.74 22.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' ASP . . . -38.32 -23.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 26' ' ' ASP . 45.1 m-20 -58.82 -33.11 70.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 15.3 mm-40 -86.37 -30.18 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.821 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.748 ' CD2' HD13 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -75.22 -39.11 60.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.256 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.44 -53.19 60.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.238 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.619 ' O ' HG13 ' A' ' 105' ' ' VAL . 7.6 ptp180 -56.83 -26.68 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 30' ' ' TYR . 15.9 tt0 -164.87 129.76 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.128 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.488 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 55.1 p-80 -143.88 169.81 17.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 37' ' ' GLU . 2.7 mt -109.1 126.65 28.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.185 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.49 24.87 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.287 1.991 . . . . 0.0 111.963 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 35' ' ' ILE . 80.5 mm-40 -138.73 25.94 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.766 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.95 146.75 23.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.672 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -86.61 153.79 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.748 HD13 ' CD2' ' A' ' 30' ' ' TYR . 45.2 tp -108.39 124.43 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.732 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -162.71 96.53 1.13 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.614 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.792 ' O ' HG22 ' A' ' 45' ' ' VAL . 39.7 Cg_exo -50.56 146.66 19.18 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.497 2.131 . . . . 0.0 112.082 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 44' ' ' SER . 1.2 pp -65.93 -23.62 66.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.782 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.452 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -74.93 -29.24 60.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 42' ' ' PRO . 23.6 m -84.92 -25.27 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.72 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 50' ' ' GLY . 3.0 tp -84.93 -46.61 11.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.571 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.61 -31.41 72.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.704 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -85.12 -30.17 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 6.7 m -94.95 -71.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 94.83 87.1 1.7 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.658 HD12 ' HB2' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -112.31 82.53 4.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.794 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' LEU . 74.8 Cg_exo -45.2 -7.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.796 2.331 . . . . 0.0 112.555 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 51' ' ' LEU . . . -43.43 -29.53 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.974 ' NZ ' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -57.11 -5.75 0.3 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 109.834 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.629 ' C ' ' H ' ' A' ' 57' ' ' HIS . 9.7 mp -94.41 -9.97 33.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.479 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.64 8.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.251 0.548 . . . . 0.0 110.271 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.629 ' H ' ' C ' ' A' ' 55' ' ' LEU . 2.0 t60 -134.88 -145.38 0.23 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.231 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 24.7 tt0 -144.4 -43.89 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.032 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.68 133.1 54.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.714 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.4 mp -139.19 147.75 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.139 0.495 . . . . 0.0 111.389 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.4 139.59 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.908 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -121.95 137.1 54.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.668 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.2 OUTLIER -129.8 134.07 47.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.104 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 24' ' ' ILE . 67.3 m -116.37 153.47 31.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.336 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 32.7 tt0 -26.74 -70.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.85 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 91' ' ' ASP . . . -100.95 -51.31 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.602 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.09 -17.39 1.93 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -59.15 -36.78 75.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.562 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -65.71 -46.77 77.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.236 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.685 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -49.15 -50.99 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.518 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -24.13 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.522 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 29.9 m120 -86.18 -46.54 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.17 -16.2 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -46.16 -30.9 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.594 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.9 -38.05 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -73.93 -26.92 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.76 -57.83 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.86 -24.0 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.35 -40.86 64.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.653 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.5 mt -85.71 -47.12 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.633 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.974 ' HB2' ' NZ ' ' A' ' 54' ' ' LYS . . . -45.78 -27.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.608 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.776 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 67.91 173.79 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.776 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 34.3 Cg_exo -53.57 65.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.699 2.266 . . . . 0.0 112.006 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.17 -172.29 2.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.536 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -102.03 117.42 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.581 HD12 ' N ' ' A' ' 86' ' ' ILE . 2.6 mp -128.47 142.2 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -121.58 169.03 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.028 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' ILE . 18.8 mt -135.6 138.35 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 92' ' ' GLY . 7.2 tt -89.92 107.95 19.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.57 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.6 tp10 -64.13 155.65 30.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.6 OUTLIER 69.52 -34.77 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 90' ' ' GLU . . . 91.4 -160.92 27.17 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.428 ' HB ' HH12 ' A' ' 25' ' ' ARG . 1.0 OUTLIER -50.3 -27.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.344 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.13 -52.39 64.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.151 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.0 -24.34 62.75 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 101' ' ' LEU . 9.6 t-105 -82.5 -35.2 27.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -77.26 -30.62 54.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.483 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -78.45 -35.07 47.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.485 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.93 4.45 3.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.48 65.94 3.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 96' ' ' TRP . 59.7 mt -119.96 149.66 49.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.122 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -35.49 146.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 123.006 2.471 . . . . 0.0 112.468 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.401 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 8.8 p -151.51 154.85 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.96 139.04 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.595 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 32' ' ' ARG . 3.7 t -98.47 137.31 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.378 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -88.51 111.35 21.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.619 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.478 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.2 pp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.872 0.368 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.8 m -116.36 156.19 27.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.013 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 p -85.41 149.48 25.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.229 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -139.09 164.2 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.061 0.458 . . . . 0.0 110.816 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -103.32 139.79 20.44 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.24 -16.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.559 2.173 . . . . 0.0 111.898 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' SER . 35.2 t60 -78.47 -35.27 46.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.944 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -75.66 -49.62 17.85 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.089 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -43.29 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.338 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.98 -50.32 58.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 5.0 mt-10 -55.27 -30.8 60.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 61' ' ' ILE . 9.1 mt -75.3 -43.87 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.497 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.4 mt -48.27 -22.72 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.412 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -81.01 -26.67 36.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 7.4 mtt180 -85.46 -38.06 19.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.462 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.54 30.62 0.96 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -57.42 175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 110.519 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.45 ' NZ ' ' HB2' ' A' ' 57' ' ' HIS . 4.6 mttp -118.61 98.05 6.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.487 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -89.39 126.67 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.991 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.654 ' C ' ' CE1' ' A' ' 63' ' ' HIS . 6.9 mt -131.62 140.79 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.984 0.421 . . . . 0.0 111.421 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 24' ' ' ILE . 64.2 t0 -99.7 149.07 23.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.641 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -150.56 91.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.762 0.792 . . . . 0.0 110.582 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 23' ' ' ASP . 7.3 ptt-85 -169.04 -143.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.091 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.461 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -96.92 107.35 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.234 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -40.74 -26.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.457 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' ASP . 41.4 t0 -57.52 -38.07 74.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.09 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' OE1' ' OE1' ' A' ' 65' ' ' GLN . 10.9 mt-10 -80.68 -32.04 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.335 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.887 ' CD2' HD13 ' A' ' 40' ' ' LEU . 12.3 t80 -78.92 -32.0 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 7.4 tp -60.27 -55.47 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.298 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 105' ' ' VAL . 16.0 mtp180 -55.0 -20.14 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.302 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.731 ' OE2' HG11 ' A' ' 103' ' ' VAL . 22.4 tt0 -163.29 120.7 1.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.696 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 15.0 p80 -138.24 160.85 38.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.591 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.6 mt -98.7 128.13 33.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.53 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.68 21.32 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.49 2.126 . . . . 0.0 111.91 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -141.96 26.49 1.87 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.34 33.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.793 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -87.64 145.68 26.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.887 HD13 ' CD2' ' A' ' 30' ' ' TYR . 62.7 tp -101.99 116.91 33.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.478 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.91 93.81 6.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 52.6 Cg_exo -47.47 118.01 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.505 2.137 . . . . 0.0 111.875 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.886 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -38.26 -34.68 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.12 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 1.8 t -71.53 -29.77 65.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.357 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -73.28 -43.3 57.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.206 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.523 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 17.6 tp -75.82 -21.65 57.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.207 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.48 -39.72 31.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -92.79 -40.99 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 8.3 t -65.71 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.44 79.95 1.49 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.643 ' C ' ' H ' ' A' ' 53' ' ' ALA . 16.0 tp -118.28 91.43 40.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.785 0.326 . . . . 0.0 110.657 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 54' ' ' LYS . 27.4 Cg_exo -58.76 21.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.739 2.293 . . . . 0.0 112.168 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 51' ' ' LEU . . . -47.19 -21.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 81' ' ' ALA . 1.4 ttpm? -63.68 -27.17 69.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.414 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 55' ' ' LEU . 11.1 mp -76.86 -9.12 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.39 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -80.66 10.91 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 110.156 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.45 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 2.0 t60 -148.87 -146.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.421 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -150.15 -36.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.346 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.68 133.13 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.814 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.86 153.34 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.321 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 14' ' ' LEU . 4.5 mt -141.9 125.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.137 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.827 ' CE2' HD13 ' A' ' 77' ' ' LEU . 80.1 m-85 -107.7 149.23 28.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.956 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.654 ' CE1' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -138.68 133.43 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.794 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.593 ' SG ' ' CB ' ' A' ' 69' ' ' ARG . 1.4 t -116.73 153.77 31.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.519 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 6.7 pt20 -36.03 -33.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.872 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -140.09 -37.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.915 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.71 -4.66 3.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -45.71 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.667 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.593 ' CB ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -59.26 -33.99 71.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.628 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.621 ' O ' ' N ' ' A' ' 74' ' ' ALA . 52.4 m -73.13 -46.22 52.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.722 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 p -62.94 -26.96 69.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.19 -27.72 24.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' CG ' HD13 ' A' ' 43' ' ' LEU . 23.2 t30 -102.57 -12.89 17.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.568 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -55.44 -35.26 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.657 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.3 -34.81 78.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.552 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -73.19 -34.21 65.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.544 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.827 HD13 ' CE2' ' A' ' 62' ' ' PHE . 28.0 mt -75.66 -56.06 5.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.409 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.04 -30.82 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.14 81.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.346 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 77' ' ' LEU . 89.3 mt -81.46 -30.52 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.563 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -55.69 -43.98 76.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 75.62 177.02 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.028 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.823 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 32.7 Cg_exo -54.55 65.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.089 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.89 -151.44 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.513 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.83 121.06 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.399 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.6 mp -125.56 126.88 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.426 ' HB3' HD12 ' A' ' 6' ' ' ILE . 43.0 m-85 -114.87 161.3 18.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.445 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 6' ' ' ILE . 9.1 mt -130.33 140.44 50.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.558 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -85.84 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.098 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 92' ' ' GLY . 1.5 tt0 -59.56 146.03 42.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.915 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.1 t0 69.19 -12.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.717 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 68.83 -158.31 52.98 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -30.58 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 110.576 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -31.1 67.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.388 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 99' ' ' ALA . . . -72.39 -59.38 4.56 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.667 ' CZ3' HD13 ' A' ' 101' ' ' LEU . 4.5 t-105 -48.38 -40.43 25.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.047 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.98 -47.08 87.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.461 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 100' ' ' GLY . 26.8 ttm180 -83.31 -17.82 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -60.22 -5.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.574 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 98' ' ' ARG . . . 88.39 33.96 9.93 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.667 HD13 ' CZ3' ' A' ' 96' ' ' TRP . 23.0 mt -125.79 144.01 47.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 148.37 42.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.586 2.191 . . . . 0.0 112.466 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.731 HG11 ' OE2' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -112.32 171.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.061 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.696 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -127.47 125.12 39.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.7 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 32' ' ' ARG . 21.2 t -97.46 137.72 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.127 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -71.4 108.54 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.202 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.622 -179.841 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 5' ' ' THR . 89.0 m -90.03 156.26 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.889 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 4' ' ' THR . 1.1 p -85.87 150.6 24.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.164 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -143.59 164.05 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.277 0.56 . . . . 0.0 111.052 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.538 ' N ' HG23 ' A' ' 6' ' ' ILE . 32.1 m -112.45 149.47 41.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.832 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -41.18 -22.59 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.501 2.134 . . . . 0.0 111.856 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.466 ' N ' ' O ' ' A' ' 7' ' ' SER . 3.4 t-80 -67.21 -38.68 85.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.159 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.79 -54.79 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.434 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.58 -39.51 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HA ' HD12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -61.38 -44.61 96.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.81 -36.84 84.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 29.5 mt -72.79 -42.99 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.705 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.621 HD12 ' HA ' ' A' ' 12' ' ' GLN . 48.0 mt -50.54 -22.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.15 -20.32 38.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.123 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 14' ' ' LEU . 4.7 mtt180 -93.94 -51.28 4.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.46 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 149.15 33.85 0.05 OUTLIER Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -62.68 179.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.227 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HB3' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -133.7 98.15 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.898 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 15' ' ' ILE . 1.6 mp -85.59 133.71 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.972 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.477 HD12 ' CE1' ' A' ' 62' ' ' PHE . 12.1 mt -132.34 142.58 42.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.96 142.13 35.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.432 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -147.21 88.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.799 0.809 . . . . 0.0 110.769 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.542 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 2.6 ptp180 -165.42 -144.45 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.619 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.459 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 38.1 t0 -97.17 107.39 19.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -37.81 -42.27 0.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.66 -38.61 2.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 109.979 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -80.09 -35.09 37.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.067 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.735 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.4 t80 -71.48 -26.98 62.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.3 tp -62.74 -50.42 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.849 ' O ' HG13 ' A' ' 105' ' ' VAL . 4.4 ptm180 -56.76 -27.12 58.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.372 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.524 ' OE2' HG21 ' A' ' 103' ' ' VAL . 31.8 tt0 -159.6 128.85 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.644 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 13.2 p80 -145.61 155.35 42.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 110.767 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 37' ' ' GLU . 8.7 mm -91.9 121.56 66.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.5 23.79 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.278 1.986 . . . . 0.0 112.091 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 35' ' ' ILE . 26.0 mt-10 -146.71 30.6 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.545 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.86 157.89 43.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.556 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.37 153.08 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.602 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.735 HD13 ' CD2' ' A' ' 30' ' ' TYR . 57.7 tp -113.46 110.57 20.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.263 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.64 95.35 6.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.649 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 45' ' ' VAL . 71.2 Cg_exo -44.83 120.32 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.565 2.177 . . . . 0.0 112.079 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.939 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -43.12 -25.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.94 -30.63 39.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.393 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -81.79 -31.38 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.972 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.47 -20.18 57.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.819 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.65 -40.15 19.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.534 ' CG ' ' N ' ' A' ' 49' ' ' SER . 4.6 pt20 -87.86 -45.2 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.012 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.534 ' N ' ' CG ' ' A' ' 48' ' ' GLN . 5.6 t -66.55 -59.01 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.59 82.19 1.39 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 53' ' ' ALA . 13.4 tp -116.08 89.52 25.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.651 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.01 64.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.774 2.316 . . . . 0.0 112.045 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -50.13 -20.0 0.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.492 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.636 ' NZ ' ' HB3' ' A' ' 82' ' ' ALA . 19.7 tttm -57.6 -26.41 61.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.612 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -80.83 -13.98 58.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -90.15 13.25 15.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.033 0.444 . . . . 0.0 109.937 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.723 ' CG ' ' H ' ' A' ' 58' ' ' GLU . 13.7 t-80 179.3 -150.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.723 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 54.7 tt0 -137.38 -41.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.946 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -111.95 132.98 54.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.53 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -132.41 150.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.001 0.429 . . . . 0.0 111.215 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 HD12 ' A' ' 14' ' ' LEU . 1.2 mt -133.58 129.69 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.967 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.72 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 97.9 m-85 -112.04 145.87 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.529 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -152.26 135.47 15.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.708 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.59 ' SG ' HD11 ' A' ' 24' ' ' ILE . 1.8 m -115.19 153.09 31.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.542 ' H ' ' NE ' ' A' ' 25' ' ' ARG . 38.1 tp60 -29.69 -47.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.662 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.87 -11.33 8.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.554 ' H ' ' HB2' ' A' ' 64' ' ' CYS . . . 91.57 2.66 69.81 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -64.56 -30.16 71.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.357 . . . . 0.0 110.523 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 9.7 mpt_? -81.38 -24.72 36.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.534 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -59.82 -55.4 34.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -27.59 67.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' OD2' ' A' ' 75' ' ' ASP . 6.5 m120 -86.69 -37.83 17.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.739 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 69' ' ' ARG . 3.7 t30 -84.9 -17.08 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -48.31 -26.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.169 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -80.78 -51.8 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -65.35 -26.22 67.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.502 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.72 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 48.1 mt -65.56 -61.16 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.71 -53.31 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.3 68.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.29 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mm -71.39 -17.85 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.182 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -121.62 100.03 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.7 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -44.02 178.93 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.448 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 29.2 Cg_exo -57.36 64.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.7 2.267 . . . . 0.0 112.34 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.8 -149.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.253 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.576 ' OE1' ' O ' ' A' ' 84' ' ' ALA . 3.1 mm-40 -115.58 103.01 10.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.07 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.1 139.1 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CG ' HD12 ' A' ' 6' ' ' ILE . 54.4 m-85 -120.97 166.92 13.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.184 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 6' ' ' ILE . 17.1 mt -135.58 142.19 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 110.753 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.623 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -97.91 109.71 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.319 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.7 tm-20 -60.12 143.51 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.755 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.22 -27.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.623 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 87.09 -155.6 27.61 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.8 tt -50.66 -32.45 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.66 -37.34 8.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -57.24 7.26 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.626 ' CD1' ' C ' ' A' ' 96' ' ' TRP . 1.7 t-105 -45.45 -39.28 6.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 110.437 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -56.18 -62.35 1.77 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 100' ' ' GLY . 14.3 ptp180 -70.54 -29.6 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.3 -15.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.491 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 98' ' ' ARG . . . 93.51 38.12 5.38 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 96' ' ' TRP . 24.9 mt -125.13 141.05 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.539 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.53 145.98 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.525 2.15 . . . . 0.0 112.073 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.524 HG21 ' OE2' ' A' ' 33' ' ' GLU . 14.4 m -112.3 172.08 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.548 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.644 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -132.52 128.93 38.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 32' ' ' ARG . 4.8 t -96.77 136.1 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.436 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.543 ' N ' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -82.79 110.68 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.535 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 tttm . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.426 179.93 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 78' ' ' ALA . 1.4 pp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.858 0.361 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 88' ' ' LEU . 71.5 m -118.87 151.98 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.544 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.31 149.18 33.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.662 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.82 HD12 ' CG ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -136.3 161.55 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 110.437 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 9' ' ' HIS . 96.0 p -98.17 135.85 21.19 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.533 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -40.85 -16.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.151 1.901 . . . . 0.0 111.565 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.598 ' N ' ' O ' ' A' ' 7' ' ' SER . 2.1 t60 -79.6 -30.79 41.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.896 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.8 OUTLIER -76.81 -52.07 10.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.241 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.36 -31.08 3.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.28 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.544 ' HA ' HD12 ' A' ' 15' ' ' ILE . 32.8 tt0 -68.66 -52.02 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.375 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.35 -37.64 70.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 65.2 mt -70.34 -40.98 73.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.552 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 12' ' ' GLN . 14.9 mt -48.4 -24.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.46 -23.61 32.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.02 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 14' ' ' LEU . 10.8 mmt180 -82.13 -44.94 15.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 143.5 -6.96 1.97 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -28.71 149.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.848 0.356 . . . . 0.0 110.653 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 39' ' ' ASP . 7.1 mtpp -104.13 98.91 8.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 21' ' ' LEU . 6.3 mp -83.24 124.32 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.969 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mt -122.96 136.67 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 111.475 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' ALA . 34.8 t70 -105.47 136.54 44.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.691 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 41' ' ' ALA . 1.1 pt -136.47 86.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.47 0.653 . . . . 0.0 110.877 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.579 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 3.1 ptp180 -157.27 -146.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.956 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 27' ' ' ALA . 48.3 m-20 -102.98 114.82 29.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.16 -39.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.503 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -42.46 -33.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.341 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 2.6 mt-10 -86.5 -33.6 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.125 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.2 t80 -73.54 -40.55 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tp -55.88 -56.04 25.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.419 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 105' ' ' VAL . 10.5 ptp180 -49.19 -28.06 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 30' ' ' TYR . 1.4 tm-20 -169.24 136.66 1.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.116 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.647 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.1 p80 -150.38 176.54 10.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 110.744 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.67 ' C ' ' H ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -119.68 98.31 49.81 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.444 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 31.9 Cg_exo -54.23 18.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.89 2.393 . . . . 0.0 113.005 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.67 ' H ' ' C ' ' A' ' 35' ' ' ILE . 1.9 pm0 -126.96 9.73 6.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.047 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.41 149.34 52.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -84.78 124.48 31.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.467 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 tp -84.47 119.95 25.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -148.88 89.65 4.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HB2' HG13 ' A' ' 45' ' ' VAL . 89.3 Cg_exo -40.46 146.78 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.068 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -72.61 -25.42 61.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.213 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -30.82 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.4 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 49' ' ' SER . 3.4 m -85.54 -30.11 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.576 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.87 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.7 tt -60.5 -50.9 71.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.684 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.4 -52.88 62.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -70.97 -44.98 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 41.7 t -61.68 -70.17 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.06 68.48 1.18 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -118.21 86.19 26.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.512 ' C ' ' N ' ' A' ' 54' ' ' LYS . 14.5 Cg_exo -64.97 79.23 0.2 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.906 2.404 . . . . 0.0 112.336 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.72 -21.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 82' ' ' ALA . 24.9 tttp -56.71 -15.35 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.114 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.49 -10.0 59.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.93 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 -118.3 17.53 13.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.252 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.38 -166.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.45 -31.54 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.18 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -112.12 133.03 54.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.702 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.58 138.84 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 111.07 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mt -116.91 133.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.236 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.576 ' CD1' HD13 ' A' ' 77' ' ' LEU . 95.1 m-85 -116.9 138.01 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.603 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 15.3 p80 -160.65 137.32 8.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -116.27 154.08 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.354 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.583 ' O ' HG22 ' A' ' 93' ' ' ILE . 1.9 tp-100 -27.4 -54.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.56 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -108.01 -3.44 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' A' ' 69' ' ' ARG . . . 79.46 -43.05 2.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 67' ' ' GLY . 13.6 mttt -31.56 -33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.552 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -63.32 -59.96 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.553 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.837 HG21 HD13 ' A' ' 88' ' ' LEU . 17.5 m -43.83 -49.57 8.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -27.16 63.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.95 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 69' ' ' ARG . 11.9 t-20 -86.69 -47.48 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.096 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.661 ' OD1' HD13 ' A' ' 43' ' ' LEU . 2.3 t30 -89.96 -10.41 45.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.998 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -48.84 -29.44 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.214 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -29.32 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.762 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.452 ' HB2' ' ND2' ' A' ' 73' ' ' ASN . 52.5 mmtt -83.95 -23.45 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.879 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 80' ' ' ILE . 11.7 mt -80.09 -57.59 3.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.849 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' A' ' 3' ' ' LEU . . . -39.98 -34.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.46 -29.23 46.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' LEU . 97.0 mt -86.37 -17.89 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB3' HD13 ' A' ' 86' ' ' ILE . . . -97.67 4.99 49.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.768 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 45.44 179.59 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.989 0.423 . . . . 0.0 110.538 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 23.1 Cg_exo -60.12 20.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.747 2.298 . . . . 0.0 112.164 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -66.11 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.586 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.66 94.12 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.816 HD13 ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -110.89 144.07 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.82 ' CG ' HD12 ' A' ' 6' ' ' ILE . 11.6 m-85 -120.56 171.02 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.691 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 70' ' ' THR . 18.6 tp -137.83 128.66 27.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.508 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.3 tt -87.28 97.41 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.563 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.496 ' C ' ' CG ' ' A' ' 91' ' ' ASP . 1.4 tt0 -46.16 139.53 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 74.15 -47.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 105.98 -156.06 16.55 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 65' ' ' GLN . 7.6 tt -50.56 -20.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.829 0.347 . . . . 0.0 110.519 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.96 -33.91 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.465 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -83.37 -36.93 13.08 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.422 ' CE2' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -67.09 -29.38 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.31 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -43.27 19.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.493 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -77.04 -24.61 52.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.371 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 95' ' ' GLY . . . -53.36 -41.57 65.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.52 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.78 30.46 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.422 HD13 ' CE2' ' A' ' 96' ' ' TRP . 14.2 mt -118.86 141.93 30.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.72 169.83 21.44 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.355 2.037 . . . . 0.0 112.09 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.62 166.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 34' ' ' HIS . . . -121.57 117.09 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.298 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 32' ' ' ARG . 15.8 t -96.64 135.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.671 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -74.88 109.07 8.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.309 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.648 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.541 HD12 HD11 ' A' ' 88' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.829 0.347 . . . . 0.0 110.634 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -113.98 138.52 50.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -77.88 145.17 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -131.81 163.21 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.385 0.612 . . . . 0.0 111.205 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' HIS . 12.4 t -105.06 142.35 24.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.656 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -41.64 -17.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.451 2.101 . . . . 0.0 112.302 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -81.42 -28.56 34.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -79.79 -52.15 8.28 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.345 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.05 -35.26 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.29 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -38.88 92.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' ASP . 21.0 mt-10 -70.66 -41.73 71.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 16.1 mt -66.98 -41.94 85.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.685 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.593 HD11 ' CD1' ' A' ' 21' ' ' LEU . 8.3 mt -48.36 -24.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.89 -23.27 36.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.396 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -86.36 -40.35 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.598 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.99 -10.69 0.9 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -30.96 147.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HG3' ' CG ' ' A' ' 57' ' ' HIS . 11.4 mtpt -112.28 109.91 19.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.563 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.593 ' CD1' HD11 ' A' ' 15' ' ' ILE . 3.6 mt -94.37 131.9 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.089 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.607 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 12.4 mt -135.55 141.99 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -98.42 137.94 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.95 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.61 83.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 0.0 110.608 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HE ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -168.32 -149.1 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.425 ' H ' ' CD ' ' A' ' 25' ' ' ARG . 4.0 m-20 -89.01 114.14 25.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.351 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.593 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -43.34 -43.58 5.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.17 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -42.29 -21.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.763 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' ALA . 3.2 mm-40 -86.84 -38.45 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.859 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -81.6 -24.26 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.17 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -45.0 94.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -68.98 -21.93 64.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 103' ' ' VAL . 2.8 tt0 -164.71 126.45 2.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.375 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 2.7 p80 -139.65 160.17 40.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.423 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 37' ' ' GLU . 10.0 mt -105.35 130.58 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.671 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.34 23.17 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.552 2.168 . . . . 0.0 111.876 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 35' ' ' ILE . 51.7 mm-40 -141.67 34.47 1.62 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.646 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.74 23.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.529 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 40' ' ' LEU . 2.0 t0 -90.32 155.48 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.684 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.649 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.5 tp -110.3 119.46 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.535 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.79 88.21 6.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.312 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 45' ' ' VAL . 88.4 Cg_exo -42.49 126.76 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.747 2.298 . . . . 0.0 112.688 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.019 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -41.99 -24.92 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.717 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' PRO . 5.6 t -79.18 -27.51 42.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.462 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 42' ' ' PRO . 33.4 m -84.74 -27.83 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.165 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.62 -43.41 69.36 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.704 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -32.27 51.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -87.41 -43.63 11.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.611 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.26 -72.83 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . 112.08 92.55 2.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.8 tp -118.59 83.57 22.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.446 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 54' ' ' LYS . 8.3 Cg_exo -68.79 62.22 1.26 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.885 2.39 . . . . 0.0 112.198 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' CB ' HD11 ' A' ' 22' ' ' ILE . . . -39.72 -27.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -51.22 -18.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.48 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.33 -13.56 54.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.985 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.508 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.5 mtp85 -109.16 18.34 20.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -179.52 -169.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.03 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.542 ' C ' ' OE1' ' A' ' 59' ' ' GLN . 4.2 tt0 -118.94 -30.57 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.542 ' OE1' ' C ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -112.06 133.76 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.6 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.892 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -127.32 145.51 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.947 0.403 . . . . 0.0 111.107 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.421 HD11 ' HB1' ' A' ' 19' ' ' ALA . 7.7 mt -137.55 136.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 77' ' ' LEU . 67.8 m-85 -119.75 132.25 55.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.733 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 1.8 p80 -129.0 134.03 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -116.29 153.39 32.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.745 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 60.1 tp60 -34.15 -36.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.481 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -125.61 -42.66 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.654 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 133.18 -32.0 2.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 67' ' ' GLY . 15.8 mmtm -38.67 -42.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.728 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -64.81 -31.92 73.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.13 -45.67 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.011 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.3 -23.14 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.852 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.33 -33.37 20.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -93.3 -17.0 24.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -51.4 -29.9 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -29.75 65.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.011 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -21.51 29.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.767 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.605 HD13 ' CD1' ' A' ' 62' ' ' PHE . 87.6 mt -80.92 -56.56 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.945 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' LEU . . . -39.27 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -80.18 -47.31 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.8 mt -80.84 -19.17 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.154 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -95.98 5.71 50.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.941 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.815 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 44.47 -178.86 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 0.0 110.371 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.815 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 23.2 Cg_exo -60.45 21.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.732 2.288 . . . . 0.0 112.244 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -68.2 179.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.27 112.69 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mt -117.27 139.12 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.44 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.499 ' O ' HD23 ' A' ' 88' ' ' LEU . 70.0 m-85 -120.02 171.98 8.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.604 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 3' ' ' LEU . 7.1 mt -137.2 131.73 32.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.993 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -81.66 85.33 6.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.205 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.646 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 46.8 tt0 -57.48 121.03 9.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.646 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 19.1 t0 94.11 -26.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.423 ' H ' HD12 ' A' ' 89' ' ' LEU . . . 78.46 -153.32 38.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.56 -21.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.15 -59.55 3.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.445 ' HA2' ' NH1' ' A' ' 98' ' ' ARG . . . -61.38 -40.35 98.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.533 ' CE2' ' CB ' ' A' ' 101' ' ' LEU . 16.7 t-105 -53.73 -35.44 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.361 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -80.68 -51.11 9.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.637 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.445 ' NH1' ' HA2' ' A' ' 95' ' ' GLY . 14.2 ttp-105 -51.48 -18.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.976 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.92 -21.12 15.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.775 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.62 72.68 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.533 ' CB ' ' CE2' ' A' ' 96' ' ' TRP . 15.1 mt -119.68 152.68 53.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.399 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' LEU . 96.3 Cg_exo -30.17 118.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 123.193 2.595 . . . . 0.0 112.446 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 2.4 p -143.64 157.04 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.088 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -143.48 130.03 20.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.076 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.416 ' C ' ' NE2' ' A' ' 34' ' ' HIS . 60.9 t -97.33 142.63 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.234 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.567 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 3.3 t30 -86.45 108.69 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.314 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.505 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.07 35.19 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.269 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 3' ' ' LEU . 4.0 pp -74.95 128.69 36.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.513 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -116.83 144.17 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.401 HG22 ' HB3' ' A' ' 88' ' ' LEU . 1.4 p -78.16 145.13 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -136.32 166.06 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.824 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 6' ' ' ILE . 1.7 t -102.46 142.58 24.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.935 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -42.06 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.369 2.046 . . . . 0.0 112.063 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -80.89 -27.94 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.11 -52.68 6.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.367 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.11 -32.33 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.424 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' HA ' HD12 ' A' ' 15' ' ' ILE . 1.7 tt0 -66.24 -56.66 10.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -45.48 -26.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 27.8 mt -82.94 -39.9 20.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 12' ' ' GLN . 67.0 mt -49.2 -24.85 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.83 -20.72 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.958 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.558 ' N ' ' O ' ' A' ' 14' ' ' LEU . 6.0 ttt180 -84.14 -41.04 17.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.504 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 139.01 -7.37 3.21 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -31.29 151.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 0.0 110.601 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.787 ' HZ2' ' HE ' ' A' ' 56' ' ' ARG . 1.4 mtpt -109.42 99.72 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.423 HD23 ' CD2' ' A' ' 63' ' ' HIS . 0.6 OUTLIER -82.23 134.7 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.959 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 22' ' ' ILE . 14.4 mt -130.85 141.18 46.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 0.0 111.096 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.581 ' OD2' ' NH2' ' A' ' 25' ' ' ARG . 5.2 t0 -111.71 135.6 52.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.135 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 70' ' ' THR . 8.2 pt -130.12 81.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.243 0.544 . . . . 0.0 110.197 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.581 ' NH2' ' OD2' ' A' ' 23' ' ' ASP . 11.8 ptt180 -154.73 -145.54 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.285 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 11.2 m-20 -101.8 116.21 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.316 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -45.61 -36.01 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.189 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -48.34 -34.35 10.49 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -85.18 -32.4 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.806 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.759 ' CZ ' ' ND1' ' A' ' 34' ' ' HIS . 10.0 t80 -73.08 -31.0 64.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 4.0 tp -65.06 -59.24 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.694 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -53.63 -25.55 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.144 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.585 ' OE2' HG11 ' A' ' 103' ' ' VAL . 19.0 tt0 -152.76 117.78 5.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.185 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.77 ' ND1' ' N ' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -140.77 152.13 44.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.513 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.77 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 5.9 mt -110.62 94.18 18.73 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.662 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 50.2 Cg_exo -49.37 66.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.871 2.38 . . . . 0.0 112.4 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.71 ' N ' ' O ' ' A' ' 35' ' ' ILE . 14.5 pt-20 -179.46 27.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 153.49 30.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.337 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -84.77 143.53 29.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.71 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.37 114.55 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.84 96.59 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.555 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' VAL . 82.9 Cg_exo -44.94 124.41 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.372 2.048 . . . . 0.0 111.875 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 73' ' ' ASN . 1.7 tt -36.6 -60.29 0.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.137 0.494 . . . . 0.0 110.565 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -44.09 -25.93 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.974 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -73.9 -39.02 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.926 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.436 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 6.5 tt -83.39 -42.97 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.825 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.88 -29.89 71.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.847 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.487 ' CG ' ' N ' ' A' ' 49' ' ' SER . 7.7 pt20 -97.18 -40.61 8.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.935 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 2.1 t -87.47 -55.36 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.756 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 83.11 0.8 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.674 ' O ' ' N ' ' A' ' 53' ' ' ALA . 14.1 tp -107.58 97.92 21.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.87 67.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.564 2.176 . . . . 0.0 112.194 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -51.71 -19.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.275 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' HIS . 5.4 tttp -63.3 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mp -77.91 -13.56 59.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.793 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.787 ' HE ' ' HZ2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.1 19.95 8.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 166.17 -167.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.786 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -113.38 -39.58 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.3 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -112.31 133.47 54.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.156 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.946 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -136.33 144.35 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -127.02 146.51 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.169 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.725 ' CD1' HD13 ' A' ' 77' ' ' LEU . 96.6 m-85 -126.62 137.36 53.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.74 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 1.0 OUTLIER -140.75 136.32 32.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.519 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.6 t -115.7 153.22 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.455 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.519 ' C ' ' O ' ' A' ' 64' ' ' CYS . 2.8 tt0 -30.08 -53.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.65 54.08 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.621 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 42.7 49.57 5.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -112.24 -42.62 3.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.759 ' HB3' HD12 ' A' ' 43' ' ' LEU . 2.9 mmt180 -83.39 -31.9 26.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.611 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.676 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -65.37 -43.34 91.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.531 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -24.7 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.37 -43.96 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.776 ' HB2' HD11 ' A' ' 43' ' ' LEU . 3.4 t-20 -88.46 -16.44 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.636 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -44.32 -38.22 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.387 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.47 -27.06 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.577 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ASN . 15.6 mmtm -78.96 -26.15 43.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.725 HD13 ' CD1' ' A' ' 62' ' ' PHE . 80.4 mt -77.9 -56.81 4.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.33 -33.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.16 -48.32 17.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.5 mt -75.8 -17.7 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -96.27 8.18 44.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.731 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 42.98 -179.47 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 110.626 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.809 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 18.1 Cg_exo -62.49 15.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.658 2.239 . . . . 0.0 112.018 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -53.1 -152.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -122.31 98.7 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.382 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 60' ' ' ILE . 3.0 mp -116.04 146.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.47 177.9 4.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.188 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -135.95 129.28 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.775 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -87.54 101.33 13.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 15.4 tt0 -54.36 121.24 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER 82.22 -50.26 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.568 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.474 ' H ' HD12 ' A' ' 89' ' ' LEU . . . 120.92 -133.87 9.9 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -77.05 -30.83 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 50.1 t0 -48.22 -30.69 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.81 -54.79 4.76 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.457 ' CE2' HD13 ' A' ' 101' ' ' LEU . 2.3 t90 -47.09 -32.19 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.914 0.387 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -73.87 -53.05 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.586 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' C ' ' N ' ' A' ' 100' ' ' GLY . 3.3 ttt180 -66.2 -29.54 69.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.534 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.52 -12.26 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.742 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 98' ' ' ARG . . . 101.24 24.19 9.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.457 HD13 ' CE2' ' A' ' 96' ' ' TRP . 16.4 mt -116.46 138.09 24.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.25 161.66 40.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.349 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.585 HG11 ' OE2' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -111.96 172.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.211 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -132.78 121.15 22.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.691 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 32' ' ' ARG . 15.0 t -96.75 144.02 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.3 108.6 4.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.295 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 tttt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.55 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.38 12.81 18.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.643 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.8 pp -44.6 126.7 5.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.427 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -122.4 158.41 29.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.581 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -87.9 144.25 26.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -136.7 164.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.458 . . . . 0.0 110.931 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 9' ' ' HIS . 17.2 t -104.07 138.99 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.796 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.23 -16.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.578 2.185 . . . . 0.0 111.854 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.645 ' N ' ' O ' ' A' ' 7' ' ' SER . 23.6 m170 -75.92 -35.98 59.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.947 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.2 t0 -76.22 -54.19 7.15 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.506 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.13 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.413 ' HA ' HD12 ' A' ' 15' ' ' ILE . 28.2 tt0 -49.73 -46.77 50.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.27 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -59.01 -42.0 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.189 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.809 HD12 HD11 ' A' ' 61' ' ' ILE . 6.9 mt -68.3 -43.85 76.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 12' ' ' GLN . 58.6 mt -48.14 -23.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.855 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.61 25.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.483 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.0 ttm-85 -81.12 -40.5 23.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.87 -11.81 0.95 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -27.07 144.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.69 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HG3' ' CG ' ' A' ' 57' ' ' HIS . 4.8 mmtm -102.24 98.38 8.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.727 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.588 HD22 ' CE1' ' A' ' 63' ' ' HIS . 0.5 OUTLIER -84.48 131.78 34.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.105 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.43 140.79 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.511 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.568 ' CG ' ' CE1' ' A' ' 30' ' ' TYR . 1.4 t70 -101.89 136.72 41.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 43' ' ' LEU . 1.1 pp -136.98 84.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 0.0 110.736 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -160.81 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.93 111.23 23.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -41.86 -33.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.276 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.16 -34.67 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -83.84 -31.89 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.538 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.862 ' CD2' HD13 ' A' ' 40' ' ' LEU . 1.5 t80 -77.67 -25.37 49.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.412 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' ALA . 1.4 tp -70.32 -47.94 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.171 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.0 -10.2 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.237 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.5 tt0 -172.83 137.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.63 ' CD2' ' OD1' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -160.63 161.28 32.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 110.796 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 37' ' ' GLU . 1.7 mt -106.27 105.33 53.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 32.2 Cg_exo -54.33 19.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.576 2.184 . . . . 0.0 113.046 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.676 ' H ' ' C ' ' A' ' 35' ' ' ILE . 56.1 mm-40 -135.12 24.15 3.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.487 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.51 149.09 42.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.81 133.59 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 30' ' ' TYR . 61.0 tp -92.79 118.0 30.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.291 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.44 93.36 4.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.6 Cg_exo -45.49 120.48 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.497 2.132 . . . . 0.0 111.954 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -41.23 -25.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.987 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.25 -26.73 32.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.51 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG1' ' N ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -78.34 -48.75 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.077 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.848 HD12 ' H ' ' A' ' 51' ' ' LEU . 13.5 tp -54.91 -27.13 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -84.38 -49.47 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -67.0 -52.87 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.6 t -82.99 -77.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.07 91.47 1.28 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 46' ' ' LEU . 17.0 tp -124.46 79.2 61.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.778 0.323 . . . . 0.0 110.579 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 54' ' ' LYS . 7.6 Cg_exo -69.33 78.12 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.987 2.458 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.52 -21.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . 14.5 tttm -57.35 -13.81 3.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.074 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.7 mt -77.55 -10.7 59.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.519 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.7 mtt180 -125.01 22.88 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.299 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -170.14 -169.04 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.167 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.7 -34.68 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.023 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -112.77 133.26 54.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' H ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -129.76 118.53 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.809 HD11 HD12 ' A' ' 14' ' ' LEU . 12.1 mt -110.5 141.74 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.15 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.563 ' CG ' HD13 ' A' ' 77' ' ' LEU . 60.4 m-85 -123.85 143.3 50.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.051 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.588 ' CE1' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -143.22 135.94 27.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.346 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.809 ' HG ' ' HG1' ' A' ' 70' ' ' THR . 1.3 m -116.48 153.07 32.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 66' ' ' ALA . 6.9 pt20 -34.91 -39.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.478 ' N ' ' HG2' ' A' ' 65' ' ' GLN . . . -128.06 -4.96 5.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.568 ' H ' ' HB2' ' A' ' 64' ' ' CYS . . . 85.32 -28.78 4.58 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -42.56 -26.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HB3' ' SG ' ' A' ' 64' ' ' CYS . 2.7 tpm_? -83.59 -25.45 30.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.068 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.809 ' HG1' ' HG ' ' A' ' 64' ' ' CYS . 0.2 OUTLIER -65.88 -54.61 24.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.765 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -65.17 -23.66 67.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -86.4 -47.5 9.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.539 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.601 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 t30 -84.28 -16.29 43.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.361 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -41.34 -33.87 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.113 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.18 -31.32 67.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 73' ' ' ASN . 33.8 mmtt -81.79 -22.08 37.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.904 0.383 . . . . 0.0 110.532 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.563 HD13 ' CG ' ' A' ' 62' ' ' PHE . 60.9 mt -80.62 -57.19 3.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.654 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.99 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.48 -54.59 34.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -18.46 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.221 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.03 2.17 50.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.841 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 52.63 -179.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.735 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 22.9 Cg_exo -60.54 7.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.878 2.386 . . . . 0.0 112.448 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -46.48 169.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.279 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.9 102.67 4.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.217 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.78 133.13 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.425 ' O ' HD23 ' A' ' 88' ' ' LEU . 46.7 m-85 -125.54 153.56 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.609 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.531 HD22 HG22 ' A' ' 70' ' ' THR . 23.1 mt -122.39 137.03 55.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.195 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.507 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.6 tt -89.04 91.34 8.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.34 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -40.66 147.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 68.35 -47.44 0.54 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 101.9 -145.76 16.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mm -51.0 -41.93 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.477 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.29 -35.26 59.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.02 -47.11 39.88 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.529 ' CD1' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.95 -37.04 81.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.45 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -80.76 -25.79 37.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.376 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -73.86 -44.75 54.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.45 63.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.564 ' O ' HD23 ' A' ' 101' ' ' LEU . . . 125.76 45.34 0.24 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 100' ' ' GLY . 9.6 mt -123.5 106.27 32.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -45.62 152.09 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.455 2.103 . . . . 0.0 112.174 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.37 169.06 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.436 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -128.65 144.12 51.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.454 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.96 130.57 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.63 ' OD1' ' CD2' ' A' ' 34' ' ' HIS . 1.7 m-20 -67.59 109.69 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 106' ' ' ASN . 17.6 tttt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.473 ' N ' ' HB1' ' A' ' 78' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.48 16.87 9.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.594 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pp -69.49 152.06 45.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.536 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 m -132.72 151.97 51.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.49 33.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.548 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -144.8 163.28 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.728 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.599 ' O ' ' N ' ' A' ' 9' ' ' HIS . 4.9 m -108.62 142.98 26.59 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.46 -17.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.477 2.118 . . . . 0.0 111.722 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.599 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -73.06 -35.81 66.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.754 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -75.66 -56.11 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.209 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.61 -23.44 0.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -70.99 -44.41 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -68.07 -26.06 65.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.776 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 14.7 mt -79.74 -45.13 19.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.5 mt -47.76 -23.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.447 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -27.46 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.118 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 14' ' ' LEU . 9.9 mtt180 -84.43 -41.54 16.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.416 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.74 28.08 0.41 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -59.82 149.09 32.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.4 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.61 102.51 13.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.673 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 21' ' ' LEU . 5.2 mp -92.56 129.22 38.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.443 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 7.3 mt -127.44 142.43 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.032 0.444 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -103.75 153.43 20.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.555 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.447 ' O ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 pp -147.73 90.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.334 0.588 . . . . 0.0 110.789 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 24.4 ttt-85 -173.91 -141.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.9 119.69 30.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.271 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.71 97.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.534 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.66 -26.28 3.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.006 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.56 -44.95 11.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.301 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.8 t80 -70.37 -31.03 68.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.195 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.56 -58.21 8.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.743 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -52.63 -28.66 22.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.27 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.9 tt0 -152.51 123.58 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -150.55 175.55 11.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.011 0.434 . . . . 0.0 111.034 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.687 ' C ' ' H ' ' A' ' 37' ' ' GLU . 43.8 mt -109.2 106.07 58.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.253 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 32.1 Cg_exo -54.44 19.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.573 2.182 . . . . 0.0 112.981 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.687 ' H ' ' C ' ' A' ' 35' ' ' ILE . 41.4 mm-40 -137.82 38.51 2.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.342 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.2 150.33 25.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.53 126.41 35.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.1 tp -85.19 117.14 23.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.177 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.36 93.75 6.34 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.569 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.3 Cg_exo -45.99 122.5 5.3 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.498 2.132 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.014 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -39.79 -29.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -75.49 -30.7 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -68.4 -38.77 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.112 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD22 HD23 ' A' ' 77' ' ' LEU . 2.4 tt -73.41 -41.81 62.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -64.99 -31.03 72.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.195 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -96.14 -32.73 12.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.145 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 10.0 t -92.07 -44.44 8.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 110.809 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 68.37 64.26 3.18 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -98.68 110.55 57.54 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' LYS . 58.6 Cg_endo -77.44 63.09 7.83 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.376 2.05 . . . . 0.0 112.353 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.62 -21.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.961 0.41 . . . . 0.0 110.046 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HE2' ' HB3' ' A' ' 82' ' ' ALA . 30.9 tttp -54.34 -21.43 9.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.454 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.59 -6.31 53.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.72 14.86 30.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.412 . . . . 0.0 110.472 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 177.97 -164.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.736 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -121.92 -26.46 4.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.089 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -113.82 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.801 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -134.56 142.16 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.795 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.27 144.85 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.431 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 47.7 m-85 -123.96 141.19 52.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.861 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -149.15 133.84 17.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.536 ' O ' ' C ' ' A' ' 65' ' ' GLN . 3.5 m -117.54 153.73 32.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.536 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.5 OUTLIER -28.23 -41.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.593 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -126.27 -60.45 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.537 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 154.7 -37.16 0.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 72' ' ' ASN . 24.6 tttt -45.14 -29.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HE ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -75.22 -36.49 61.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.773 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -65.66 -42.98 90.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.423 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -66.31 -21.17 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.633 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.423 ' CG ' ' O ' ' A' ' 68' ' ' LYS . 24.8 m-20 -82.75 -41.74 18.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 76' ' ' LYS . 13.0 t30 -98.72 -13.81 20.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -47.16 -29.97 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.53 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -80.81 -31.37 35.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.528 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 73' ' ' ASN . 36.7 mmtm -76.76 -41.29 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.655 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.538 HD23 HD22 ' A' ' 46' ' ' LEU . 10.1 mt -67.81 -57.8 5.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.473 ' HB1' ' N ' ' A' ' 1' ' ' MET . . . -47.17 -29.8 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.454 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.5 -56.38 20.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.38 -20.51 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.55 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -77.27 -2.76 36.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 44.95 -179.27 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 110.472 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 22.7 Cg_exo -60.23 26.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.764 2.309 . . . . 0.0 112.09 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.623 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -69.11 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.506 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -110.31 99.09 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.464 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.83 133.24 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.87 163.38 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.851 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 89' ' ' LEU . 10.1 tp -131.92 132.32 43.46 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.876 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 88' ' ' LEU . 7.2 tt -99.24 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' O ' ' OD2' ' A' ' 91' ' ' ASP . 2.7 tm-20 -63.28 158.55 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.424 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.591 ' OD2' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER 69.34 -40.21 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.664 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.521 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 94.2 -160.86 24.08 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.86 -26.6 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.265 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -23.05 6.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.346 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . -86.56 -52.49 3.16 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.01 -28.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -76.53 -51.45 11.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 99' ' ' ALA . 5.9 mmt180 -61.27 -44.37 97.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 98' ' ' ARG . . . -39.26 -33.89 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.448 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.11 1.53 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mt -123.53 137.19 28.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.421 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -72.85 174.01 12.56 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.444 2.096 . . . . 0.0 112.379 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.551 HG21 ' OE2' ' A' ' 33' ' ' GLU . 35.1 m -112.09 172.12 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -141.08 135.21 30.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.62 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 32' ' ' ARG . 19.5 t -97.13 158.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.459 ' OD1' ' CD2' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -84.8 109.04 17.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 tptp . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.444 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mtp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 3' ' ' LEU . . . -122.13 12.14 10.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.489 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -38.55 143.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.58 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 147.87 45.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.603 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -78.75 151.32 32.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.544 HG23 ' N ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -137.51 166.4 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.442 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.4 OUTLIER -109.21 140.31 21.87 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.514 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.06 -18.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.278 1.985 . . . . 0.0 111.585 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.9 m170 -73.87 -30.63 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.37 -52.73 7.33 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.782 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.01 -32.08 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.708 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.563 ' HA ' HD12 ' A' ' 15' ' ' ILE . 2.9 tt0 -68.89 -44.11 73.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.631 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 7.2 mt-10 -66.36 -42.18 88.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 22.5 mt -63.73 -42.76 97.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 12' ' ' GLN . 22.0 mt -48.22 -24.37 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 13' ' ' GLU . . . -78.65 -28.2 45.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.86 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 14' ' ' LEU . 3.4 mtp180 -84.33 -30.5 25.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.098 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.8 23.9 2.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -54.35 153.94 5.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -104.83 97.7 7.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.548 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 131.98 40.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.864 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.635 HD12 ' CZ ' ' A' ' 62' ' ' PHE . 9.7 mt -135.79 141.08 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.601 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 25' ' ' ARG . 11.1 t0 -110.8 145.12 38.71 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.819 HG22 ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -112.89 -73.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.891 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 24' ' ' ILE . 8.5 ptm180 20.57 -143.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.156 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -116.15 109.64 17.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.046 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.0 -42.1 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -43.08 -38.43 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.44 -22.84 26.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.382 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.818 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.5 t80 -82.32 -29.16 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -43.77 93.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.449 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.755 ' O ' HG13 ' A' ' 105' ' ' VAL . 30.4 mtp85 -74.59 -13.84 60.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.065 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.555 ' O ' ' O ' ' A' ' 30' ' ' TYR . 5.9 tt0 -157.48 122.01 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.279 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.591 ' ND1' ' O ' ' A' ' 104' ' ' ALA . 39.0 p-80 -145.21 147.57 32.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mt -90.95 130.96 38.62 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.365 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.7 24.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.511 2.141 . . . . 0.0 112.444 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -146.18 35.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.778 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -162.89 147.33 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -84.57 161.22 20.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.454 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.818 HD13 ' CD2' ' A' ' 30' ' ' TYR . 56.5 tp -115.33 122.01 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.68 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.819 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -160.25 95.57 1.53 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.065 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -46.85 147.46 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.578 2.185 . . . . 0.0 112.034 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 44' ' ' SER . 1.1 pp -71.72 -24.13 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.249 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 46.8 p -76.81 -35.53 57.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.966 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.8 -30.36 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.34 -40.42 89.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.53 -50.13 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -69.47 -34.16 73.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 t -72.8 -78.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.16 75.91 1.0 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 53' ' ' ALA . 32.5 tp -117.7 89.1 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 110.701 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.1 73.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.802 2.335 . . . . 0.0 112.136 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -57.35 -28.13 62.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.389 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . 8.9 tttm -51.94 -24.7 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.387 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.88 -13.6 59.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.565 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 54.9 mtp180 -91.77 16.82 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 169.51 -163.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.902 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.26 -31.15 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.916 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.494 ' C ' HD12 ' A' ' 60' ' ' ILE . 3.2 mt-30 -112.46 132.92 54.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.425 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.89 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -142.27 148.16 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -136.86 144.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.435 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 49.5 m-85 -124.64 151.04 45.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.425 ' HA ' HG21 ' A' ' 70' ' ' THR . 48.3 p-80 -159.98 144.36 14.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 111.656 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.583 ' O ' ' C ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -116.74 154.1 31.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.171 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.583 ' C ' ' O ' ' A' ' 64' ' ' CYS . 5.0 tm0? -21.66 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.783 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -109.22 -22.4 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.457 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 113.29 -33.58 5.48 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 67' ' ' GLY . 2.6 pttp -35.49 -64.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.708 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 19.6 mtt85 -52.12 -38.62 57.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.682 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.861 HG22 HD11 ' A' ' 88' ' ' LEU . 2.1 m -58.74 -47.83 83.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.685 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -70.4 -18.86 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.786 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.04 -47.77 10.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -84.55 -14.18 49.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.718 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -49.89 -26.75 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.517 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -37.25 76.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.62 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -74.89 -26.91 59.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 79' ' ' ALA . 75.2 mt -74.86 -56.89 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' A' ' 3' ' ' LEU . . . -41.31 -22.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.671 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -76.83 -53.06 8.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -75.99 -17.75 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.533 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -87.14 -2.95 59.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 45.71 179.53 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 25.0 Cg_exo -58.25 9.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.596 2.197 . . . . 0.0 111.93 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -55.26 -167.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.332 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 85' ' ' GLU . 3.8 mm-40 -105.42 106.21 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.34 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -116.32 169.48 9.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.861 HD11 HG22 ' A' ' 70' ' ' THR . 7.9 tp -137.85 128.73 27.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 92' ' ' GLY . 4.9 tt -88.17 108.78 19.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.627 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 8.1 tt0 -66.16 147.85 52.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 66' ' ' ALA . 19.7 t0 77.7 -35.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.748 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.511 ' H ' HD23 ' A' ' 89' ' ' LEU . . . 92.84 -164.57 27.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.3 -21.41 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.482 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -61.8 -25.65 67.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.33 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.74 -35.3 25.55 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -30.8 70.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.934 0.397 . . . . 0.0 110.134 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -72.12 -38.13 69.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.355 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -75.57 -33.67 60.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.293 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.54 -15.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.548 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.92 32.31 7.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.6 mt -120.0 104.11 44.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.87 160.17 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.571 2.18 . . . . 0.0 112.4 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.76 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.591 ' O ' ' ND1' ' A' ' 34' ' ' HIS . . . -125.41 126.24 44.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.306 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 32' ' ' ARG . 18.3 t -96.01 133.74 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.472 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 107' ' ' LYS . 63.3 t-20 -87.17 109.6 19.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 106' ' ' ASN . 75.5 tttt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.567 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 3' ' ' LEU . . . -109.77 22.22 15.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.766 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -38.08 116.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -105.87 147.05 29.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.764 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.77 150.63 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -140.28 163.3 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.421 0.629 . . . . 0.0 111.547 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.525 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -109.12 145.33 31.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.318 178.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -39.64 -26.25 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.374 2.05 . . . . 0.0 111.897 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' SER . 78.3 m80 -65.99 -33.37 75.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.416 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.8 t0 -77.85 -55.66 5.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.141 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.88 5.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.284 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.07 -38.88 87.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -74.52 -44.9 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.536 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 3.3 mt -65.28 -47.36 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt -47.69 -25.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.795 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.11 -24.69 26.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.215 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -81.35 -41.2 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.703 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 151.43 -15.85 0.85 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -28.41 137.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.425 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.21 98.28 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.545 HD22 ' CE1' ' A' ' 63' ' ' HIS . 1.8 mt -81.39 136.27 35.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.796 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.503 HD12 ' CZ ' ' A' ' 62' ' ' PHE . 5.7 mt -128.9 139.58 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.109 0.481 . . . . 0.0 111.3 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' OD2' ' CD1' ' A' ' 30' ' ' TYR . 14.9 t70 -103.57 132.36 49.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.61 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.465 HD13 ' HG ' ' A' ' 43' ' ' LEU . 1.1 pt -133.65 82.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 110.83 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 65' ' ' GLN . 3.5 ptt180 -156.63 -150.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.358 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -92.15 116.87 29.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.584 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -47.67 -31.73 4.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.083 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 2.5 m-20 -52.71 -44.41 66.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -74.71 -32.6 62.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.693 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.5 t80 -72.19 -25.79 61.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.961 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -67.85 -55.66 12.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp85 -52.17 -18.69 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.18 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 30' ' ' TYR . 2.3 mt-10 -172.03 139.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.475 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.672 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 15.6 p80 -153.64 150.81 29.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.483 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 122.59 52.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.548 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.45 51.27 3.67 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -158.74 18.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.688 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.21 151.48 38.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -85.05 124.05 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.424 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.693 HD13 ' CD2' ' A' ' 30' ' ' TYR . 50.1 tp -83.31 117.81 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.643 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.5 90.68 4.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.344 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 81.4 Cg_exo -45.79 124.29 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.827 2.351 . . . . 0.0 112.617 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -34.0 -62.58 0.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.441 0.638 . . . . 0.0 110.444 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -43.13 -29.8 0.4 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.307 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -76.73 -42.59 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.774 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.47 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 7.3 tp -78.06 -20.16 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.797 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -39.08 30.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.755 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -90.59 -38.68 12.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.801 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 11.7 t -73.14 -77.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.77 75.97 1.09 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.6 89.36 52.35 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.473 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 54' ' ' LYS . 25.0 Cg_exo -58.67 83.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.844 2.363 . . . . 0.0 112.294 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.64 -20.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.001 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.981 ' HZ3' ' HB3' ' A' ' 82' ' ' ALA . 9.4 tttt -60.57 -14.73 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.029 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.1 mt -77.09 -13.34 59.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.615 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -113.76 23.04 13.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.83 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.077 0.465 . . . . 0.0 110.985 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -119.65 -34.09 3.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.156 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.451 ' OE1' HD11 ' A' ' 61' ' ' ILE . 9.4 tt0 -112.13 133.32 54.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.936 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -133.42 120.5 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.451 HD11 ' OE1' ' A' ' 59' ' ' GLN . 6.4 mt -115.43 149.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 23.1 m-85 -130.07 151.35 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.559 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' A' ' 63' ' ' HIS . 3.4 p-80 -154.59 134.03 12.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.768 ' SG ' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -116.46 155.15 29.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.561 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -22.86 -59.96 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.138 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.31 20.69 14.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.98 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.768 ' N ' ' SG ' ' A' ' 64' ' ' CYS . . . 63.47 6.28 14.94 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.764 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -70.4 -57.46 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.432 ' NH1' ' HA ' ' A' ' 25' ' ' ARG . 3.1 ttm180 -61.24 -23.21 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.556 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -64.15 -59.8 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -57.08 -18.88 16.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.752 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -80.03 -44.23 20.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.493 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.451 ' CG ' HD21 ' A' ' 43' ' ' LEU . 16.9 t30 -84.93 -17.01 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.411 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.64 -26.75 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.427 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -85.2 -37.74 19.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.689 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.72 -28.22 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.61 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.458 HD13 ' CG ' ' A' ' 62' ' ' PHE . 95.0 mt -68.47 -53.86 20.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.664 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.04 -56.68 4.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.321 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.6 55.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.968 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -78.01 -18.18 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.146 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -122.99 101.09 7.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.017 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.981 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . . . -39.43 170.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.755 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 32.8 Cg_exo -50.36 65.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.751 2.3 . . . . 0.0 112.433 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.706 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.73 -167.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.78 98.44 11.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.24 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -111.67 135.84 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.54 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CG ' HD12 ' A' ' 6' ' ' ILE . 69.2 m-85 -124.52 168.73 12.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -137.47 133.32 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 92' ' ' GLY . 5.2 tt -89.09 100.69 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.587 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 79.1 tt0 -60.84 149.59 35.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.423 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 12.2 t0 77.79 -46.07 0.45 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.618 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.522 ' H ' HD23 ' A' ' 89' ' ' LEU . . . 104.37 -167.97 16.13 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.728 HD11 HG11 ' A' ' 103' ' ' VAL . 2.2 tt -50.92 -20.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 110.31 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.32 -31.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.268 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.94 -49.67 8.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.672 ' NE1' ' O ' ' A' ' 101' ' ' LEU . 2.4 t-105 -51.97 -38.86 58.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.189 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -70.27 -38.1 75.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.309 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -77.58 -26.22 50.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.63 4.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.53 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.07 18.01 33.0 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.672 ' O ' ' NE1' ' A' ' 96' ' ' TRP . 50.9 mt -118.4 96.52 49.93 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 0.0 110.53 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.37 177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.649 2.233 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.728 HG11 HD11 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -121.41 172.11 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.541 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -115.68 128.73 56.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 33' ' ' GLU . 6.0 t -96.45 133.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.421 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.672 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 1.4 t30 -67.5 108.81 2.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 106' ' ' ASN . 24.2 tptt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.578 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.81 38.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.558 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.1 pp -42.26 117.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.487 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 5' ' ' THR . 24.2 m -128.93 158.47 38.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.509 ' N ' HG22 ' A' ' 4' ' ' THR . 0.8 OUTLIER -88.05 148.65 24.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.177 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -137.26 166.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.191 0.519 . . . . 0.0 110.953 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.555 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -106.83 142.13 24.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.889 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.74 -19.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.498 2.132 . . . . 0.0 112.058 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.9 m80 -76.12 -28.03 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.426 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -84.19 -52.45 6.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.97 -32.94 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -68.31 -51.12 48.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.66 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -56.23 -27.91 56.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 17' ' ' ARG . 25.9 mt -76.18 -42.33 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.2 mt -47.91 -22.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -85.6 -24.23 27.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.151 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -79.39 -51.25 9.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.419 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 136.81 32.47 0.24 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.0 -177.46 3.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -125.36 111.04 14.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.474 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.11 125.27 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.461 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.557 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 18.6 mt -136.31 138.31 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 111.397 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.657 ' OD1' ' NE ' ' A' ' 25' ' ' ARG . 10.9 t0 -108.83 146.31 33.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.608 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -114.78 -73.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.911 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.657 ' NE ' ' OD1' ' A' ' 23' ' ' ASP . 8.4 ptp180 16.42 -139.61 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.555 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -117.01 113.74 22.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' ASP . . . -38.32 -23.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 26' ' ' ASP . 45.1 m-20 -58.82 -33.11 70.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 15.3 mm-40 -86.37 -30.18 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.821 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.748 ' CD2' HD13 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -75.22 -39.11 60.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.256 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.44 -53.19 60.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.238 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.619 ' O ' HG13 ' A' ' 105' ' ' VAL . 7.6 ptp180 -56.83 -26.68 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 30' ' ' TYR . 15.9 tt0 -164.87 129.76 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.128 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.488 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 55.1 p-80 -143.88 169.81 17.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 37' ' ' GLU . 2.7 mt -109.1 126.65 28.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.185 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.49 24.87 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.287 1.991 . . . . 0.0 111.963 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 35' ' ' ILE . 80.5 mm-40 -138.73 25.94 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.766 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.95 146.75 23.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.672 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -86.61 153.79 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.748 HD13 ' CD2' ' A' ' 30' ' ' TYR . 45.2 tp -108.39 124.43 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.732 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -162.71 96.53 1.13 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.614 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.792 ' O ' HG22 ' A' ' 45' ' ' VAL . 39.7 Cg_exo -50.56 146.66 19.18 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.497 2.131 . . . . 0.0 112.082 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 44' ' ' SER . 1.2 pp -65.93 -23.62 66.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.782 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.452 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -74.93 -29.24 60.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 42' ' ' PRO . 23.6 m -84.92 -25.27 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.72 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 50' ' ' GLY . 3.0 tp -84.93 -46.61 11.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.571 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.61 -31.41 72.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.704 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -85.12 -30.17 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 6.7 m -94.95 -71.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 94.83 87.1 1.7 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.658 HD12 ' HB2' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -112.31 82.53 4.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.794 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' LEU . 74.8 Cg_exo -45.2 -7.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.796 2.331 . . . . 0.0 112.555 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 51' ' ' LEU . . . -43.43 -29.53 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.974 ' NZ ' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -57.11 -5.75 0.3 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 109.834 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.629 ' C ' ' H ' ' A' ' 57' ' ' HIS . 9.7 mp -94.41 -9.97 33.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.479 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.64 8.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.251 0.548 . . . . 0.0 110.271 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.629 ' H ' ' C ' ' A' ' 55' ' ' LEU . 2.0 t60 -134.88 -145.38 0.23 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.231 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 24.7 tt0 -144.4 -43.89 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.032 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.68 133.1 54.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.714 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.4 mp -139.19 147.75 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.139 0.495 . . . . 0.0 111.389 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.4 139.59 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.908 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -121.95 137.1 54.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.668 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.2 OUTLIER -129.8 134.07 47.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.104 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 24' ' ' ILE . 67.3 m -116.37 153.47 31.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.336 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 32.7 tt0 -26.74 -70.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.85 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 91' ' ' ASP . . . -100.95 -51.31 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.602 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.09 -17.39 1.93 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -59.15 -36.78 75.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.562 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -65.71 -46.77 77.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.236 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.685 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -49.15 -50.99 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.518 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -24.13 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 29.9 m120 -86.18 -46.54 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.17 -16.2 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -46.16 -30.9 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.594 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.9 -38.05 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -73.93 -26.92 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.76 -57.83 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.86 -24.0 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.35 -40.86 64.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.653 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.5 mt -85.71 -47.12 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.633 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.974 ' HB2' ' NZ ' ' A' ' 54' ' ' LYS . . . -45.78 -27.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.608 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.776 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 67.91 173.79 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.776 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 34.3 Cg_exo -53.57 65.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.699 2.266 . . . . 0.0 112.006 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.17 -172.29 2.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.536 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -102.03 117.42 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.581 HD12 ' N ' ' A' ' 86' ' ' ILE . 2.6 mp -128.47 142.2 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -121.58 169.03 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.028 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' ILE . 18.8 mt -135.6 138.35 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 92' ' ' GLY . 7.2 tt -89.92 107.95 19.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.57 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.6 tp10 -64.13 155.65 30.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.6 OUTLIER 69.52 -34.77 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 90' ' ' GLU . . . 91.4 -160.92 27.17 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.428 ' HB ' HH12 ' A' ' 25' ' ' ARG . 1.0 OUTLIER -50.3 -27.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.344 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.13 -52.39 64.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.151 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.0 -24.34 62.75 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 101' ' ' LEU . 9.6 t-105 -82.5 -35.2 27.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -77.26 -30.62 54.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.483 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -78.45 -35.07 47.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.485 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.93 4.45 3.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.48 65.94 3.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 96' ' ' TRP . 59.7 mt -119.96 149.66 49.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.122 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -35.49 146.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 123.006 2.471 . . . . 0.0 112.468 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.401 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 8.8 p -151.51 154.85 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.96 139.04 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.595 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 32' ' ' ARG . 3.7 t -98.47 137.31 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.378 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -88.51 111.35 21.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.619 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.478 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 3' ' ' LEU . . . -100.53 36.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.823 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.2 pp -39.61 120.81 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.251 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.8 m -116.36 156.19 27.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.013 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 p -85.41 149.48 25.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.229 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -139.09 164.2 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.061 0.458 . . . . 0.0 110.816 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -103.32 139.79 20.44 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.24 -16.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.559 2.173 . . . . 0.0 111.898 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' SER . 35.2 t60 -78.47 -35.27 46.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.944 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -75.66 -49.62 17.85 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.089 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -43.29 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.338 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -50.98 -50.32 58.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 5.0 mt-10 -55.27 -30.8 60.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 61' ' ' ILE . 9.1 mt -75.3 -43.87 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.497 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.4 mt -48.27 -22.72 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -81.01 -26.67 36.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 7.4 mtt180 -85.46 -38.06 19.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.462 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.54 30.62 0.96 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -57.42 175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 110.519 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' NZ ' ' HB2' ' A' ' 57' ' ' HIS . 4.6 mttp -118.61 98.05 6.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.487 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -89.39 126.67 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.991 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.654 ' C ' ' CE1' ' A' ' 63' ' ' HIS . 6.9 mt -131.62 140.79 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.984 0.421 . . . . 0.0 111.421 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 24' ' ' ILE . 64.2 t0 -99.7 149.07 23.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.641 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -150.56 91.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.762 0.792 . . . . 0.0 110.582 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 23' ' ' ASP . 7.3 ptt-85 -169.04 -143.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.091 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.461 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -96.92 107.35 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.234 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -40.74 -26.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.457 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' ASP . 41.4 t0 -57.52 -38.07 74.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.09 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' OE1' ' OE1' ' A' ' 65' ' ' GLN . 10.9 mt-10 -80.68 -32.04 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.335 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.887 ' CD2' HD13 ' A' ' 40' ' ' LEU . 12.3 t80 -78.92 -32.0 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 7.4 tp -60.27 -55.47 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.298 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 105' ' ' VAL . 16.0 mtp180 -55.0 -20.14 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.302 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.731 ' OE2' HG11 ' A' ' 103' ' ' VAL . 22.4 tt0 -163.29 120.7 1.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.696 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 15.0 p80 -138.24 160.85 38.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.591 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.6 mt -98.7 128.13 33.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.53 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.68 21.32 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.49 2.126 . . . . 0.0 111.91 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -141.96 26.49 1.87 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.34 33.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.793 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -87.64 145.68 26.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.887 HD13 ' CD2' ' A' ' 30' ' ' TYR . 62.7 tp -101.99 116.91 33.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.478 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.91 93.81 6.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 52.6 Cg_exo -47.47 118.01 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.505 2.137 . . . . 0.0 111.875 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.886 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -38.26 -34.68 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.12 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 1.8 t -71.53 -29.77 65.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.357 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -73.28 -43.3 57.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.206 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.523 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 17.6 tp -75.82 -21.65 57.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.207 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.48 -39.72 31.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -92.79 -40.99 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 8.3 t -65.71 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.44 79.95 1.49 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.643 ' C ' ' H ' ' A' ' 53' ' ' ALA . 16.0 tp -118.28 91.43 40.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.785 0.326 . . . . 0.0 110.657 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 54' ' ' LYS . 27.4 Cg_exo -58.76 21.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.739 2.293 . . . . 0.0 112.168 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 51' ' ' LEU . . . -47.19 -21.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 81' ' ' ALA . 1.4 ttpm? -63.68 -27.17 69.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.414 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 55' ' ' LEU . 11.1 mp -76.86 -9.12 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.39 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -80.66 10.91 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 110.156 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.45 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 2.0 t60 -148.87 -146.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.421 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -150.15 -36.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.346 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.68 133.13 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.814 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.86 153.34 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.321 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 14' ' ' LEU . 4.5 mt -141.9 125.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.137 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.827 ' CE2' HD13 ' A' ' 77' ' ' LEU . 80.1 m-85 -107.7 149.23 28.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.956 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.654 ' CE1' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -138.68 133.43 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.794 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.593 ' SG ' ' CB ' ' A' ' 69' ' ' ARG . 1.4 t -116.73 153.77 31.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.519 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 6.7 pt20 -36.03 -33.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.872 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -140.09 -37.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.915 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.71 -4.66 3.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -45.71 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.667 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.593 ' CB ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -59.26 -33.99 71.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.628 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.621 ' O ' ' N ' ' A' ' 74' ' ' ALA . 52.4 m -73.13 -46.22 52.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.722 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 p -62.94 -26.96 69.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.19 -27.72 24.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' CG ' HD13 ' A' ' 43' ' ' LEU . 23.2 t30 -102.57 -12.89 17.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.568 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -55.44 -35.26 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.657 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.3 -34.81 78.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.552 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -73.19 -34.21 65.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.544 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.827 HD13 ' CE2' ' A' ' 62' ' ' PHE . 28.0 mt -75.66 -56.06 5.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.409 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.04 -30.82 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.14 81.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.346 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 77' ' ' LEU . 89.3 mt -81.46 -30.52 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.563 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -55.69 -43.98 76.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 75.62 177.02 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.028 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.823 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 32.7 Cg_exo -54.55 65.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.089 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.89 -151.44 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.513 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.83 121.06 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.399 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.6 mp -125.56 126.88 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.426 ' HB3' HD12 ' A' ' 6' ' ' ILE . 43.0 m-85 -114.87 161.3 18.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.445 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 6' ' ' ILE . 9.1 mt -130.33 140.44 50.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.558 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -85.84 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.098 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 92' ' ' GLY . 1.5 tt0 -59.56 146.03 42.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.915 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.1 t0 69.19 -12.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.717 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 68.83 -158.31 52.98 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -30.58 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 110.576 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -31.1 67.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.388 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 99' ' ' ALA . . . -72.39 -59.38 4.56 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.667 ' CZ3' HD13 ' A' ' 101' ' ' LEU . 4.5 t-105 -48.38 -40.43 25.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.047 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.98 -47.08 87.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.461 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 100' ' ' GLY . 26.8 ttm180 -83.31 -17.82 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -60.22 -5.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.574 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 98' ' ' ARG . . . 88.39 33.96 9.93 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.667 HD13 ' CZ3' ' A' ' 96' ' ' TRP . 23.0 mt -125.79 144.01 47.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 148.37 42.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.586 2.191 . . . . 0.0 112.466 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.731 HG11 ' OE2' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -112.32 171.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.061 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.696 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -127.47 125.12 39.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.7 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 32' ' ' ARG . 21.2 t -97.46 137.72 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.127 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -71.4 108.54 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.202 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.622 -179.841 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 4' ' ' THR . . . -122.06 33.54 5.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.724 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -39.44 99.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 5' ' ' THR . 89.0 m -90.03 156.26 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.889 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 4' ' ' THR . 1.1 p -85.87 150.6 24.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.164 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -143.59 164.05 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.277 0.56 . . . . 0.0 111.052 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.538 ' N ' HG23 ' A' ' 6' ' ' ILE . 32.1 m -112.45 149.47 41.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.832 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -41.18 -22.59 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.501 2.134 . . . . 0.0 111.856 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.466 ' N ' ' O ' ' A' ' 7' ' ' SER . 3.4 t-80 -67.21 -38.68 85.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.159 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.79 -54.79 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.434 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.58 -39.51 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HA ' HD12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -61.38 -44.61 96.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.81 -36.84 84.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 29.5 mt -72.79 -42.99 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.705 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.621 HD12 ' HA ' ' A' ' 12' ' ' GLN . 48.0 mt -50.54 -22.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.15 -20.32 38.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.123 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 14' ' ' LEU . 4.7 mtt180 -93.94 -51.28 4.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.46 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 149.15 33.85 0.05 OUTLIER Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -62.68 179.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.227 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HB3' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -133.7 98.15 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.898 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 15' ' ' ILE . 1.6 mp -85.59 133.71 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.972 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.477 HD12 ' CE1' ' A' ' 62' ' ' PHE . 12.1 mt -132.34 142.58 42.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.96 142.13 35.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.432 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -147.21 88.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.799 0.809 . . . . 0.0 110.769 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.542 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 2.6 ptp180 -165.42 -144.45 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.619 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.459 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 38.1 t0 -97.17 107.39 19.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -37.81 -42.27 0.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.66 -38.61 2.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 109.979 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -80.09 -35.09 37.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.067 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.735 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.4 t80 -71.48 -26.98 62.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.3 tp -62.74 -50.42 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.849 ' O ' HG13 ' A' ' 105' ' ' VAL . 4.4 ptm180 -56.76 -27.12 58.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.372 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.524 ' OE2' HG21 ' A' ' 103' ' ' VAL . 31.8 tt0 -159.6 128.85 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.644 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 13.2 p80 -145.61 155.35 42.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 110.767 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 37' ' ' GLU . 8.7 mm -91.9 121.56 66.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.5 23.79 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.278 1.986 . . . . 0.0 112.091 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 35' ' ' ILE . 26.0 mt-10 -146.71 30.6 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.545 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.86 157.89 43.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.556 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.37 153.08 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.602 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.735 HD13 ' CD2' ' A' ' 30' ' ' TYR . 57.7 tp -113.46 110.57 20.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.263 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.64 95.35 6.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.649 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 45' ' ' VAL . 71.2 Cg_exo -44.83 120.32 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.565 2.177 . . . . 0.0 112.079 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.939 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -43.12 -25.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.94 -30.63 39.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.393 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -81.79 -31.38 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.972 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.47 -20.18 57.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.819 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.65 -40.15 19.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.534 ' CG ' ' N ' ' A' ' 49' ' ' SER . 4.6 pt20 -87.86 -45.2 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.012 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.534 ' N ' ' CG ' ' A' ' 48' ' ' GLN . 5.6 t -66.55 -59.01 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.59 82.19 1.39 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 53' ' ' ALA . 13.4 tp -116.08 89.52 25.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.651 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.01 64.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.774 2.316 . . . . 0.0 112.045 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -50.13 -20.0 0.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.492 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.636 ' NZ ' ' HB3' ' A' ' 82' ' ' ALA . 19.7 tttm -57.6 -26.41 61.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.612 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -80.83 -13.98 58.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -90.15 13.25 15.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.033 0.444 . . . . 0.0 109.937 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.723 ' CG ' ' H ' ' A' ' 58' ' ' GLU . 13.7 t-80 179.3 -150.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.723 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 54.7 tt0 -137.38 -41.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.946 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -111.95 132.98 54.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.53 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -132.41 150.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.001 0.429 . . . . 0.0 111.215 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 HD12 ' A' ' 14' ' ' LEU . 1.2 mt -133.58 129.69 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.967 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.72 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 97.9 m-85 -112.04 145.87 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.529 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -152.26 135.47 15.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.708 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.59 ' SG ' HD11 ' A' ' 24' ' ' ILE . 1.8 m -115.19 153.09 31.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.542 ' H ' ' NE ' ' A' ' 25' ' ' ARG . 38.1 tp60 -29.69 -47.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.662 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.87 -11.33 8.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.554 ' H ' ' HB2' ' A' ' 64' ' ' CYS . . . 91.57 2.66 69.81 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -64.56 -30.16 71.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.357 . . . . 0.0 110.523 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 9.7 mpt_? -81.38 -24.72 36.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.534 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -59.82 -55.4 34.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -27.59 67.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' OD2' ' A' ' 75' ' ' ASP . 6.5 m120 -86.69 -37.83 17.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.739 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 69' ' ' ARG . 3.7 t30 -84.9 -17.08 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -48.31 -26.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.169 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -80.78 -51.8 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -65.35 -26.22 67.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.502 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.72 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 48.1 mt -65.56 -61.16 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.71 -53.31 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.3 68.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.29 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mm -71.39 -17.85 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.182 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -121.62 100.03 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.7 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -44.02 178.93 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.448 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 29.2 Cg_exo -57.36 64.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.7 2.267 . . . . 0.0 112.34 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.8 -149.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.253 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.576 ' OE1' ' O ' ' A' ' 84' ' ' ALA . 3.1 mm-40 -115.58 103.01 10.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.07 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.1 139.1 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CG ' HD12 ' A' ' 6' ' ' ILE . 54.4 m-85 -120.97 166.92 13.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.184 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 6' ' ' ILE . 17.1 mt -135.58 142.19 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 110.753 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.623 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -97.91 109.71 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.319 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.7 tm-20 -60.12 143.51 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.755 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.22 -27.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.623 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 87.09 -155.6 27.61 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.8 tt -50.66 -32.45 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.66 -37.34 8.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -57.24 7.26 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.626 ' CD1' ' C ' ' A' ' 96' ' ' TRP . 1.7 t-105 -45.45 -39.28 6.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 110.437 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -56.18 -62.35 1.77 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 100' ' ' GLY . 14.3 ptp180 -70.54 -29.6 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.3 -15.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.491 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 98' ' ' ARG . . . 93.51 38.12 5.38 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 96' ' ' TRP . 24.9 mt -125.13 141.05 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.539 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.53 145.98 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.525 2.15 . . . . 0.0 112.073 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.524 HG21 ' OE2' ' A' ' 33' ' ' GLU . 14.4 m -112.3 172.08 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.548 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.644 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -132.52 128.93 38.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 32' ' ' ARG . 4.8 t -96.77 136.1 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.436 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.543 ' N ' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -82.79 110.68 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.535 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 tttm . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.426 179.93 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.83 7.59 14.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.459 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 78' ' ' ALA . 1.4 pp -94.37 144.54 25.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.617 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 88' ' ' LEU . 71.5 m -118.87 151.98 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.544 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.31 149.18 33.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.662 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.82 HD12 ' CG ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -136.3 161.55 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 110.437 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 9' ' ' HIS . 96.0 p -98.17 135.85 21.19 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.533 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -40.85 -16.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.151 1.901 . . . . 0.0 111.565 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.598 ' N ' ' O ' ' A' ' 7' ' ' SER . 2.1 t60 -79.6 -30.79 41.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.896 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.8 OUTLIER -76.81 -52.07 10.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.241 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.36 -31.08 3.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.28 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.544 ' HA ' HD12 ' A' ' 15' ' ' ILE . 32.8 tt0 -68.66 -52.02 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.375 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.35 -37.64 70.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 65.2 mt -70.34 -40.98 73.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.552 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 12' ' ' GLN . 14.9 mt -48.4 -24.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.46 -23.61 32.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.02 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 14' ' ' LEU . 10.8 mmt180 -82.13 -44.94 15.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 143.5 -6.96 1.97 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -28.71 149.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.848 0.356 . . . . 0.0 110.653 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 39' ' ' ASP . 7.1 mtpp -104.13 98.91 8.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 21' ' ' LEU . 6.3 mp -83.24 124.32 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.969 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mt -122.96 136.67 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 111.475 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' ALA . 34.8 t70 -105.47 136.54 44.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.691 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 41' ' ' ALA . 1.1 pt -136.47 86.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.47 0.653 . . . . 0.0 110.877 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.579 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 3.1 ptp180 -157.27 -146.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.956 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 27' ' ' ALA . 48.3 m-20 -102.98 114.82 29.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.16 -39.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.503 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -42.46 -33.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.341 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 2.6 mt-10 -86.5 -33.6 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.125 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.2 t80 -73.54 -40.55 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tp -55.88 -56.04 25.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.419 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 105' ' ' VAL . 10.5 ptp180 -49.19 -28.06 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 30' ' ' TYR . 1.4 tm-20 -169.24 136.66 1.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.116 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.647 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.1 p80 -150.38 176.54 10.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 110.744 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.67 ' C ' ' H ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -119.68 98.31 49.81 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.444 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 31.9 Cg_exo -54.23 18.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.89 2.393 . . . . 0.0 113.005 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.67 ' H ' ' C ' ' A' ' 35' ' ' ILE . 1.9 pm0 -126.96 9.73 6.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.047 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.41 149.34 52.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -84.78 124.48 31.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.467 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 tp -84.47 119.95 25.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -148.88 89.65 4.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HB2' HG13 ' A' ' 45' ' ' VAL . 89.3 Cg_exo -40.46 146.78 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.068 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -72.61 -25.42 61.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.213 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -30.82 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.4 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 49' ' ' SER . 3.4 m -85.54 -30.11 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.576 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.87 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.7 tt -60.5 -50.9 71.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.684 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.4 -52.88 62.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -70.97 -44.98 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 41.7 t -61.68 -70.17 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.06 68.48 1.18 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -118.21 86.19 26.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.512 ' C ' ' N ' ' A' ' 54' ' ' LYS . 14.5 Cg_exo -64.97 79.23 0.2 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.906 2.404 . . . . 0.0 112.336 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.72 -21.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 82' ' ' ALA . 24.9 tttp -56.71 -15.35 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.114 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.49 -10.0 59.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.93 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 -118.3 17.53 13.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.252 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.38 -166.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.45 -31.54 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.18 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -112.12 133.03 54.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.702 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.58 138.84 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 111.07 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mt -116.91 133.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.236 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.576 ' CD1' HD13 ' A' ' 77' ' ' LEU . 95.1 m-85 -116.9 138.01 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.603 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 15.3 p80 -160.65 137.32 8.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -116.27 154.08 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.354 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.583 ' O ' HG22 ' A' ' 93' ' ' ILE . 1.9 tp-100 -27.4 -54.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.56 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -108.01 -3.44 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' A' ' 69' ' ' ARG . . . 79.46 -43.05 2.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 67' ' ' GLY . 13.6 mttt -31.56 -33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.552 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -63.32 -59.96 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.553 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.837 HG21 HD13 ' A' ' 88' ' ' LEU . 17.5 m -43.83 -49.57 8.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -27.16 63.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.95 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 69' ' ' ARG . 11.9 t-20 -86.69 -47.48 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.096 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.661 ' OD1' HD13 ' A' ' 43' ' ' LEU . 2.3 t30 -89.96 -10.41 45.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.998 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -48.84 -29.44 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.214 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -29.32 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.762 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.452 ' HB2' ' ND2' ' A' ' 73' ' ' ASN . 52.5 mmtt -83.95 -23.45 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.879 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 80' ' ' ILE . 11.7 mt -80.09 -57.59 3.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.849 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' A' ' 3' ' ' LEU . . . -39.98 -34.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.46 -29.23 46.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' LEU . 97.0 mt -86.37 -17.89 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB3' HD13 ' A' ' 86' ' ' ILE . . . -97.67 4.99 49.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.768 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 45.44 179.59 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.989 0.423 . . . . 0.0 110.538 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 23.1 Cg_exo -60.12 20.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.747 2.298 . . . . 0.0 112.164 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -66.11 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.586 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.66 94.12 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.816 HD13 ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -110.89 144.07 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.82 ' CG ' HD12 ' A' ' 6' ' ' ILE . 11.6 m-85 -120.56 171.02 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.691 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 70' ' ' THR . 18.6 tp -137.83 128.66 27.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.508 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.3 tt -87.28 97.41 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.563 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.496 ' C ' ' CG ' ' A' ' 91' ' ' ASP . 1.4 tt0 -46.16 139.53 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 74.15 -47.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 105.98 -156.06 16.55 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 65' ' ' GLN . 7.6 tt -50.56 -20.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.829 0.347 . . . . 0.0 110.519 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.96 -33.91 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.465 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -83.37 -36.93 13.08 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.422 ' CE2' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -67.09 -29.38 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.31 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -43.27 19.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.493 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -77.04 -24.61 52.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.371 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 95' ' ' GLY . . . -53.36 -41.57 65.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.52 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.78 30.46 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.422 HD13 ' CE2' ' A' ' 96' ' ' TRP . 14.2 mt -118.86 141.93 30.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.72 169.83 21.44 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.355 2.037 . . . . 0.0 112.09 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.62 166.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 34' ' ' HIS . . . -121.57 117.09 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.298 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 32' ' ' ARG . 15.8 t -96.64 135.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.671 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -74.88 109.07 8.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.309 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.648 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 174.85 82.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.575 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.541 HD12 HD11 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -130.38 125.67 35.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.634 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -113.98 138.52 50.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -77.88 145.17 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -131.81 163.21 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.385 0.612 . . . . 0.0 111.205 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' HIS . 12.4 t -105.06 142.35 24.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.656 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -41.64 -17.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.451 2.101 . . . . 0.0 112.302 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -81.42 -28.56 34.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -79.79 -52.15 8.28 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.345 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.05 -35.26 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.29 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -38.88 92.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' ASP . 21.0 mt-10 -70.66 -41.73 71.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 16.1 mt -66.98 -41.94 85.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.685 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.593 HD11 ' CD1' ' A' ' 21' ' ' LEU . 8.3 mt -48.36 -24.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.89 -23.27 36.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.396 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -86.36 -40.35 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.598 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.99 -10.69 0.9 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -30.96 147.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HG3' ' CG ' ' A' ' 57' ' ' HIS . 11.4 mtpt -112.28 109.91 19.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.563 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.593 ' CD1' HD11 ' A' ' 15' ' ' ILE . 3.6 mt -94.37 131.9 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.089 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.607 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 12.4 mt -135.55 141.99 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -98.42 137.94 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.95 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.61 83.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 0.0 110.608 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HE ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -168.32 -149.1 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.425 ' H ' ' CD ' ' A' ' 25' ' ' ARG . 4.0 m-20 -89.01 114.14 25.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.351 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.593 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -43.34 -43.58 5.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.17 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -42.29 -21.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.763 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' ALA . 3.2 mm-40 -86.84 -38.45 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.859 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -81.6 -24.26 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.17 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -45.0 94.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -68.98 -21.93 64.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 103' ' ' VAL . 2.8 tt0 -164.71 126.45 2.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.375 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 2.7 p80 -139.65 160.17 40.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.423 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 37' ' ' GLU . 10.0 mt -105.35 130.58 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.671 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.34 23.17 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.552 2.168 . . . . 0.0 111.876 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 35' ' ' ILE . 51.7 mm-40 -141.67 34.47 1.62 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.646 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.74 23.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.529 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 40' ' ' LEU . 2.0 t0 -90.32 155.48 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.684 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.649 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.5 tp -110.3 119.46 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.535 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.79 88.21 6.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.312 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 45' ' ' VAL . 88.4 Cg_exo -42.49 126.76 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.747 2.298 . . . . 0.0 112.688 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.019 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -41.99 -24.92 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.717 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' PRO . 5.6 t -79.18 -27.51 42.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.462 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 42' ' ' PRO . 33.4 m -84.74 -27.83 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.165 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.62 -43.41 69.36 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.704 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -32.27 51.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -87.41 -43.63 11.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.611 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.26 -72.83 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . 112.08 92.55 2.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.8 tp -118.59 83.57 22.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.446 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 54' ' ' LYS . 8.3 Cg_exo -68.79 62.22 1.26 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.885 2.39 . . . . 0.0 112.198 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' CB ' HD11 ' A' ' 22' ' ' ILE . . . -39.72 -27.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -51.22 -18.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.48 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.33 -13.56 54.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.985 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.508 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.5 mtp85 -109.16 18.34 20.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -179.52 -169.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.03 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.542 ' C ' ' OE1' ' A' ' 59' ' ' GLN . 4.2 tt0 -118.94 -30.57 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.542 ' OE1' ' C ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -112.06 133.76 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.6 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.892 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -127.32 145.51 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.947 0.403 . . . . 0.0 111.107 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.421 HD11 ' HB1' ' A' ' 19' ' ' ALA . 7.7 mt -137.55 136.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 77' ' ' LEU . 67.8 m-85 -119.75 132.25 55.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.733 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 1.8 p80 -129.0 134.03 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -116.29 153.39 32.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.745 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 60.1 tp60 -34.15 -36.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.481 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -125.61 -42.66 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.654 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 133.18 -32.0 2.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 67' ' ' GLY . 15.8 mmtm -38.67 -42.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.728 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -64.81 -31.92 73.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.13 -45.67 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.011 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.3 -23.14 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.852 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.33 -33.37 20.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -93.3 -17.0 24.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -51.4 -29.9 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -29.75 65.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.011 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -21.51 29.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.767 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.605 HD13 ' CD1' ' A' ' 62' ' ' PHE . 87.6 mt -80.92 -56.56 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.945 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' LEU . . . -39.27 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -80.18 -47.31 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.8 mt -80.84 -19.17 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.154 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -95.98 5.71 50.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.941 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.815 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 44.47 -178.86 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 0.0 110.371 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.815 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 23.2 Cg_exo -60.45 21.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.732 2.288 . . . . 0.0 112.244 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -68.2 179.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.27 112.69 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mt -117.27 139.12 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.44 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.499 ' O ' HD23 ' A' ' 88' ' ' LEU . 70.0 m-85 -120.02 171.98 8.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.604 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 3' ' ' LEU . 7.1 mt -137.2 131.73 32.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.993 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -81.66 85.33 6.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.205 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.646 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 46.8 tt0 -57.48 121.03 9.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.646 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 19.1 t0 94.11 -26.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.423 ' H ' HD12 ' A' ' 89' ' ' LEU . . . 78.46 -153.32 38.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.56 -21.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.15 -59.55 3.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.445 ' HA2' ' NH1' ' A' ' 98' ' ' ARG . . . -61.38 -40.35 98.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.533 ' CE2' ' CB ' ' A' ' 101' ' ' LEU . 16.7 t-105 -53.73 -35.44 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.361 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -80.68 -51.11 9.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.637 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.445 ' NH1' ' HA2' ' A' ' 95' ' ' GLY . 14.2 ttp-105 -51.48 -18.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.976 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.92 -21.12 15.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.775 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.62 72.68 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.533 ' CB ' ' CE2' ' A' ' 96' ' ' TRP . 15.1 mt -119.68 152.68 53.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.399 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' LEU . 96.3 Cg_exo -30.17 118.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 123.193 2.595 . . . . 0.0 112.446 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 2.4 p -143.64 157.04 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.088 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -143.48 130.03 20.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.076 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.416 ' C ' ' NE2' ' A' ' 34' ' ' HIS . 60.9 t -97.33 142.63 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.234 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.567 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 3.3 t30 -86.45 108.69 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.314 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.505 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 3' ' ' LEU . 4.0 pp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.827 0.346 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -116.83 144.17 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.401 HG22 ' HB3' ' A' ' 88' ' ' LEU . 1.4 p -78.16 145.13 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -136.32 166.06 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.824 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 6' ' ' ILE . 1.7 t -102.46 142.58 24.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.935 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -42.06 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.369 2.046 . . . . 0.0 112.063 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -80.89 -27.94 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.11 -52.68 6.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.367 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.11 -32.33 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.424 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.414 ' HA ' HD12 ' A' ' 15' ' ' ILE . 1.7 tt0 -66.24 -56.66 10.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -45.48 -26.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 27.8 mt -82.94 -39.9 20.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 12' ' ' GLN . 67.0 mt -49.2 -24.85 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.83 -20.72 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.958 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.558 ' N ' ' O ' ' A' ' 14' ' ' LEU . 6.0 ttt180 -84.14 -41.04 17.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.504 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 139.01 -7.37 3.21 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -31.29 151.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 0.0 110.601 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.787 ' HZ2' ' HE ' ' A' ' 56' ' ' ARG . 1.4 mtpt -109.42 99.72 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.423 HD23 ' CD2' ' A' ' 63' ' ' HIS . 0.6 OUTLIER -82.23 134.7 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.959 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 22' ' ' ILE . 14.4 mt -130.85 141.18 46.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 0.0 111.096 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.581 ' OD2' ' NH2' ' A' ' 25' ' ' ARG . 5.2 t0 -111.71 135.6 52.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.135 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 70' ' ' THR . 8.2 pt -130.12 81.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.243 0.544 . . . . 0.0 110.197 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.581 ' NH2' ' OD2' ' A' ' 23' ' ' ASP . 11.8 ptt180 -154.73 -145.54 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.285 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 11.2 m-20 -101.8 116.21 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.316 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -45.61 -36.01 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.189 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -48.34 -34.35 10.49 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -85.18 -32.4 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.806 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.759 ' CZ ' ' ND1' ' A' ' 34' ' ' HIS . 10.0 t80 -73.08 -31.0 64.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 4.0 tp -65.06 -59.24 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.694 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -53.63 -25.55 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.144 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.585 ' OE2' HG11 ' A' ' 103' ' ' VAL . 19.0 tt0 -152.76 117.78 5.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.185 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.77 ' ND1' ' N ' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -140.77 152.13 44.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.513 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.77 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 5.9 mt -110.62 94.18 18.73 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.662 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 50.2 Cg_exo -49.37 66.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.871 2.38 . . . . 0.0 112.4 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.71 ' N ' ' O ' ' A' ' 35' ' ' ILE . 14.5 pt-20 -179.46 27.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 153.49 30.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.337 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -84.77 143.53 29.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.71 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.37 114.55 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.84 96.59 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.555 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' VAL . 82.9 Cg_exo -44.94 124.41 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.372 2.048 . . . . 0.0 111.875 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 73' ' ' ASN . 1.7 tt -36.6 -60.29 0.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.137 0.494 . . . . 0.0 110.565 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -44.09 -25.93 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.974 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -73.9 -39.02 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.926 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.617 HD22 HD21 ' A' ' 73' ' ' ASN . 6.5 tt -83.39 -42.97 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.825 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.88 -29.89 71.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.847 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.487 ' CG ' ' N ' ' A' ' 49' ' ' SER . 7.7 pt20 -97.18 -40.61 8.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.935 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 2.1 t -87.47 -55.36 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.756 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 83.11 0.8 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.674 ' O ' ' N ' ' A' ' 53' ' ' ALA . 14.1 tp -107.58 97.92 21.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.87 67.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.564 2.176 . . . . 0.0 112.194 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -51.71 -19.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.275 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' HIS . 5.4 tttp -63.3 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mp -77.91 -13.56 59.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.793 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.787 ' HE ' ' HZ2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.1 19.95 8.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 166.17 -167.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.786 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -113.38 -39.58 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.3 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -112.31 133.47 54.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.156 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.946 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -136.33 144.35 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -127.02 146.51 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.169 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.725 ' CD1' HD13 ' A' ' 77' ' ' LEU . 96.6 m-85 -126.62 137.36 53.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.74 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 1.0 OUTLIER -140.75 136.32 32.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.519 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.6 t -115.7 153.22 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.455 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.519 ' C ' ' O ' ' A' ' 64' ' ' CYS . 2.8 tt0 -30.08 -53.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.65 54.08 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.621 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 42.7 49.57 5.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -112.24 -42.62 3.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.759 ' HB3' HD12 ' A' ' 43' ' ' LEU . 2.9 mmt180 -83.39 -31.9 26.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.611 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.676 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -65.37 -43.34 91.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.531 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -24.7 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.37 -43.96 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.776 ' HB2' HD11 ' A' ' 43' ' ' LEU . 9.2 t30 -88.46 -16.44 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.636 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -44.32 -38.22 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.387 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.47 -27.06 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.577 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ASN . 15.6 mmtm -78.96 -26.15 43.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.725 HD13 ' CD1' ' A' ' 62' ' ' PHE . 80.4 mt -77.9 -56.81 4.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.33 -33.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.16 -48.32 17.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.5 mt -75.8 -17.7 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -96.27 8.18 44.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.731 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 42.98 -179.47 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 110.626 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.809 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 18.1 Cg_exo -62.49 15.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.658 2.239 . . . . 0.0 112.018 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -53.1 -152.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -122.31 98.7 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.382 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 60' ' ' ILE . 3.0 mp -116.04 146.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.47 177.9 4.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.188 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -135.95 129.28 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.775 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -87.54 101.33 13.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 15.4 tt0 -54.36 121.24 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER 82.22 -50.26 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.568 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.474 ' H ' HD12 ' A' ' 89' ' ' LEU . . . 120.92 -133.87 9.9 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -77.05 -30.83 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 50.1 t0 -48.22 -30.69 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.81 -54.79 4.76 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.457 ' CE2' HD13 ' A' ' 101' ' ' LEU . 2.3 t90 -47.09 -32.19 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.914 0.387 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -73.87 -53.05 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.586 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' C ' ' N ' ' A' ' 100' ' ' GLY . 3.3 ttt180 -66.2 -29.54 69.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.534 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.52 -12.26 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.742 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 98' ' ' ARG . . . 101.24 24.19 9.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.457 HD13 ' CE2' ' A' ' 96' ' ' TRP . 16.4 mt -116.46 138.09 24.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.25 161.66 40.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.349 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.585 HG11 ' OE2' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -111.96 172.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.211 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -132.78 121.15 22.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.691 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 32' ' ' ARG . 15.0 t -96.75 144.02 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.3 108.6 4.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.295 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 tttt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.55 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.8 pp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.814 0.34 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -122.4 158.41 29.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.581 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -87.9 144.25 26.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -136.7 164.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.458 . . . . 0.0 110.931 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 9' ' ' HIS . 17.2 t -104.07 138.99 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.796 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.23 -16.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.578 2.185 . . . . 0.0 111.854 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.645 ' N ' ' O ' ' A' ' 7' ' ' SER . 23.6 m170 -75.92 -35.98 59.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.947 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.2 t0 -76.22 -54.19 7.15 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.506 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.13 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.413 ' HA ' HD12 ' A' ' 15' ' ' ILE . 5.0 tt0 -49.73 -46.77 50.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.27 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -59.01 -42.0 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.189 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.809 HD12 HD11 ' A' ' 61' ' ' ILE . 6.9 mt -68.3 -43.85 76.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 12' ' ' GLN . 58.6 mt -48.14 -23.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.855 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.61 25.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.483 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.0 ttm-85 -81.12 -40.5 23.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.87 -11.81 0.95 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -27.07 144.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.69 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HG3' ' CG ' ' A' ' 57' ' ' HIS . 4.8 mmtm -102.24 98.38 8.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.727 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.588 HD22 ' CE1' ' A' ' 63' ' ' HIS . 0.5 OUTLIER -84.48 131.78 34.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.105 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.43 140.79 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.511 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.568 ' CG ' ' CE1' ' A' ' 30' ' ' TYR . 1.4 t70 -101.89 136.72 41.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 43' ' ' LEU . 1.1 pp -136.98 84.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 0.0 110.736 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -160.81 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.93 111.23 23.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -41.86 -33.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.276 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.16 -34.67 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -83.84 -31.89 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.538 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.862 ' CD2' HD13 ' A' ' 40' ' ' LEU . 1.5 t80 -77.67 -25.37 49.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.412 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' ALA . 1.4 tp -70.32 -47.94 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.171 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.0 -10.2 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.237 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.5 tt0 -172.83 137.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CE1' ' OD1' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -160.63 161.28 32.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 110.796 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 37' ' ' GLU . 1.7 mt -106.27 105.33 53.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 32.2 Cg_exo -54.33 19.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.576 2.184 . . . . 0.0 113.046 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.676 ' H ' ' C ' ' A' ' 35' ' ' ILE . 56.1 mm-40 -135.12 24.15 3.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.487 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.51 149.09 42.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.81 133.59 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 30' ' ' TYR . 61.0 tp -92.79 118.0 30.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.291 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.44 93.36 4.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.6 Cg_exo -45.49 120.48 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.497 2.132 . . . . 0.0 111.954 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -41.23 -25.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.987 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.25 -26.73 32.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.51 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG1' ' N ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -78.34 -48.75 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.077 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.848 HD12 ' H ' ' A' ' 51' ' ' LEU . 13.5 tp -54.91 -27.13 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -84.38 -49.47 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -67.0 -52.87 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.6 t -82.99 -77.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.07 91.47 1.28 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 46' ' ' LEU . 17.0 tp -124.46 79.2 61.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.778 0.323 . . . . 0.0 110.579 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 54' ' ' LYS . 7.6 Cg_exo -69.33 78.12 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.987 2.458 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.52 -21.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . 14.5 tttm -57.35 -13.81 3.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.074 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.7 mt -77.55 -10.7 59.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.519 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.7 mtt180 -125.01 22.88 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.299 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -170.14 -169.04 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.167 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.7 -34.68 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.023 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -112.77 133.26 54.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' H ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -129.76 118.53 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.809 HD11 HD12 ' A' ' 14' ' ' LEU . 12.1 mt -110.5 141.74 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.15 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.563 ' CG ' HD13 ' A' ' 77' ' ' LEU . 60.4 m-85 -123.85 143.3 50.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.051 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.588 ' CE1' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -143.22 135.94 27.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.346 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.809 ' HG ' ' HG1' ' A' ' 70' ' ' THR . 1.3 m -116.48 153.07 32.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 66' ' ' ALA . 6.9 pt20 -34.91 -39.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.478 ' N ' ' HG2' ' A' ' 65' ' ' GLN . . . -128.06 -4.96 5.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.568 ' H ' ' HB2' ' A' ' 64' ' ' CYS . . . 85.32 -28.78 4.58 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -42.56 -26.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HB3' ' SG ' ' A' ' 64' ' ' CYS . 2.7 tpm_? -83.59 -25.45 30.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.068 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.809 ' HG1' ' HG ' ' A' ' 64' ' ' CYS . 0.2 OUTLIER -65.88 -54.61 24.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.765 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -65.17 -23.66 67.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -86.4 -47.5 9.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.539 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.601 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 t30 -84.28 -16.29 43.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.361 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -41.34 -33.87 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.113 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.18 -31.32 67.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 73' ' ' ASN . 33.8 mmtt -81.79 -22.08 37.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.904 0.383 . . . . 0.0 110.532 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.563 HD13 ' CG ' ' A' ' 62' ' ' PHE . 60.9 mt -80.62 -57.19 3.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.654 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.99 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.48 -54.59 34.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -18.46 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.221 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.03 2.17 50.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.841 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 52.63 -179.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.735 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 22.9 Cg_exo -60.54 7.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.878 2.386 . . . . 0.0 112.448 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -46.48 169.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.279 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.9 102.67 4.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.217 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.78 133.13 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.425 ' O ' HD23 ' A' ' 88' ' ' LEU . 46.7 m-85 -125.54 153.56 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.609 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.531 HD22 HG22 ' A' ' 70' ' ' THR . 23.1 mt -122.39 137.03 55.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.195 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.507 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.6 tt -89.04 91.34 8.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.34 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -40.66 147.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 68.35 -47.44 0.54 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 101.9 -145.76 16.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mm -51.0 -41.93 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.477 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.29 -35.26 59.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.02 -47.11 39.88 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.529 ' CD1' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.95 -37.04 81.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.45 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -80.76 -25.79 37.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.376 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -73.86 -44.75 54.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.45 63.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.564 ' O ' HD23 ' A' ' 101' ' ' LEU . . . 125.76 45.34 0.24 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 100' ' ' GLY . 9.6 mt -123.5 106.27 32.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -45.62 152.09 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.455 2.103 . . . . 0.0 112.174 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.37 169.06 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.436 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -128.65 144.12 51.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.454 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.96 130.57 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.663 ' OD1' ' CE1' ' A' ' 34' ' ' HIS . 1.7 m-20 -67.59 109.69 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 106' ' ' ASN . 17.6 tttt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.852 0.358 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 m -132.72 151.97 51.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.49 33.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.548 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -144.8 163.28 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.728 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.599 ' O ' ' N ' ' A' ' 9' ' ' HIS . 4.9 m -108.62 142.98 26.59 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.46 -17.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.477 2.118 . . . . 0.0 111.722 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.599 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -73.06 -35.81 66.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.754 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -75.66 -56.11 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.209 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.61 -23.44 0.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -70.99 -44.41 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -68.07 -26.06 65.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.776 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 14.7 mt -79.74 -45.13 19.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.5 mt -47.76 -23.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.447 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -27.46 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.118 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 14' ' ' LEU . 9.9 mtt180 -84.43 -41.54 16.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.416 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.74 28.08 0.41 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -59.82 149.09 32.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.4 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.61 102.51 13.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.673 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 21' ' ' LEU . 5.2 mp -92.56 129.22 38.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.443 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 7.3 mt -127.44 142.43 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.032 0.444 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -103.75 153.43 20.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.555 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.447 ' O ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 pp -147.73 90.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.334 0.588 . . . . 0.0 110.789 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 24.4 ttt-85 -173.91 -141.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.9 119.69 30.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.271 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.71 97.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.534 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.66 -26.28 3.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.006 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.56 -44.95 11.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.301 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.8 t80 -70.37 -31.03 68.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.195 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.56 -58.21 8.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.743 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -52.63 -28.66 22.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.27 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.9 tt0 -152.51 123.58 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.607 ' CD2' ' ND2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -150.55 175.55 11.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.011 0.434 . . . . 0.0 111.034 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.687 ' C ' ' H ' ' A' ' 37' ' ' GLU . 43.8 mt -109.2 106.07 58.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.253 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 32.1 Cg_exo -54.44 19.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.573 2.182 . . . . 0.0 112.981 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.687 ' H ' ' C ' ' A' ' 35' ' ' ILE . 41.4 mm-40 -137.82 38.51 2.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.342 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.2 150.33 25.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.53 126.41 35.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.1 tp -85.19 117.14 23.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.177 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.36 93.75 6.34 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.569 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.3 Cg_exo -45.99 122.5 5.3 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.498 2.132 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.014 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -39.79 -29.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -75.49 -30.7 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -68.4 -38.77 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.112 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD22 HD23 ' A' ' 77' ' ' LEU . 2.4 tt -73.41 -41.81 62.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -64.99 -31.03 72.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.195 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -96.14 -32.73 12.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.145 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 10.0 t -92.07 -44.44 8.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 110.809 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 68.37 64.26 3.18 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -98.68 110.55 57.54 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' LYS . 58.6 Cg_endo -77.44 63.09 7.83 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.376 2.05 . . . . 0.0 112.353 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.62 -21.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.961 0.41 . . . . 0.0 110.046 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HE2' ' HB3' ' A' ' 82' ' ' ALA . 30.9 tttp -54.34 -21.43 9.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.454 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.59 -6.31 53.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.72 14.86 30.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.412 . . . . 0.0 110.472 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t60 177.97 -164.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.736 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -121.92 -26.46 4.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.089 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -113.82 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.801 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -134.56 142.16 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.795 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.27 144.85 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.431 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 47.7 m-85 -123.96 141.19 52.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.861 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -149.15 133.84 17.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.536 ' O ' ' C ' ' A' ' 65' ' ' GLN . 3.5 m -117.54 153.73 32.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.536 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.5 OUTLIER -28.23 -41.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.593 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -126.27 -60.45 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.537 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 154.7 -37.16 0.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 24.6 tttt -45.14 -29.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HE ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -75.22 -36.49 61.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.773 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -65.66 -42.98 90.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.423 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -66.31 -21.17 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.633 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 68' ' ' LYS . 3.0 m120 -82.75 -41.74 18.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 76' ' ' LYS . 2.0 t-20 -98.72 -13.81 20.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -47.16 -29.97 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.53 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -80.81 -31.37 35.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.528 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 73' ' ' ASN . 36.7 mmtm -76.76 -41.29 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.655 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.538 HD23 HD22 ' A' ' 46' ' ' LEU . 10.1 mt -67.81 -57.8 5.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.17 -29.8 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.454 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.5 -56.38 20.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.38 -20.51 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.55 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -77.27 -2.76 36.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 44.95 -179.27 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 110.472 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 22.7 Cg_exo -60.23 26.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.764 2.309 . . . . 0.0 112.09 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.623 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -69.11 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.506 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -110.31 99.09 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.464 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.83 133.24 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.87 163.38 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.851 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 89' ' ' LEU . 10.1 tp -131.92 132.32 43.46 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.876 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 88' ' ' LEU . 7.2 tt -99.24 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' O ' ' OD2' ' A' ' 91' ' ' ASP . 2.7 tm-20 -63.28 158.55 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.424 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.591 ' OD2' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER 69.34 -40.21 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.664 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.521 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 94.2 -160.86 24.08 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.86 -26.6 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.265 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -23.05 6.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.346 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . -86.56 -52.49 3.16 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.01 -28.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -76.53 -51.45 11.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 99' ' ' ALA . 5.9 mmt180 -61.27 -44.37 97.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 98' ' ' ARG . . . -39.26 -33.89 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.448 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.11 1.53 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mt -123.53 137.19 28.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.421 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -72.85 174.01 12.56 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.444 2.096 . . . . 0.0 112.379 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.551 HG21 ' OE2' ' A' ' 33' ' ' GLU . 35.1 m -112.09 172.12 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -141.08 135.21 30.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.62 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 32' ' ' ARG . 19.5 t -97.13 158.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.607 ' ND2' ' CD2' ' A' ' 34' ' ' HIS . 2.3 m-20 -84.8 109.04 17.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 tptp . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.444 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.435 HD22 ' HB2' ' A' ' 78' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.775 0.322 . . . . 0.0 110.58 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 147.87 45.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.603 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -78.75 151.32 32.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.544 HG23 ' N ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -137.51 166.4 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.442 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.4 OUTLIER -109.21 140.31 21.87 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.514 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.06 -18.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.278 1.985 . . . . 0.0 111.585 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.9 m170 -73.87 -30.63 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.37 -52.73 7.33 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.782 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.01 -32.08 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.708 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.563 ' HA ' HD12 ' A' ' 15' ' ' ILE . 2.9 tt0 -68.89 -44.11 73.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.631 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 7.2 mt-10 -66.36 -42.18 88.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 22.5 mt -63.73 -42.76 97.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 12' ' ' GLN . 22.0 mt -48.22 -24.37 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 13' ' ' GLU . . . -78.65 -28.2 45.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.86 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 14' ' ' LEU . 3.4 mtp180 -84.33 -30.5 25.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.098 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.8 23.9 2.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -54.35 153.94 5.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -104.83 97.7 7.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.548 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 131.98 40.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.864 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.635 HD12 ' CZ ' ' A' ' 62' ' ' PHE . 9.7 mt -135.79 141.08 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.601 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 25' ' ' ARG . 11.1 t0 -110.8 145.12 38.71 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.819 HG22 ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -112.89 -73.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.891 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 24' ' ' ILE . 8.5 ptm180 20.57 -143.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.156 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -116.15 109.64 17.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.046 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.0 -42.1 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -43.08 -38.43 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.44 -22.84 26.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.382 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.818 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.5 t80 -82.32 -29.16 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -43.77 93.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.449 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.755 ' O ' HG13 ' A' ' 105' ' ' VAL . 30.4 mtp85 -74.59 -13.84 60.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.065 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.555 ' O ' ' O ' ' A' ' 30' ' ' TYR . 5.9 tt0 -157.48 122.01 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.279 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.591 ' ND1' ' O ' ' A' ' 104' ' ' ALA . 39.0 p-80 -145.21 147.57 32.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mt -90.95 130.96 38.62 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.365 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.7 24.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.511 2.141 . . . . 0.0 112.444 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -146.18 35.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.778 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -162.89 147.33 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -84.57 161.22 20.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.454 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.818 HD13 ' CD2' ' A' ' 30' ' ' TYR . 56.5 tp -115.33 122.01 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.68 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.819 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -160.25 95.57 1.53 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.065 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -46.85 147.46 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.578 2.185 . . . . 0.0 112.034 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 44' ' ' SER . 1.1 pp -71.72 -24.13 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.249 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 46.8 p -76.81 -35.53 57.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.966 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.8 -30.36 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.34 -40.42 89.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.53 -50.13 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -69.47 -34.16 73.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 t -72.8 -78.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.16 75.91 1.0 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 53' ' ' ALA . 32.5 tp -117.7 89.1 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 110.701 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.1 73.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.802 2.335 . . . . 0.0 112.136 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -57.35 -28.13 62.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.389 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . 8.9 tttm -51.94 -24.7 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.387 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.88 -13.6 59.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.565 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 54.9 mtp180 -91.77 16.82 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 169.51 -163.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.902 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.26 -31.15 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.916 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.494 ' C ' HD12 ' A' ' 60' ' ' ILE . 3.2 mt-30 -112.46 132.92 54.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.425 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.89 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -142.27 148.16 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -136.86 144.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.435 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 49.5 m-85 -124.64 151.04 45.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.425 ' HA ' HG21 ' A' ' 70' ' ' THR . 48.3 p-80 -159.98 144.36 14.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 111.656 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.583 ' O ' ' C ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -116.74 154.1 31.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.171 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.583 ' C ' ' O ' ' A' ' 64' ' ' CYS . 5.0 tm0? -21.66 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.783 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -109.22 -22.4 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.457 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 113.29 -33.58 5.48 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 67' ' ' GLY . 2.6 pttp -35.49 -64.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.708 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 19.6 mtt85 -52.12 -38.62 57.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.682 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.861 HG22 HD11 ' A' ' 88' ' ' LEU . 2.1 m -58.74 -47.83 83.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.685 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -70.4 -18.86 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.786 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.04 -47.77 10.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -84.55 -14.18 49.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.718 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -49.89 -26.75 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.517 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -37.25 76.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.62 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -74.89 -26.91 59.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 79' ' ' ALA . 75.2 mt -74.86 -56.89 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' A' ' 3' ' ' LEU . . . -41.31 -22.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.671 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -76.83 -53.06 8.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -75.99 -17.75 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.533 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -87.14 -2.95 59.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 45.71 179.53 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 25.0 Cg_exo -58.25 9.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.596 2.197 . . . . 0.0 111.93 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -55.26 -167.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.332 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 85' ' ' GLU . 3.8 mm-40 -105.42 106.21 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.34 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -116.32 169.48 9.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.861 HD11 HG22 ' A' ' 70' ' ' THR . 7.9 tp -137.85 128.73 27.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 92' ' ' GLY . 4.9 tt -88.17 108.78 19.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.627 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 8.1 tt0 -66.16 147.85 52.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 66' ' ' ALA . 19.7 t0 77.7 -35.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.748 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.511 ' H ' HD23 ' A' ' 89' ' ' LEU . . . 92.84 -164.57 27.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.3 -21.41 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.482 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -61.8 -25.65 67.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.33 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.74 -35.3 25.55 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -30.8 70.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.934 0.397 . . . . 0.0 110.134 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -72.12 -38.13 69.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.355 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -75.57 -33.67 60.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.293 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.54 -15.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.548 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.92 32.31 7.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.6 mt -120.0 104.11 44.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.87 160.17 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.571 2.18 . . . . 0.0 112.4 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.76 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.591 ' O ' ' ND1' ' A' ' 34' ' ' HIS . . . -125.41 126.24 44.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.306 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 32' ' ' ARG . 18.3 t -96.01 133.74 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.472 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 107' ' ' LYS . 63.3 t-20 -87.17 109.6 19.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 106' ' ' ASN . 75.5 tttt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.567 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -105.87 147.05 29.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.764 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.77 150.63 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -140.28 163.3 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.421 0.629 . . . . 0.0 111.547 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.525 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -109.12 145.33 31.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.318 178.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -39.64 -26.25 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.374 2.05 . . . . 0.0 111.897 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' SER . 78.3 m80 -65.99 -33.37 75.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.416 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.8 t0 -77.85 -55.66 5.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.141 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.88 5.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.284 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -38.88 87.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -74.52 -44.9 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.536 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 3.3 mt -65.28 -47.36 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt -47.69 -25.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.795 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.11 -24.69 26.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.215 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -81.35 -41.2 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.703 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 151.43 -15.85 0.85 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -28.41 137.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.425 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.21 98.28 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.545 HD22 ' CE1' ' A' ' 63' ' ' HIS . 1.8 mt -81.39 136.27 35.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.796 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.503 HD12 ' CZ ' ' A' ' 62' ' ' PHE . 5.7 mt -128.9 139.58 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.109 0.481 . . . . 0.0 111.3 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' OD2' ' CD1' ' A' ' 30' ' ' TYR . 14.9 t70 -103.57 132.36 49.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.61 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.465 HD13 ' HG ' ' A' ' 43' ' ' LEU . 1.1 pt -133.65 82.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 110.83 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 65' ' ' GLN . 3.5 ptt180 -156.63 -150.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.358 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -92.15 116.87 29.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.584 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -47.67 -31.73 4.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.083 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 2.5 m-20 -52.71 -44.41 66.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -74.71 -32.6 62.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.693 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.5 t80 -72.19 -25.79 61.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.961 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -67.85 -55.66 12.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp85 -52.17 -18.69 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.18 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 30' ' ' TYR . 2.3 mt-10 -172.03 139.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.475 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.672 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 15.6 p80 -153.64 150.81 29.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.483 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 122.59 52.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.548 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.45 51.27 3.67 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -158.74 18.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.688 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.21 151.48 38.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -85.05 124.05 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.424 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.693 HD13 ' CD2' ' A' ' 30' ' ' TYR . 50.1 tp -83.31 117.81 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.643 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.5 90.68 4.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.344 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 81.4 Cg_exo -45.79 124.29 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.827 2.351 . . . . 0.0 112.617 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -34.0 -62.58 0.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.441 0.638 . . . . 0.0 110.444 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -43.13 -29.8 0.4 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.307 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -76.73 -42.59 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.774 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.47 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 7.3 tp -78.06 -20.16 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.797 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -39.08 30.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.755 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -90.59 -38.68 12.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.801 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 11.7 t -73.14 -77.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.77 75.97 1.09 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.6 89.36 52.35 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.473 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 54' ' ' LYS . 25.0 Cg_exo -58.67 83.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.844 2.363 . . . . 0.0 112.294 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.64 -20.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.001 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.981 ' HZ3' ' HB3' ' A' ' 82' ' ' ALA . 9.4 tttt -60.57 -14.73 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.029 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.1 mt -77.09 -13.34 59.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.615 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -113.76 23.04 13.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.83 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.077 0.465 . . . . 0.0 110.985 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -119.65 -34.09 3.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.156 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.451 ' OE1' HD11 ' A' ' 61' ' ' ILE . 9.4 tt0 -112.13 133.32 54.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.936 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -133.42 120.5 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.451 HD11 ' OE1' ' A' ' 59' ' ' GLN . 6.4 mt -115.43 149.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 23.1 m-85 -130.07 151.35 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.559 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' A' ' 63' ' ' HIS . 3.4 p-80 -154.59 134.03 12.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.768 ' SG ' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -116.46 155.15 29.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.561 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -22.86 -59.96 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.138 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.31 20.69 14.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.98 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.768 ' N ' ' SG ' ' A' ' 64' ' ' CYS . . . 63.47 6.28 14.94 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.764 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -70.4 -57.46 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.432 ' NH1' ' HA ' ' A' ' 25' ' ' ARG . 3.1 ttm180 -61.24 -23.21 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.556 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -64.15 -59.8 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -57.08 -18.88 16.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.752 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -80.03 -44.23 20.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.493 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.451 ' CG ' HD21 ' A' ' 43' ' ' LEU . 16.9 t30 -84.93 -17.01 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.411 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.64 -26.75 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.427 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -85.2 -37.74 19.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.689 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.72 -28.22 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.61 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.458 HD13 ' CG ' ' A' ' 62' ' ' PHE . 95.0 mt -68.47 -53.86 20.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.664 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.04 -56.68 4.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.321 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.6 55.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.968 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -78.01 -18.18 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.146 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -122.99 101.09 7.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.017 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.981 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . . . -39.43 170.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.755 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 32.8 Cg_exo -50.36 65.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.751 2.3 . . . . 0.0 112.433 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.706 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.73 -167.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.78 98.44 11.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.24 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -111.67 135.84 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.54 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CG ' HD12 ' A' ' 6' ' ' ILE . 69.2 m-85 -124.52 168.73 12.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -137.47 133.32 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 92' ' ' GLY . 5.2 tt -89.09 100.69 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.587 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 79.1 tt0 -60.84 149.59 35.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.423 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 12.2 t0 77.79 -46.07 0.45 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.618 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.522 ' H ' HD23 ' A' ' 89' ' ' LEU . . . 104.37 -167.97 16.13 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.728 HD11 HG11 ' A' ' 103' ' ' VAL . 2.2 tt -50.92 -20.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 110.31 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.32 -31.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.268 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.94 -49.67 8.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.672 ' NE1' ' O ' ' A' ' 101' ' ' LEU . 2.4 t-105 -51.97 -38.86 58.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.189 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -70.27 -38.1 75.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.309 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -77.58 -26.22 50.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.63 4.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.53 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.07 18.01 33.0 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.672 ' O ' ' NE1' ' A' ' 96' ' ' TRP . 50.9 mt -118.4 96.52 49.93 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 0.0 110.53 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.37 177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.649 2.233 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.728 HG11 HD11 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -121.41 172.11 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.541 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -115.68 128.73 56.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 33' ' ' GLU . 6.0 t -96.45 133.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.421 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.672 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 1.4 t30 -67.5 108.81 2.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 106' ' ' ASN . 24.2 tptt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.578 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.1 pp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.833 0.349 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 5' ' ' THR . 24.2 m -128.93 158.47 38.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.509 ' N ' HG22 ' A' ' 4' ' ' THR . 0.8 OUTLIER -88.05 148.65 24.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.177 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -137.26 166.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.191 0.519 . . . . 0.0 110.953 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.555 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -106.83 142.13 24.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.889 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.74 -19.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.498 2.132 . . . . 0.0 112.058 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 7' ' ' SER . 7.8 m-70 -76.12 -28.03 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.426 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -84.19 -52.45 6.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.97 -32.94 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -68.31 -51.12 48.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.66 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -56.23 -27.91 56.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 17' ' ' ARG . 25.9 mt -76.18 -42.33 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.2 mt -47.91 -22.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -85.6 -24.23 27.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.151 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -79.39 -51.25 9.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.419 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.578 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 136.81 32.47 0.24 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.0 -177.46 3.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -125.36 111.04 14.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.474 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.11 125.27 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.461 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.557 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 18.6 mt -136.31 138.31 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 111.397 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.657 ' OD1' ' NE ' ' A' ' 25' ' ' ARG . 10.9 t0 -108.83 146.31 33.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.608 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -114.78 -73.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.911 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.657 ' NE ' ' OD1' ' A' ' 23' ' ' ASP . 8.4 ptp180 16.42 -139.61 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.555 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -117.01 113.74 22.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' ASP . . . -38.32 -23.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 26' ' ' ASP . 45.1 m-20 -58.82 -33.11 70.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 15.3 mm-40 -86.37 -30.18 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.821 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.748 ' CD2' HD13 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -75.22 -39.11 60.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.256 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.44 -53.19 60.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.238 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.619 ' O ' HG13 ' A' ' 105' ' ' VAL . 7.6 ptp180 -56.83 -26.68 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 30' ' ' TYR . 15.9 tt0 -164.87 129.76 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.128 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 20.4 p80 -143.88 169.81 17.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 37' ' ' GLU . 2.7 mt -109.1 126.65 28.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.185 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.49 24.87 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.287 1.991 . . . . 0.0 111.963 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 35' ' ' ILE . 80.5 mm-40 -138.73 25.94 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.766 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.95 146.75 23.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.672 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -86.61 153.79 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.748 HD13 ' CD2' ' A' ' 30' ' ' TYR . 45.2 tp -108.39 124.43 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.732 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -162.71 96.53 1.13 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.614 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.792 ' O ' HG22 ' A' ' 45' ' ' VAL . 39.7 Cg_exo -50.56 146.66 19.18 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.497 2.131 . . . . 0.0 112.082 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 44' ' ' SER . 1.2 pp -65.93 -23.62 66.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.782 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.452 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -74.93 -29.24 60.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 42' ' ' PRO . 23.6 m -84.92 -25.27 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.72 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 50' ' ' GLY . 3.0 tp -84.93 -46.61 11.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.571 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.61 -31.41 72.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.704 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -85.12 -30.17 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 6.7 m -94.95 -71.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 94.83 87.1 1.7 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.658 HD12 ' HB2' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -112.31 82.53 4.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.794 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' LEU . 74.8 Cg_exo -45.2 -7.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.796 2.331 . . . . 0.0 112.555 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 51' ' ' LEU . . . -43.43 -29.53 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.974 ' NZ ' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -57.11 -5.75 0.3 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 109.834 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.629 ' C ' ' H ' ' A' ' 57' ' ' HIS . 9.7 mp -94.41 -9.97 33.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.479 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.64 8.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.251 0.548 . . . . 0.0 110.271 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.629 ' H ' ' C ' ' A' ' 55' ' ' LEU . 2.0 t60 -134.88 -145.38 0.23 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.231 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 24.7 tt0 -144.4 -43.89 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.032 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.68 133.1 54.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.714 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.4 mp -139.19 147.75 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.139 0.495 . . . . 0.0 111.389 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.4 139.59 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.908 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -121.95 137.1 54.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.668 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.2 OUTLIER -129.8 134.07 47.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.104 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 24' ' ' ILE . 67.3 m -116.37 153.47 31.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.336 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 32.7 tt0 -26.74 -70.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.85 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 91' ' ' ASP . . . -100.95 -51.31 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.602 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.09 -17.39 1.93 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -59.15 -36.78 75.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.562 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -65.71 -46.77 77.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.236 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.685 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -49.15 -50.99 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.518 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -24.13 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.522 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 29.9 m120 -86.18 -46.54 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.17 -16.2 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -46.16 -30.9 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.594 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.9 -38.05 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -73.93 -26.92 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.76 -57.83 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.86 -24.0 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.35 -40.86 64.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.653 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.5 mt -85.71 -47.12 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.633 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.974 ' HB2' ' NZ ' ' A' ' 54' ' ' LYS . . . -45.78 -27.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.608 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.776 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 67.91 173.79 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.776 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 34.3 Cg_exo -53.57 65.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.699 2.266 . . . . 0.0 112.006 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.17 -172.29 2.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.536 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -102.03 117.42 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.581 HD12 ' N ' ' A' ' 86' ' ' ILE . 2.6 mp -128.47 142.2 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -121.58 169.03 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.028 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' ILE . 18.8 mt -135.6 138.35 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 92' ' ' GLY . 7.2 tt -89.92 107.95 19.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.57 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.6 tp10 -64.13 155.65 30.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.6 OUTLIER 69.52 -34.77 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 90' ' ' GLU . . . 91.4 -160.92 27.17 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.428 ' HB ' HH12 ' A' ' 25' ' ' ARG . 1.0 OUTLIER -50.3 -27.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.344 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.13 -52.39 64.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.151 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.0 -24.34 62.75 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 101' ' ' LEU . 9.6 t-105 -82.5 -35.2 27.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -77.26 -30.62 54.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.483 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -78.45 -35.07 47.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.485 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.93 4.45 3.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.48 65.94 3.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 96' ' ' TRP . 59.7 mt -119.96 149.66 49.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.122 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -35.49 146.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 123.006 2.471 . . . . 0.0 112.468 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.401 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 8.8 p -151.51 154.85 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -146.96 139.04 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.595 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 32' ' ' ARG . 3.7 t -98.47 137.31 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.378 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.51 111.35 21.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.619 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.478 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.2 pp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.872 0.368 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.8 m -116.36 156.19 27.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.013 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 p -85.41 149.48 25.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.229 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -139.09 164.2 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.061 0.458 . . . . 0.0 110.816 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -103.32 139.79 20.44 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.24 -16.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.559 2.173 . . . . 0.0 111.898 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' SER . 35.2 t60 -78.47 -35.27 46.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.944 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -75.66 -49.62 17.85 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.089 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -43.29 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.338 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.98 -50.32 58.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 5.0 mt-10 -55.27 -30.8 60.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 61' ' ' ILE . 9.1 mt -75.3 -43.87 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.497 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.4 mt -48.27 -22.72 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.412 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -81.01 -26.67 36.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 7.4 mtt180 -85.46 -38.06 19.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.462 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.54 30.62 0.96 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -57.42 175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 110.519 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.45 ' NZ ' ' HB2' ' A' ' 57' ' ' HIS . 4.6 mttp -118.61 98.05 6.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.487 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -89.39 126.67 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.991 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.654 ' C ' ' CE1' ' A' ' 63' ' ' HIS . 6.9 mt -131.62 140.79 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.984 0.421 . . . . 0.0 111.421 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 24' ' ' ILE . 64.2 t0 -99.7 149.07 23.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.641 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -150.56 91.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.762 0.792 . . . . 0.0 110.582 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 23' ' ' ASP . 7.3 ptt-85 -169.04 -143.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.091 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.461 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -96.92 107.35 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.234 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -40.74 -26.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.457 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' ASP . 41.4 t0 -57.52 -38.07 74.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.09 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' OE1' ' OE1' ' A' ' 65' ' ' GLN . 10.9 mt-10 -80.68 -32.04 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.335 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.887 ' CD2' HD13 ' A' ' 40' ' ' LEU . 12.3 t80 -78.92 -32.0 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 7.4 tp -60.27 -55.47 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.298 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 105' ' ' VAL . 16.0 mtp180 -55.0 -20.14 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.302 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.731 ' OE2' HG11 ' A' ' 103' ' ' VAL . 22.4 tt0 -163.29 120.7 1.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.696 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 15.0 p80 -138.24 160.85 38.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.591 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.6 mt -98.7 128.13 33.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.53 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.68 21.32 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.49 2.126 . . . . 0.0 111.91 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -141.96 26.49 1.87 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.34 33.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.793 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -87.64 145.68 26.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.887 HD13 ' CD2' ' A' ' 30' ' ' TYR . 62.7 tp -101.99 116.91 33.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.478 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.91 93.81 6.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 52.6 Cg_exo -47.47 118.01 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.505 2.137 . . . . 0.0 111.875 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.886 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -38.26 -34.68 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.12 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 1.8 t -71.53 -29.77 65.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.357 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -73.28 -43.3 57.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.206 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.523 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 17.6 tp -75.82 -21.65 57.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.207 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.48 -39.72 31.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -92.79 -40.99 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 8.3 t -65.71 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.44 79.95 1.49 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.643 ' C ' ' H ' ' A' ' 53' ' ' ALA . 16.0 tp -118.28 91.43 40.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.785 0.326 . . . . 0.0 110.657 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 54' ' ' LYS . 27.4 Cg_exo -58.76 21.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.739 2.293 . . . . 0.0 112.168 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 51' ' ' LEU . . . -47.19 -21.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 81' ' ' ALA . 1.4 ttpm? -63.68 -27.17 69.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.414 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 55' ' ' LEU . 11.1 mp -76.86 -9.12 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.39 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -80.66 10.91 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 110.156 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.45 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 2.0 t60 -148.87 -146.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.421 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -150.15 -36.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.346 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.68 133.13 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.814 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.86 153.34 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.321 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 14' ' ' LEU . 4.5 mt -141.9 125.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.137 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.827 ' CE2' HD13 ' A' ' 77' ' ' LEU . 80.1 m-85 -107.7 149.23 28.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.956 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.654 ' CE1' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -138.68 133.43 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.794 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.593 ' SG ' ' CB ' ' A' ' 69' ' ' ARG . 1.4 t -116.73 153.77 31.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.519 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 6.7 pt20 -36.03 -33.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.872 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -140.09 -37.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.915 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.71 -4.66 3.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -45.71 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.667 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.593 ' CB ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -59.26 -33.99 71.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.628 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.621 ' O ' ' N ' ' A' ' 74' ' ' ALA . 52.4 m -73.13 -46.22 52.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.722 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 p -62.94 -26.96 69.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.19 -27.72 24.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' CG ' HD13 ' A' ' 43' ' ' LEU . 23.2 t30 -102.57 -12.89 17.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.568 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -55.44 -35.26 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.657 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.3 -34.81 78.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.552 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -73.19 -34.21 65.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.544 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.827 HD13 ' CE2' ' A' ' 62' ' ' PHE . 28.0 mt -75.66 -56.06 5.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.409 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.04 -30.82 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.14 81.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.346 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 77' ' ' LEU . 89.3 mt -81.46 -30.52 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.563 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -55.69 -43.98 76.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 75.62 177.02 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.028 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.823 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 32.7 Cg_exo -54.55 65.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.089 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.89 -151.44 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.513 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.83 121.06 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.399 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.6 mp -125.56 126.88 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.426 ' HB3' HD12 ' A' ' 6' ' ' ILE . 43.0 m-85 -114.87 161.3 18.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.445 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 6' ' ' ILE . 9.1 mt -130.33 140.44 50.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.558 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -85.84 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.098 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 92' ' ' GLY . 1.5 tt0 -59.56 146.03 42.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.915 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.1 t0 69.19 -12.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.717 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 68.83 -158.31 52.98 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -30.58 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 110.576 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -31.1 67.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.388 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 99' ' ' ALA . . . -72.39 -59.38 4.56 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.667 ' CZ3' HD13 ' A' ' 101' ' ' LEU . 4.5 t-105 -48.38 -40.43 25.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.047 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.98 -47.08 87.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.461 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 100' ' ' GLY . 26.8 ttm180 -83.31 -17.82 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -60.22 -5.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.574 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 98' ' ' ARG . . . 88.39 33.96 9.93 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.667 HD13 ' CZ3' ' A' ' 96' ' ' TRP . 23.0 mt -125.79 144.01 47.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 148.37 42.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.586 2.191 . . . . 0.0 112.466 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.731 HG11 ' OE2' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -112.32 171.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.061 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.696 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -127.47 125.12 39.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.7 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 32' ' ' ARG . 21.2 t -97.46 137.72 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.127 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -71.4 108.54 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.202 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.622 -179.841 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 5' ' ' THR . 89.0 m -90.03 156.26 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.889 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 4' ' ' THR . 1.1 p -85.87 150.6 24.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.164 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -143.59 164.05 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.277 0.56 . . . . 0.0 111.052 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.538 ' N ' HG23 ' A' ' 6' ' ' ILE . 32.1 m -112.45 149.47 41.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.832 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -41.18 -22.59 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.501 2.134 . . . . 0.0 111.856 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.466 ' N ' ' O ' ' A' ' 7' ' ' SER . 3.4 t-80 -67.21 -38.68 85.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.159 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.79 -54.79 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.434 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.58 -39.51 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HA ' HD12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -61.38 -44.61 96.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.81 -36.84 84.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 29.5 mt -72.79 -42.99 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.705 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.621 HD12 ' HA ' ' A' ' 12' ' ' GLN . 48.0 mt -50.54 -22.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.15 -20.32 38.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.123 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 14' ' ' LEU . 4.7 mtt180 -93.94 -51.28 4.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.46 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 149.15 33.85 0.05 OUTLIER Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -62.68 179.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.227 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HB3' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -133.7 98.15 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.898 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 15' ' ' ILE . 1.6 mp -85.59 133.71 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.972 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.477 HD12 ' CE1' ' A' ' 62' ' ' PHE . 12.1 mt -132.34 142.58 42.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.96 142.13 35.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.432 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -147.21 88.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.799 0.809 . . . . 0.0 110.769 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.542 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 2.6 ptp180 -165.42 -144.45 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.619 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.459 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 38.1 t0 -97.17 107.39 19.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -37.81 -42.27 0.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.66 -38.61 2.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 109.979 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -80.09 -35.09 37.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.067 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.735 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.4 t80 -71.48 -26.98 62.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.3 tp -62.74 -50.42 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.849 ' O ' HG13 ' A' ' 105' ' ' VAL . 4.4 ptm180 -56.76 -27.12 58.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.372 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.524 ' OE2' HG21 ' A' ' 103' ' ' VAL . 31.8 tt0 -159.6 128.85 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.644 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 13.2 p80 -145.61 155.35 42.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 110.767 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 37' ' ' GLU . 8.7 mm -91.9 121.56 66.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.5 23.79 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.278 1.986 . . . . 0.0 112.091 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 35' ' ' ILE . 26.0 mt-10 -146.71 30.6 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.545 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.86 157.89 43.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.556 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.37 153.08 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.602 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.735 HD13 ' CD2' ' A' ' 30' ' ' TYR . 57.7 tp -113.46 110.57 20.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.263 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.64 95.35 6.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.649 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 45' ' ' VAL . 71.2 Cg_exo -44.83 120.32 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.565 2.177 . . . . 0.0 112.079 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.939 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -43.12 -25.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.94 -30.63 39.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.393 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -81.79 -31.38 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.972 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.47 -20.18 57.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.819 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.65 -40.15 19.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.534 ' CG ' ' N ' ' A' ' 49' ' ' SER . 4.6 pt20 -87.86 -45.2 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.012 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.534 ' N ' ' CG ' ' A' ' 48' ' ' GLN . 5.6 t -66.55 -59.01 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.59 82.19 1.39 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 53' ' ' ALA . 13.4 tp -116.08 89.52 25.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.651 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.01 64.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.774 2.316 . . . . 0.0 112.045 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -50.13 -20.0 0.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.492 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.636 ' NZ ' ' HB3' ' A' ' 82' ' ' ALA . 19.7 tttm -57.6 -26.41 61.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.612 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -80.83 -13.98 58.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -90.15 13.25 15.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.033 0.444 . . . . 0.0 109.937 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.723 ' CG ' ' H ' ' A' ' 58' ' ' GLU . 13.7 t-80 179.3 -150.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.723 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 54.7 tt0 -137.38 -41.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.946 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -111.95 132.98 54.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.53 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -132.41 150.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.001 0.429 . . . . 0.0 111.215 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 HD12 ' A' ' 14' ' ' LEU . 1.2 mt -133.58 129.69 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.967 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.72 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 97.9 m-85 -112.04 145.87 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.529 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -152.26 135.47 15.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.708 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.59 ' SG ' HD11 ' A' ' 24' ' ' ILE . 1.8 m -115.19 153.09 31.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.542 ' H ' ' NE ' ' A' ' 25' ' ' ARG . 38.1 tp60 -29.69 -47.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.662 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.87 -11.33 8.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.554 ' H ' ' HB2' ' A' ' 64' ' ' CYS . . . 91.57 2.66 69.81 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -64.56 -30.16 71.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.357 . . . . 0.0 110.523 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 9.7 mpt_? -81.38 -24.72 36.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.534 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -59.82 -55.4 34.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -27.59 67.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' OD2' ' A' ' 75' ' ' ASP . 6.5 m120 -86.69 -37.83 17.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.739 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 69' ' ' ARG . 3.7 t30 -84.9 -17.08 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -48.31 -26.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.169 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -80.78 -51.8 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -65.35 -26.22 67.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.502 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.72 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 48.1 mt -65.56 -61.16 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.71 -53.31 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.3 68.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.29 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mm -71.39 -17.85 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.182 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -121.62 100.03 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.7 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -44.02 178.93 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.448 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 29.2 Cg_exo -57.36 64.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.7 2.267 . . . . 0.0 112.34 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.8 -149.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.253 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.576 ' OE1' ' O ' ' A' ' 84' ' ' ALA . 3.1 mm-40 -115.58 103.01 10.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.07 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.1 139.1 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CG ' HD12 ' A' ' 6' ' ' ILE . 54.4 m-85 -120.97 166.92 13.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.184 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 6' ' ' ILE . 17.1 mt -135.58 142.19 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 110.753 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.623 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -97.91 109.71 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.319 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.7 tm-20 -60.12 143.51 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.755 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.22 -27.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.623 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 87.09 -155.6 27.61 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.8 tt -50.66 -32.45 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.66 -37.34 8.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -57.24 7.26 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.626 ' CD1' ' C ' ' A' ' 96' ' ' TRP . 1.7 t-105 -45.45 -39.28 6.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 110.437 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -56.18 -62.35 1.77 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 100' ' ' GLY . 14.3 ptp180 -70.54 -29.6 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.3 -15.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.491 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 98' ' ' ARG . . . 93.51 38.12 5.38 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 96' ' ' TRP . 24.9 mt -125.13 141.05 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.539 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.53 145.98 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.525 2.15 . . . . 0.0 112.073 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.524 HG21 ' OE2' ' A' ' 33' ' ' GLU . 14.4 m -112.3 172.08 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.548 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.644 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -132.52 128.93 38.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 32' ' ' ARG . 4.8 t -96.77 136.1 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.436 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.543 ' N ' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -82.79 110.68 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.535 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 tttm . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.426 179.93 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 78' ' ' ALA . 1.4 pp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.858 0.361 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 88' ' ' LEU . 71.5 m -118.87 151.98 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.544 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.31 149.18 33.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.662 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.82 HD12 ' CG ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -136.3 161.55 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 110.437 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 9' ' ' HIS . 96.0 p -98.17 135.85 21.19 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.533 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -40.85 -16.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.151 1.901 . . . . 0.0 111.565 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.598 ' N ' ' O ' ' A' ' 7' ' ' SER . 2.1 t60 -79.6 -30.79 41.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.896 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.8 OUTLIER -76.81 -52.07 10.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.241 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.36 -31.08 3.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.28 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.544 ' HA ' HD12 ' A' ' 15' ' ' ILE . 32.8 tt0 -68.66 -52.02 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.375 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.35 -37.64 70.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 65.2 mt -70.34 -40.98 73.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.552 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 12' ' ' GLN . 14.9 mt -48.4 -24.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.46 -23.61 32.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.02 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 14' ' ' LEU . 10.8 mmt180 -82.13 -44.94 15.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 143.5 -6.96 1.97 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -28.71 149.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.848 0.356 . . . . 0.0 110.653 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 39' ' ' ASP . 7.1 mtpp -104.13 98.91 8.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 21' ' ' LEU . 6.3 mp -83.24 124.32 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.969 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mt -122.96 136.67 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 111.475 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' ALA . 34.8 t70 -105.47 136.54 44.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.691 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 41' ' ' ALA . 1.1 pt -136.47 86.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.47 0.653 . . . . 0.0 110.877 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.579 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 3.1 ptp180 -157.27 -146.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.956 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 27' ' ' ALA . 48.3 m-20 -102.98 114.82 29.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.16 -39.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.503 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -42.46 -33.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.341 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 2.6 mt-10 -86.5 -33.6 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.125 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.2 t80 -73.54 -40.55 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tp -55.88 -56.04 25.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.419 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 105' ' ' VAL . 10.5 ptp180 -49.19 -28.06 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 30' ' ' TYR . 1.4 tm-20 -169.24 136.66 1.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.116 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.647 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.1 p80 -150.38 176.54 10.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 110.744 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.67 ' C ' ' H ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -119.68 98.31 49.81 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.444 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 31.9 Cg_exo -54.23 18.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.89 2.393 . . . . 0.0 113.005 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.67 ' H ' ' C ' ' A' ' 35' ' ' ILE . 1.9 pm0 -126.96 9.73 6.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.047 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.41 149.34 52.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -84.78 124.48 31.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.467 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 tp -84.47 119.95 25.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -148.88 89.65 4.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HB2' HG13 ' A' ' 45' ' ' VAL . 89.3 Cg_exo -40.46 146.78 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.068 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -72.61 -25.42 61.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.213 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -30.82 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.4 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 49' ' ' SER . 3.4 m -85.54 -30.11 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.576 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.87 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.7 tt -60.5 -50.9 71.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.684 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.4 -52.88 62.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 48' ' ' GLN . 5.8 mt-30 -70.97 -44.98 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 41.7 t -61.68 -70.17 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.06 68.48 1.18 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -118.21 86.19 26.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.512 ' C ' ' N ' ' A' ' 54' ' ' LYS . 14.5 Cg_exo -64.97 79.23 0.2 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.906 2.404 . . . . 0.0 112.336 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.72 -21.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 82' ' ' ALA . 24.9 tttp -56.71 -15.35 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.114 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.49 -10.0 59.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.93 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 -118.3 17.53 13.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.252 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.38 -166.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.45 -31.54 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.18 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -112.12 133.03 54.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.702 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.58 138.84 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 111.07 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mt -116.91 133.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.236 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.576 ' CD1' HD13 ' A' ' 77' ' ' LEU . 95.1 m-85 -116.9 138.01 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.603 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 15.3 p80 -160.65 137.32 8.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -116.27 154.08 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.354 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.583 ' O ' HG22 ' A' ' 93' ' ' ILE . 1.9 tp-100 -27.4 -54.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.56 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -108.01 -3.44 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' A' ' 69' ' ' ARG . . . 79.46 -43.05 2.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 67' ' ' GLY . 13.6 mttt -31.56 -33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.552 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -63.32 -59.96 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.553 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.837 HG21 HD13 ' A' ' 88' ' ' LEU . 17.5 m -43.83 -49.57 8.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -27.16 63.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.95 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -86.69 -47.48 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.096 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.661 ' OD1' HD13 ' A' ' 43' ' ' LEU . 2.3 t30 -89.96 -10.41 45.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.998 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -48.84 -29.44 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.214 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -29.32 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.762 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.452 ' HB2' ' ND2' ' A' ' 73' ' ' ASN . 52.5 mmtt -83.95 -23.45 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.879 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 80' ' ' ILE . 11.7 mt -80.09 -57.59 3.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.849 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' A' ' 3' ' ' LEU . . . -39.98 -34.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.46 -29.23 46.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' LEU . 97.0 mt -86.37 -17.89 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB3' HD13 ' A' ' 86' ' ' ILE . . . -97.67 4.99 49.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.768 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 45.44 179.59 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.989 0.423 . . . . 0.0 110.538 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 23.1 Cg_exo -60.12 20.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.747 2.298 . . . . 0.0 112.164 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -66.11 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.586 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.66 94.12 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.816 HD13 ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -110.89 144.07 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.82 ' CG ' HD12 ' A' ' 6' ' ' ILE . 11.6 m-85 -120.56 171.02 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.691 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 70' ' ' THR . 18.6 tp -137.83 128.66 27.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.508 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.3 tt -87.28 97.41 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.563 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.496 ' C ' ' CG ' ' A' ' 91' ' ' ASP . 1.4 tt0 -46.16 139.53 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 74.15 -47.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 105.98 -156.06 16.55 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 65' ' ' GLN . 7.6 tt -50.56 -20.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.829 0.347 . . . . 0.0 110.519 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.96 -33.91 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.465 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -83.37 -36.93 13.08 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.422 ' CE2' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -67.09 -29.38 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.31 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -43.27 19.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.493 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -77.04 -24.61 52.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.371 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 95' ' ' GLY . . . -53.36 -41.57 65.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.52 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.78 30.46 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.422 HD13 ' CE2' ' A' ' 96' ' ' TRP . 14.2 mt -118.86 141.93 30.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.72 169.83 21.44 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.355 2.037 . . . . 0.0 112.09 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.62 166.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 34' ' ' HIS . . . -121.57 117.09 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.298 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 32' ' ' ARG . 15.8 t -96.64 135.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.671 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.408 HD22 ' N ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -74.88 109.07 8.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.309 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.408 ' N ' HD22 ' A' ' 106' ' ' ASN . 21.0 ttpt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.648 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.541 HD12 HD11 ' A' ' 88' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.829 0.347 . . . . 0.0 110.634 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -113.98 138.52 50.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -77.88 145.17 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -131.81 163.21 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.385 0.612 . . . . 0.0 111.205 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' HIS . 12.4 t -105.06 142.35 24.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.656 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -41.64 -17.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.451 2.101 . . . . 0.0 112.302 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -81.42 -28.56 34.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -79.79 -52.15 8.28 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.345 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.05 -35.26 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.29 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -38.88 92.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' ASP . 21.0 mt-10 -70.66 -41.73 71.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 16.1 mt -66.98 -41.94 85.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.685 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.593 HD11 ' CD1' ' A' ' 21' ' ' LEU . 8.3 mt -48.36 -24.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.89 -23.27 36.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.396 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -86.36 -40.35 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.598 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.99 -10.69 0.9 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -30.96 147.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HG3' ' CG ' ' A' ' 57' ' ' HIS . 11.4 mtpt -112.28 109.91 19.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.563 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.593 ' CD1' HD11 ' A' ' 15' ' ' ILE . 3.6 mt -94.37 131.9 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.089 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.607 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 12.4 mt -135.55 141.99 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -98.42 137.94 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.95 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 73' ' ' ASN . 1.3 pt -138.61 83.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 0.0 110.608 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HE ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -168.32 -149.1 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.425 ' H ' ' CD ' ' A' ' 25' ' ' ARG . 4.0 m-20 -89.01 114.14 25.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.351 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.593 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -43.34 -43.58 5.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.17 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -42.29 -21.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.763 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' ALA . 3.2 mm-40 -86.84 -38.45 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.859 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -81.6 -24.26 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.17 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -45.0 94.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -68.98 -21.93 64.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 103' ' ' VAL . 2.8 tt0 -164.71 126.45 2.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.375 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 2.7 p80 -139.65 160.17 40.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.423 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 37' ' ' GLU . 10.0 mt -105.35 130.58 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.671 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.34 23.17 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.552 2.168 . . . . 0.0 111.876 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 35' ' ' ILE . 51.7 mm-40 -141.67 34.47 1.62 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.646 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.74 23.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.529 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 40' ' ' LEU . 2.0 t0 -90.32 155.48 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.684 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.649 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.5 tp -110.3 119.46 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.535 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.79 88.21 6.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.312 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 45' ' ' VAL . 88.4 Cg_exo -42.49 126.76 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.747 2.298 . . . . 0.0 112.688 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.019 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -41.99 -24.92 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.717 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' PRO . 5.6 t -79.18 -27.51 42.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.462 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 42' ' ' PRO . 33.4 m -84.74 -27.83 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.165 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.62 -43.41 69.36 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.704 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -32.27 51.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -87.41 -43.63 11.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.611 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.26 -72.83 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . 112.08 92.55 2.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.8 tp -118.59 83.57 22.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.446 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 54' ' ' LYS . 8.3 Cg_exo -68.79 62.22 1.26 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.885 2.39 . . . . 0.0 112.198 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' CB ' HD11 ' A' ' 22' ' ' ILE . . . -39.72 -27.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -51.22 -18.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.48 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.33 -13.56 54.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.985 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.508 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.5 mtp85 -109.16 18.34 20.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -179.52 -169.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.03 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.542 ' C ' ' OE1' ' A' ' 59' ' ' GLN . 4.2 tt0 -118.94 -30.57 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.542 ' OE1' ' C ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -112.06 133.76 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.6 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.892 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -127.32 145.51 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.947 0.403 . . . . 0.0 111.107 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.421 HD11 ' HB1' ' A' ' 19' ' ' ALA . 7.7 mt -137.55 136.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 77' ' ' LEU . 67.8 m-85 -119.75 132.25 55.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.733 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 1.8 p80 -129.0 134.03 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -116.29 153.39 32.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.745 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 60.1 tp60 -34.15 -36.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.481 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -125.61 -42.66 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.654 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 133.18 -32.0 2.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 67' ' ' GLY . 15.8 mmtm -38.67 -42.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.728 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -64.81 -31.92 73.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.13 -45.67 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.011 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.3 -23.14 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.852 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.33 -33.37 20.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.401 HD22 HD13 ' A' ' 24' ' ' ILE . 52.6 t30 -93.3 -17.0 24.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -51.4 -29.9 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -29.75 65.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.011 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -21.51 29.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.767 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.605 HD13 ' CD1' ' A' ' 62' ' ' PHE . 87.6 mt -80.92 -56.56 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.945 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' LEU . . . -39.27 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -80.18 -47.31 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.8 mt -80.84 -19.17 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.154 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -95.98 5.71 50.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.941 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.815 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 44.47 -178.86 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 0.0 110.371 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.815 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 23.2 Cg_exo -60.45 21.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.732 2.288 . . . . 0.0 112.244 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -68.2 179.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.27 112.69 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mt -117.27 139.12 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.44 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.499 ' O ' HD23 ' A' ' 88' ' ' LEU . 70.0 m-85 -120.02 171.98 8.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.604 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 3' ' ' LEU . 7.1 mt -137.2 131.73 32.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.993 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -81.66 85.33 6.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.205 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.646 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 46.8 tt0 -57.48 121.03 9.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.646 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 19.1 t0 94.11 -26.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.423 ' H ' HD12 ' A' ' 89' ' ' LEU . . . 78.46 -153.32 38.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.56 -21.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.15 -59.55 3.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.445 ' HA2' ' NH1' ' A' ' 98' ' ' ARG . . . -61.38 -40.35 98.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.533 ' CE2' ' CB ' ' A' ' 101' ' ' LEU . 16.7 t-105 -53.73 -35.44 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.361 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -80.68 -51.11 9.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.637 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.445 ' NH1' ' HA2' ' A' ' 95' ' ' GLY . 14.2 ttp-105 -51.48 -18.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.976 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.92 -21.12 15.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.775 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.62 72.68 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.533 ' CB ' ' CE2' ' A' ' 96' ' ' TRP . 15.1 mt -119.68 152.68 53.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.399 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' LEU . 96.3 Cg_exo -30.17 118.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 123.193 2.595 . . . . 0.0 112.446 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 2.4 p -143.64 157.04 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.088 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -143.48 130.03 20.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.076 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.416 ' C ' ' NE2' ' A' ' 34' ' ' HIS . 60.9 t -97.33 142.63 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.234 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.567 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -86.45 108.69 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.314 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.505 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.07 35.19 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.269 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 3' ' ' LEU . 4.0 pp -74.95 128.69 36.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.513 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -116.83 144.17 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.401 HG22 ' HB3' ' A' ' 88' ' ' LEU . 1.4 p -78.16 145.13 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -136.32 166.06 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.824 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 6' ' ' ILE . 1.7 t -102.46 142.58 24.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.935 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -42.06 -16.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.369 2.046 . . . . 0.0 112.063 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -80.89 -27.94 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.11 -52.68 6.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.367 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.11 -32.33 1.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.424 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' HA ' HD12 ' A' ' 15' ' ' ILE . 1.7 tt0 -66.24 -56.66 10.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -45.48 -26.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.25 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 27.8 mt -82.94 -39.9 20.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.242 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 12' ' ' GLN . 67.0 mt -49.2 -24.85 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.83 -20.72 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.958 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.558 ' N ' ' O ' ' A' ' 14' ' ' LEU . 6.0 ttt180 -84.14 -41.04 17.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.504 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 139.01 -7.37 3.21 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -31.29 151.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 0.0 110.601 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.787 ' HZ2' ' HE ' ' A' ' 56' ' ' ARG . 1.4 mtpt -109.42 99.72 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.423 HD23 ' CD2' ' A' ' 63' ' ' HIS . 0.6 OUTLIER -82.23 134.7 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.959 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 22' ' ' ILE . 14.4 mt -130.85 141.18 46.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 0.0 111.096 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.581 ' OD2' ' NH2' ' A' ' 25' ' ' ARG . 5.2 t0 -111.71 135.6 52.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.135 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 70' ' ' THR . 8.2 pt -130.12 81.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.243 0.544 . . . . 0.0 110.197 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.581 ' NH2' ' OD2' ' A' ' 23' ' ' ASP . 11.8 ptt180 -154.73 -145.54 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.285 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 11.2 m-20 -101.8 116.21 32.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.316 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -45.61 -36.01 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.189 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -48.34 -34.35 10.49 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -85.18 -32.4 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.806 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.759 ' CZ ' ' ND1' ' A' ' 34' ' ' HIS . 10.0 t80 -73.08 -31.0 64.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 4.0 tp -65.06 -59.24 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.694 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -53.63 -25.55 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.144 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.585 ' OE2' HG11 ' A' ' 103' ' ' VAL . 19.0 tt0 -152.76 117.78 5.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.185 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.77 ' ND1' ' N ' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -140.77 152.13 44.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.513 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.77 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 5.9 mt -110.62 94.18 18.73 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.662 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 50.2 Cg_exo -49.37 66.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.871 2.38 . . . . 0.0 112.4 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.71 ' N ' ' O ' ' A' ' 35' ' ' ILE . 14.5 pt-20 -179.46 27.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.487 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 153.49 30.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.337 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -84.77 143.53 29.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.71 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.37 114.55 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.414 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.84 96.59 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.555 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' VAL . 82.9 Cg_exo -44.94 124.41 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.372 2.048 . . . . 0.0 111.875 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 73' ' ' ASN . 1.7 tt -36.6 -60.29 0.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.137 0.494 . . . . 0.0 110.565 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -44.09 -25.93 0.26 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.974 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 49' ' ' SER . 0.3 OUTLIER -73.9 -39.02 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.926 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.617 HD22 HD21 ' A' ' 73' ' ' ASN . 6.5 tt -83.39 -42.97 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.825 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.88 -29.89 71.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.847 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.487 ' CG ' ' N ' ' A' ' 49' ' ' SER . 7.7 pt20 -97.18 -40.61 8.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.935 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 2.1 t -87.47 -55.36 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.756 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 83.11 0.8 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.674 ' O ' ' N ' ' A' ' 53' ' ' ALA . 14.1 tp -107.58 97.92 21.93 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.87 67.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.564 2.176 . . . . 0.0 112.194 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -51.71 -19.84 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.275 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' HIS . 5.4 tttp -63.3 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mp -77.91 -13.56 59.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.793 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.787 ' HE ' ' HZ2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.1 19.95 8.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 166.17 -167.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.786 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -113.38 -39.58 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.3 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -112.31 133.47 54.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.156 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.946 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -136.33 144.35 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -127.02 146.51 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.169 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.725 ' CD1' HD13 ' A' ' 77' ' ' LEU . 96.6 m-85 -126.62 137.36 53.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.74 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 1.0 OUTLIER -140.75 136.32 32.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.519 ' O ' ' C ' ' A' ' 65' ' ' GLN . 8.6 t -115.7 153.22 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.455 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.519 ' C ' ' O ' ' A' ' 64' ' ' CYS . 2.8 tt0 -30.08 -53.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.65 54.08 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.621 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 42.7 49.57 5.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -112.24 -42.62 3.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.759 ' HB3' HD12 ' A' ' 43' ' ' LEU . 2.9 mmt180 -83.39 -31.9 26.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.611 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.676 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -65.37 -43.34 91.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.531 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -24.7 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.37 -43.96 12.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.776 ' HB2' HD11 ' A' ' 43' ' ' LEU . 9.2 t30 -88.46 -16.44 32.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.636 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -44.32 -38.22 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.387 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.47 -27.06 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.577 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ASN . 15.6 mmtm -78.96 -26.15 43.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.725 HD13 ' CD1' ' A' ' 62' ' ' PHE . 80.4 mt -77.9 -56.81 4.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.33 -33.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.655 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.16 -48.32 17.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.5 mt -75.8 -17.7 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -96.27 8.18 44.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.731 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.809 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 42.98 -179.47 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 110.626 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.809 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 18.1 Cg_exo -62.49 15.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.658 2.239 . . . . 0.0 112.018 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -53.1 -152.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.533 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -122.31 98.7 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.382 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 60' ' ' ILE . 3.0 mp -116.04 146.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.47 177.9 4.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.188 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -135.95 129.28 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.775 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -87.54 101.33 13.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 15.4 tt0 -54.36 121.24 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER 82.22 -50.26 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.568 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.474 ' H ' HD12 ' A' ' 89' ' ' LEU . . . 120.92 -133.87 9.9 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -77.05 -30.83 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 50.1 t0 -48.22 -30.69 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.81 -54.79 4.76 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.457 ' CE2' HD13 ' A' ' 101' ' ' LEU . 2.3 t90 -47.09 -32.19 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.914 0.387 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -73.87 -53.05 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.586 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' C ' ' N ' ' A' ' 100' ' ' GLY . 3.3 ttt180 -66.2 -29.54 69.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.534 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.52 -12.26 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.742 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 98' ' ' ARG . . . 101.24 24.19 9.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.457 HD13 ' CE2' ' A' ' 96' ' ' TRP . 16.4 mt -116.46 138.09 24.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.25 161.66 40.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.349 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.585 HG11 ' OE2' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -111.96 172.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.211 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -132.78 121.15 22.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.691 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 32' ' ' ARG . 15.0 t -96.75 144.02 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.139 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.3 108.6 4.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.295 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 tttt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.55 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.38 12.81 18.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.643 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.8 pp -44.6 126.7 5.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.427 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -122.4 158.41 29.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.581 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -87.9 144.25 26.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -136.7 164.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.061 0.458 . . . . 0.0 110.931 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 9' ' ' HIS . 17.2 t -104.07 138.99 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.796 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.23 -16.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.578 2.185 . . . . 0.0 111.854 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.645 ' N ' ' O ' ' A' ' 7' ' ' SER . 23.6 m170 -75.92 -35.98 59.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.947 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.2 t0 -76.22 -54.19 7.15 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.506 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.13 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.413 ' HA ' HD12 ' A' ' 15' ' ' ILE . 5.0 tt0 -49.73 -46.77 50.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.27 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -59.01 -42.0 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.189 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.809 HD12 HD11 ' A' ' 61' ' ' ILE . 6.9 mt -68.3 -43.85 76.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 12' ' ' GLN . 58.6 mt -48.14 -23.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.855 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.57 -27.61 25.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.483 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.0 ttm-85 -81.12 -40.5 23.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.817 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.87 -11.81 0.95 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -27.07 144.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.69 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HG3' ' CG ' ' A' ' 57' ' ' HIS . 4.8 mmtm -102.24 98.38 8.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.727 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.588 HD22 ' CE1' ' A' ' 63' ' ' HIS . 0.5 OUTLIER -84.48 131.78 34.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.105 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.43 140.79 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.511 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.568 ' CG ' ' CE1' ' A' ' 30' ' ' TYR . 1.4 t70 -101.89 136.72 41.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 43' ' ' LEU . 1.1 pp -136.98 84.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 0.0 110.736 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -160.81 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -102.93 111.23 23.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -41.86 -33.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.276 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.16 -34.67 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -83.84 -31.89 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.538 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.862 ' CD2' HD13 ' A' ' 40' ' ' LEU . 1.5 t80 -77.67 -25.37 49.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.412 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' ALA . 1.4 tp -70.32 -47.94 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.171 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.0 -10.2 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.237 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.5 tt0 -172.83 137.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CE1' ' OD1' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -160.63 161.28 32.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 110.796 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 37' ' ' GLU . 1.7 mt -106.27 105.33 53.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 32.2 Cg_exo -54.33 19.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.576 2.184 . . . . 0.0 113.046 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.676 ' H ' ' C ' ' A' ' 35' ' ' ILE . 56.1 mm-40 -135.12 24.15 3.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.487 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.51 149.09 42.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.81 133.59 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 30' ' ' TYR . 61.0 tp -92.79 118.0 30.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.291 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.44 93.36 4.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.6 Cg_exo -45.49 120.48 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.497 2.132 . . . . 0.0 111.954 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -41.23 -25.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.987 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.25 -26.73 32.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.51 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG1' ' N ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -78.34 -48.75 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.077 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.848 HD12 ' H ' ' A' ' 51' ' ' LEU . 13.5 tp -54.91 -27.13 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.839 0.352 . . . . 0.0 110.446 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -84.38 -49.47 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.716 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -67.0 -52.87 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.6 t -82.99 -77.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.07 91.47 1.28 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 46' ' ' LEU . 17.0 tp -124.46 79.2 61.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.778 0.323 . . . . 0.0 110.579 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 54' ' ' LYS . 7.6 Cg_exo -69.33 78.12 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.987 2.458 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.52 -21.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . 14.5 tttm -57.35 -13.81 3.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.074 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.7 mt -77.55 -10.7 59.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.98 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.519 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.7 mtt180 -125.01 22.88 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.299 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -170.14 -169.04 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.041 0.448 . . . . 0.0 111.167 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.7 -34.68 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.023 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -112.77 133.26 54.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' H ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -129.76 118.53 45.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.809 HD11 HD12 ' A' ' 14' ' ' LEU . 12.1 mt -110.5 141.74 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.15 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.563 ' CG ' HD13 ' A' ' 77' ' ' LEU . 60.4 m-85 -123.85 143.3 50.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.051 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.588 ' CE1' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -143.22 135.94 27.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.346 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.809 ' HG ' ' HG1' ' A' ' 70' ' ' THR . 1.3 m -116.48 153.07 32.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.98 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 66' ' ' ALA . 6.9 pt20 -34.91 -39.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.478 ' N ' ' HG2' ' A' ' 65' ' ' GLN . . . -128.06 -4.96 5.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.568 ' H ' ' HB2' ' A' ' 64' ' ' CYS . . . 85.32 -28.78 4.58 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -42.56 -26.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HB3' ' SG ' ' A' ' 64' ' ' CYS . 2.7 tpm_? -83.59 -25.45 30.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.068 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.809 ' HG1' ' HG ' ' A' ' 64' ' ' CYS . 0.2 OUTLIER -65.88 -54.61 24.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.765 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -65.17 -23.66 67.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -86.4 -47.5 9.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.539 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.601 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 t30 -84.28 -16.29 43.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.361 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -41.34 -33.87 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.113 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.18 -31.32 67.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 73' ' ' ASN . 33.8 mmtt -81.79 -22.08 37.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.904 0.383 . . . . 0.0 110.532 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.563 HD13 ' CG ' ' A' ' 62' ' ' PHE . 60.9 mt -80.62 -57.19 3.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.654 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.99 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.48 -54.59 34.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -18.46 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.221 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.03 2.17 50.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.841 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 52.63 -179.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.937 0.398 . . . . 0.0 110.735 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 22.9 Cg_exo -60.54 7.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.878 2.386 . . . . 0.0 112.448 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -46.48 169.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.279 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.9 102.67 4.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.217 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.78 133.13 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.425 ' O ' HD23 ' A' ' 88' ' ' LEU . 46.7 m-85 -125.54 153.56 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.609 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.531 HD22 HG22 ' A' ' 70' ' ' THR . 23.1 mt -122.39 137.03 55.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.195 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.507 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.6 tt -89.04 91.34 8.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.34 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -40.66 147.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 68.35 -47.44 0.54 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 101.9 -145.76 16.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mm -51.0 -41.93 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.477 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.29 -35.26 59.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.02 -47.11 39.88 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.529 ' CD1' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.95 -37.04 81.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.45 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -80.76 -25.79 37.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.376 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -73.86 -44.75 54.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.45 63.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.564 ' O ' HD23 ' A' ' 101' ' ' LEU . . . 125.76 45.34 0.24 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 100' ' ' GLY . 9.6 mt -123.5 106.27 32.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -45.62 152.09 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.455 2.103 . . . . 0.0 112.174 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.37 169.06 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.436 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -128.65 144.12 51.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.454 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.96 130.57 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.663 ' OD1' ' CE1' ' A' ' 34' ' ' HIS . 1.7 m-20 -67.59 109.69 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.397 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 106' ' ' ASN . 17.6 tttt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.473 ' N ' ' HB1' ' A' ' 78' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.48 16.87 9.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.594 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pp -69.49 152.06 45.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.536 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 m -132.72 151.97 51.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.619 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.49 33.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.548 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -144.8 163.28 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.728 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.599 ' O ' ' N ' ' A' ' 9' ' ' HIS . 4.9 m -108.62 142.98 26.59 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.959 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.46 -17.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.477 2.118 . . . . 0.0 111.722 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.599 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -73.06 -35.81 66.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.754 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -75.66 -56.11 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.209 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.61 -23.44 0.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -70.99 -44.41 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -68.07 -26.06 65.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.776 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 14.7 mt -79.74 -45.13 19.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.5 mt -47.76 -23.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.447 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -27.46 40.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.118 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 14' ' ' LEU . 9.9 mtt180 -84.43 -41.54 16.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.416 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.74 28.08 0.41 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -59.82 149.09 32.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.4 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.61 102.51 13.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.673 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 21' ' ' LEU . 5.2 mp -92.56 129.22 38.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.443 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 7.3 mt -127.44 142.43 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.032 0.444 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -103.75 153.43 20.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.555 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.447 ' O ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 pp -147.73 90.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.334 0.588 . . . . 0.0 110.789 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 24.4 ttt-85 -173.91 -141.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.9 119.69 30.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.271 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.71 97.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.534 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.66 -26.28 3.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 110.006 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.56 -44.95 11.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.301 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.8 t80 -70.37 -31.03 68.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.195 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.56 -58.21 8.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.743 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -52.63 -28.66 22.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.27 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 30' ' ' TYR . 23.9 tt0 -152.51 123.58 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.607 ' CD2' ' ND2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -150.55 175.55 11.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.011 0.434 . . . . 0.0 111.034 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.687 ' C ' ' H ' ' A' ' 37' ' ' GLU . 43.8 mt -109.2 106.07 58.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.253 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 32.1 Cg_exo -54.44 19.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.573 2.182 . . . . 0.0 112.981 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.687 ' H ' ' C ' ' A' ' 35' ' ' ILE . 41.4 mm-40 -137.82 38.51 2.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.342 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.2 150.33 25.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -88.53 126.41 35.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.1 tp -85.19 117.14 23.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.177 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.36 93.75 6.34 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.569 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 45' ' ' VAL . 76.3 Cg_exo -45.99 122.5 5.3 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.498 2.132 . . . . 0.0 111.893 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.014 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -39.79 -29.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -75.49 -30.7 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.965 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -68.4 -38.77 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.112 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD22 HD23 ' A' ' 77' ' ' LEU . 2.4 tt -73.41 -41.81 62.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.142 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -64.99 -31.03 72.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.195 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -96.14 -32.73 12.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.145 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 10.0 t -92.07 -44.44 8.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 110.809 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 68.37 64.26 3.18 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -98.68 110.55 57.54 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' LYS . 58.6 Cg_endo -77.44 63.09 7.83 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.376 2.05 . . . . 0.0 112.353 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.62 -21.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.961 0.41 . . . . 0.0 110.046 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HE2' ' HB3' ' A' ' 82' ' ' ALA . 30.9 tttp -54.34 -21.43 9.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.454 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.59 -6.31 53.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.72 14.86 30.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.412 . . . . 0.0 110.472 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t60 177.97 -164.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.736 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -121.92 -26.46 4.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.089 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -113.82 133.63 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.801 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -134.56 142.16 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.795 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.27 144.85 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.431 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 47.7 m-85 -123.96 141.19 52.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.861 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -149.15 133.84 17.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.536 ' O ' ' C ' ' A' ' 65' ' ' GLN . 3.5 m -117.54 153.73 32.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.536 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.5 OUTLIER -28.23 -41.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.593 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -126.27 -60.45 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.537 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 154.7 -37.16 0.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 24.6 tttt -45.14 -29.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HE ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -75.22 -36.49 61.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.773 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -65.66 -42.98 90.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.423 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -66.31 -21.17 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.633 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 68' ' ' LYS . 3.0 m120 -82.75 -41.74 18.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 76' ' ' LYS . 2.0 t-20 -98.72 -13.81 20.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.527 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -47.16 -29.97 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.53 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -80.81 -31.37 35.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.528 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 73' ' ' ASN . 36.7 mmtm -76.76 -41.29 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.655 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.538 HD23 HD22 ' A' ' 46' ' ' LEU . 10.1 mt -67.81 -57.8 5.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.473 ' HB1' ' N ' ' A' ' 1' ' ' MET . . . -47.17 -29.8 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.454 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.5 -56.38 20.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.38 -20.51 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.55 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -77.27 -2.76 36.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 44.95 -179.27 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 110.472 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 22.7 Cg_exo -60.23 26.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.764 2.309 . . . . 0.0 112.09 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.623 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -69.11 -162.68 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.506 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -110.31 99.09 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.464 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.83 133.24 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.87 163.38 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.851 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 89' ' ' LEU . 10.1 tp -131.92 132.32 43.46 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.876 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 88' ' ' LEU . 7.2 tt -99.24 103.99 15.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' O ' ' OD2' ' A' ' 91' ' ' ASP . 2.7 tm-20 -63.28 158.55 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.424 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.591 ' OD2' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER 69.34 -40.21 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.664 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.521 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 94.2 -160.86 24.08 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.86 -26.6 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.265 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -23.05 6.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.346 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . -86.56 -52.49 3.16 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.01 -28.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -76.53 -51.45 11.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 99' ' ' ALA . 5.9 mmt180 -61.27 -44.37 97.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 98' ' ' ARG . . . -39.26 -33.89 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.448 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.11 1.53 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mt -123.53 137.19 28.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.421 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -72.85 174.01 12.56 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.444 2.096 . . . . 0.0 112.379 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.551 HG21 ' OE2' ' A' ' 33' ' ' GLU . 35.1 m -112.09 172.12 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -141.08 135.21 30.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 0.0 110.62 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 32' ' ' ARG . 19.5 t -97.13 158.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.607 ' ND2' ' CD2' ' A' ' 34' ' ' HIS . 2.3 m-20 -84.8 109.04 17.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 tptp . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.444 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mtp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 3' ' ' LEU . . . -122.13 12.14 10.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.489 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -38.55 143.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.58 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 147.87 45.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.603 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -78.75 151.32 32.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.544 HG23 ' N ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -137.51 166.4 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.442 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.4 OUTLIER -109.21 140.31 21.87 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.514 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.06 -18.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.278 1.985 . . . . 0.0 111.585 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 7' ' ' SER . 21.9 m170 -73.87 -30.63 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.37 -52.73 7.33 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.782 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.01 -32.08 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.708 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.563 ' HA ' HD12 ' A' ' 15' ' ' ILE . 2.9 tt0 -68.89 -44.11 73.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.631 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 7.2 mt-10 -66.36 -42.18 88.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 22.5 mt -63.73 -42.76 97.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 12' ' ' GLN . 22.0 mt -48.22 -24.37 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 13' ' ' GLU . . . -78.65 -28.2 45.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.86 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 14' ' ' LEU . 3.4 mtp180 -84.33 -30.5 25.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.098 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.8 23.9 2.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -54.35 153.94 5.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -104.83 97.7 7.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.548 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.06 131.98 40.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.864 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.635 HD12 ' CZ ' ' A' ' 62' ' ' PHE . 9.7 mt -135.79 141.08 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.601 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 25' ' ' ARG . 11.1 t0 -110.8 145.12 38.71 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.819 HG22 ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -112.89 -73.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.891 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 24' ' ' ILE . 8.5 ptm180 20.57 -143.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.156 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -116.15 109.64 17.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.046 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.0 -42.1 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -43.08 -38.43 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.902 0.382 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.44 -22.84 26.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.382 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.818 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.5 t80 -82.32 -29.16 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.618 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -43.77 93.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.449 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.755 ' O ' HG13 ' A' ' 105' ' ' VAL . 30.4 mtp85 -74.59 -13.84 60.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.065 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.555 ' O ' ' O ' ' A' ' 30' ' ' TYR . 5.9 tt0 -157.48 122.01 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.279 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.591 ' ND1' ' O ' ' A' ' 104' ' ' ALA . 39.0 p-80 -145.21 147.57 32.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mt -90.95 130.96 38.62 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.365 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.7 24.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.511 2.141 . . . . 0.0 112.444 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -146.18 35.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.778 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -162.89 147.33 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -84.57 161.22 20.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.454 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.818 HD13 ' CD2' ' A' ' 30' ' ' TYR . 56.5 tp -115.33 122.01 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.68 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.819 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -160.25 95.57 1.53 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.065 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -46.85 147.46 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.578 2.185 . . . . 0.0 112.034 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 44' ' ' SER . 1.1 pp -71.72 -24.13 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.249 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 46.8 p -76.81 -35.53 57.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.966 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.8 -30.36 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.34 -40.42 89.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.53 -50.13 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.006 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -69.47 -34.16 73.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 t -72.8 -78.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.16 75.91 1.0 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 53' ' ' ALA . 32.5 tp -117.7 89.1 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 110.701 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.1 73.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.802 2.335 . . . . 0.0 112.136 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -57.35 -28.13 62.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.389 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . 8.9 tttm -51.94 -24.7 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.387 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.88 -13.6 59.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.565 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 54.9 mtp180 -91.77 16.82 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 169.51 -163.75 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.902 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.26 -31.15 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.916 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.494 ' C ' HD12 ' A' ' 60' ' ' ILE . 3.2 mt-30 -112.46 132.92 54.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.425 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.89 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -142.27 148.16 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -136.86 144.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.435 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 49.5 m-85 -124.64 151.04 45.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.425 ' HA ' HG21 ' A' ' 70' ' ' THR . 48.3 p-80 -159.98 144.36 14.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.181 0.515 . . . . 0.0 111.656 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.583 ' O ' ' C ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -116.74 154.1 31.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.171 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.583 ' C ' ' O ' ' A' ' 64' ' ' CYS . 5.0 tm0? -21.66 -56.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.783 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -109.22 -22.4 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.457 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 113.29 -33.58 5.48 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 67' ' ' GLY . 2.6 pttp -35.49 -64.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.708 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 19.6 mtt85 -52.12 -38.62 57.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.682 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.861 HG22 HD11 ' A' ' 88' ' ' LEU . 2.1 m -58.74 -47.83 83.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.685 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -70.4 -18.86 63.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.786 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.04 -47.77 10.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -84.55 -14.18 49.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.718 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -49.89 -26.75 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.517 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -37.25 76.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.62 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -74.89 -26.91 59.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 79' ' ' ALA . 75.2 mt -74.86 -56.89 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' A' ' 3' ' ' LEU . . . -41.31 -22.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.671 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -76.83 -53.06 8.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -75.99 -17.75 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.533 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -87.14 -2.95 59.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 45.71 179.53 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 25.0 Cg_exo -58.25 9.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.596 2.197 . . . . 0.0 111.93 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -55.26 -167.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.332 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 85' ' ' GLU . 3.8 mm-40 -105.42 106.21 16.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.34 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -116.32 169.48 9.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.861 HD11 HG22 ' A' ' 70' ' ' THR . 7.9 tp -137.85 128.73 27.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 92' ' ' GLY . 4.9 tt -88.17 108.78 19.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.627 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 8.1 tt0 -66.16 147.85 52.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 66' ' ' ALA . 19.7 t0 77.7 -35.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.748 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.511 ' H ' HD23 ' A' ' 89' ' ' LEU . . . 92.84 -164.57 27.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.0 tt -52.3 -21.41 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.482 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -61.8 -25.65 67.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.33 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.74 -35.3 25.55 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -30.8 70.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.934 0.397 . . . . 0.0 110.134 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -72.12 -38.13 69.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.355 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -75.57 -33.67 60.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.293 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.54 -15.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.548 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.92 32.31 7.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.6 mt -120.0 104.11 44.45 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.87 160.17 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.571 2.18 . . . . 0.0 112.4 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.76 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.591 ' O ' ' ND1' ' A' ' 34' ' ' HIS . . . -125.41 126.24 44.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.306 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 32' ' ' ARG . 18.3 t -96.01 133.74 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.472 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 107' ' ' LYS . 63.3 t-20 -87.17 109.6 19.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 106' ' ' ASN . 75.5 tttt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.567 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 3' ' ' LEU . . . -109.77 22.22 15.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.766 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -38.08 116.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -105.87 147.05 29.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.764 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.77 150.63 34.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.912 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -140.28 163.3 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.421 0.629 . . . . 0.0 111.547 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.525 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -109.12 145.33 31.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.318 178.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -39.64 -26.25 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.374 2.05 . . . . 0.0 111.897 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' SER . 78.3 m80 -65.99 -33.37 75.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.416 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.8 t0 -77.85 -55.66 5.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.141 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.88 5.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.284 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -38.88 87.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -74.52 -44.9 49.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.536 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 3.3 mt -65.28 -47.36 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt -47.69 -25.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.795 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.11 -24.69 26.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.215 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -81.35 -41.2 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.703 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 151.43 -15.85 0.85 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -28.41 137.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.425 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.21 98.28 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.545 HD22 ' CE1' ' A' ' 63' ' ' HIS . 1.8 mt -81.39 136.27 35.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.796 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.503 HD12 ' CZ ' ' A' ' 62' ' ' PHE . 5.7 mt -128.9 139.58 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.109 0.481 . . . . 0.0 111.3 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' OD2' ' CD1' ' A' ' 30' ' ' TYR . 14.9 t70 -103.57 132.36 49.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.61 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.465 HD13 ' HG ' ' A' ' 43' ' ' LEU . 1.1 pt -133.65 82.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 110.83 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 65' ' ' GLN . 3.5 ptt180 -156.63 -150.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.358 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -92.15 116.87 29.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.584 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -47.67 -31.73 4.95 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.083 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 2.5 m-20 -52.71 -44.41 66.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -74.71 -32.6 62.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.693 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.5 t80 -72.19 -25.79 61.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.961 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -67.85 -55.66 12.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp85 -52.17 -18.69 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.18 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 30' ' ' TYR . 2.3 mt-10 -172.03 139.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.475 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.672 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 15.6 p80 -153.64 150.81 29.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.483 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.55 122.59 52.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.548 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.45 51.27 3.67 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -158.74 18.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.688 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.21 151.48 38.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -85.05 124.05 31.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.424 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.693 HD13 ' CD2' ' A' ' 30' ' ' TYR . 50.1 tp -83.31 117.81 23.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.643 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.5 90.68 4.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.344 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 81.4 Cg_exo -45.79 124.29 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.827 2.351 . . . . 0.0 112.617 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -34.0 -62.58 0.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.441 0.638 . . . . 0.0 110.444 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -43.13 -29.8 0.4 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.307 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -76.73 -42.59 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.774 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.47 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 7.3 tp -78.06 -20.16 52.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.797 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -39.08 30.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.755 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -90.59 -38.68 12.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.801 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 11.7 t -73.14 -77.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.77 75.97 1.09 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.6 89.36 52.35 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.842 0.353 . . . . 0.0 110.473 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 54' ' ' LYS . 25.0 Cg_exo -58.67 83.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.844 2.363 . . . . 0.0 112.294 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.64 -20.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.001 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.981 ' HZ3' ' HB3' ' A' ' 82' ' ' ALA . 9.4 tttt -60.57 -14.73 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.029 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.1 mt -77.09 -13.34 59.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.615 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -113.76 23.04 13.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.83 -167.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.077 0.465 . . . . 0.0 110.985 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -119.65 -34.09 3.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.156 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.451 ' OE1' HD11 ' A' ' 61' ' ' ILE . 9.4 tt0 -112.13 133.32 54.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.936 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -133.42 120.5 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.451 HD11 ' OE1' ' A' ' 59' ' ' GLN . 6.4 mt -115.43 149.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 22' ' ' ILE . 23.1 m-85 -130.07 151.35 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.559 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' A' ' 63' ' ' HIS . 3.4 p-80 -154.59 134.03 12.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.768 ' SG ' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -116.46 155.15 29.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.561 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -22.86 -59.96 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.138 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.31 20.69 14.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.98 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.768 ' N ' ' SG ' ' A' ' 64' ' ' CYS . . . 63.47 6.28 14.94 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.764 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -70.4 -57.46 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.432 ' NH1' ' HA ' ' A' ' 25' ' ' ARG . 3.1 ttm180 -61.24 -23.21 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.556 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -64.15 -59.8 3.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -57.08 -18.88 16.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.752 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -80.03 -44.23 20.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.493 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.451 ' CG ' HD21 ' A' ' 43' ' ' LEU . 16.9 t30 -84.93 -17.01 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.411 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.64 -26.75 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.427 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -85.2 -37.74 19.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.689 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.72 -28.22 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.61 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.458 HD13 ' CG ' ' A' ' 62' ' ' PHE . 95.0 mt -68.47 -53.86 20.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.664 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.04 -56.68 4.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.321 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.6 55.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.968 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -78.01 -18.18 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.146 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -122.99 101.09 7.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.017 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.981 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . . . -39.43 170.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.755 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 32.8 Cg_exo -50.36 65.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.751 2.3 . . . . 0.0 112.433 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.706 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.73 -167.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.78 98.44 11.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.24 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -111.67 135.84 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.54 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CG ' HD12 ' A' ' 6' ' ' ILE . 69.2 m-85 -124.52 168.73 12.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -137.47 133.32 34.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 92' ' ' GLY . 5.2 tt -89.09 100.69 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.587 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 79.1 tt0 -60.84 149.59 35.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.423 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 12.2 t0 77.79 -46.07 0.45 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.618 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.522 ' H ' HD23 ' A' ' 89' ' ' LEU . . . 104.37 -167.97 16.13 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.728 HD11 HG11 ' A' ' 103' ' ' VAL . 2.2 tt -50.92 -20.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.334 . . . . 0.0 110.31 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.32 -31.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.268 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.94 -49.67 8.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.672 ' NE1' ' O ' ' A' ' 101' ' ' LEU . 2.4 t-105 -51.97 -38.86 58.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.189 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -70.27 -38.1 75.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.309 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -77.58 -26.22 50.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.63 4.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.53 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.07 18.01 33.0 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.672 ' O ' ' NE1' ' A' ' 96' ' ' TRP . 50.9 mt -118.4 96.52 49.93 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.655 0.264 . . . . 0.0 110.53 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.37 177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.649 2.233 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.728 HG11 HD11 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -121.41 172.11 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.541 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -115.68 128.73 56.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 33' ' ' GLU . 6.0 t -96.45 133.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.421 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.672 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 1.4 t30 -67.5 108.81 2.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.456 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 106' ' ' ASN . 24.2 tptt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.578 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.81 38.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.558 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.1 pp -42.26 117.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.487 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 5' ' ' THR . 24.2 m -128.93 158.47 38.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.509 ' N ' HG22 ' A' ' 4' ' ' THR . 0.8 OUTLIER -88.05 148.65 24.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.177 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -137.26 166.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.191 0.519 . . . . 0.0 110.953 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.555 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -106.83 142.13 24.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.889 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -40.74 -19.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.498 2.132 . . . . 0.0 112.058 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 7' ' ' SER . 7.8 m-70 -76.12 -28.03 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.426 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -84.19 -52.45 6.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.919 0.39 . . . . 0.0 110.574 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.97 -32.94 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -68.31 -51.12 48.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.66 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -56.23 -27.91 56.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 17' ' ' ARG . 25.9 mt -76.18 -42.33 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.2 mt -47.91 -22.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -85.6 -24.23 27.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.151 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -79.39 -51.25 9.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.419 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 136.81 32.47 0.24 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.0 -177.46 3.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -125.36 111.04 14.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.474 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.11 125.27 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.461 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.557 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 18.6 mt -136.31 138.31 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 111.397 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.657 ' OD1' ' NE ' ' A' ' 25' ' ' ARG . 10.9 t0 -108.83 146.31 33.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.608 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -114.78 -73.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.911 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.657 ' NE ' ' OD1' ' A' ' 23' ' ' ASP . 8.4 ptp180 16.42 -139.61 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.555 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -117.01 113.74 22.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.294 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 26' ' ' ASP . . . -38.32 -23.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 26' ' ' ASP . 45.1 m-20 -58.82 -33.11 70.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.5 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 15.3 mm-40 -86.37 -30.18 22.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.821 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.748 ' CD2' HD13 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -75.22 -39.11 60.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.256 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.44 -53.19 60.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.238 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.619 ' O ' HG13 ' A' ' 105' ' ' VAL . 7.6 ptp180 -56.83 -26.68 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 30' ' ' TYR . 15.9 tt0 -164.87 129.76 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.128 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 20.4 p80 -143.88 169.81 17.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 37' ' ' GLU . 2.7 mt -109.1 126.65 28.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.185 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.49 24.87 0.36 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.287 1.991 . . . . 0.0 111.963 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 35' ' ' ILE . 80.5 mm-40 -138.73 25.94 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.766 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.95 146.75 23.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.672 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -86.61 153.79 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.617 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.748 HD13 ' CD2' ' A' ' 30' ' ' TYR . 45.2 tp -108.39 124.43 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.732 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -162.71 96.53 1.13 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.614 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.792 ' O ' HG22 ' A' ' 45' ' ' VAL . 39.7 Cg_exo -50.56 146.66 19.18 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.497 2.131 . . . . 0.0 112.082 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 44' ' ' SER . 1.2 pp -65.93 -23.62 66.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.782 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.452 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -74.93 -29.24 60.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 42' ' ' PRO . 23.6 m -84.92 -25.27 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.72 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 50' ' ' GLY . 3.0 tp -84.93 -46.61 11.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.571 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.61 -31.41 72.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.704 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -85.12 -30.17 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 6.7 m -94.95 -71.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 94.83 87.1 1.7 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.658 HD12 ' HB2' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -112.31 82.53 4.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 110.794 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' LEU . 74.8 Cg_exo -45.2 -7.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.796 2.331 . . . . 0.0 112.555 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 51' ' ' LEU . . . -43.43 -29.53 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.405 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.974 ' NZ ' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -57.11 -5.75 0.3 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 109.834 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.629 ' C ' ' H ' ' A' ' 57' ' ' HIS . 9.7 mp -94.41 -9.97 33.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.479 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.64 8.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.251 0.548 . . . . 0.0 110.271 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.629 ' H ' ' C ' ' A' ' 55' ' ' LEU . 2.0 t60 -134.88 -145.38 0.23 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.231 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 24.7 tt0 -144.4 -43.89 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.032 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.68 133.1 54.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.714 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.4 mp -139.19 147.75 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.139 0.495 . . . . 0.0 111.389 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.4 139.59 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.908 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -121.95 137.1 54.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.215 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.668 ' CD2' ' N ' ' A' ' 63' ' ' HIS . 0.2 OUTLIER -129.8 134.07 47.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.104 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 24' ' ' ILE . 67.3 m -116.37 153.47 31.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.336 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.553 ' C ' ' O ' ' A' ' 64' ' ' CYS . 32.7 tt0 -26.74 -70.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.85 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 91' ' ' ASP . . . -100.95 -51.31 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.602 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.09 -17.39 1.93 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -59.15 -36.78 75.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.562 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -65.71 -46.77 77.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.236 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.685 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -49.15 -50.99 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.518 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -24.13 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' OD1' ' O ' ' A' ' 68' ' ' LYS . 29.9 m120 -86.18 -46.54 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.657 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.17 -16.2 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.565 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -46.16 -30.9 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.594 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -71.9 -38.05 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -73.93 -26.92 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.76 -57.83 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.86 -24.0 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.35 -40.86 64.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.653 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.5 mt -85.71 -47.12 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.633 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.974 ' HB2' ' NZ ' ' A' ' 54' ' ' LYS . . . -45.78 -27.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.608 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.776 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 67.91 173.79 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.776 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 34.3 Cg_exo -53.57 65.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.699 2.266 . . . . 0.0 112.006 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.17 -172.29 2.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.536 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -102.03 117.42 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.581 HD12 ' N ' ' A' ' 86' ' ' ILE . 2.6 mp -128.47 142.2 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.326 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -121.58 169.03 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.028 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' ILE . 18.8 mt -135.6 138.35 42.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 92' ' ' GLY . 7.2 tt -89.92 107.95 19.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.57 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.6 tp10 -64.13 155.65 30.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.826 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.6 OUTLIER 69.52 -34.77 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 90' ' ' GLU . . . 91.4 -160.92 27.17 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.428 ' HB ' HH12 ' A' ' 25' ' ' ARG . 1.0 OUTLIER -50.3 -27.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.344 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.13 -52.39 64.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.151 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.0 -24.34 62.75 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 101' ' ' LEU . 9.6 t-105 -82.5 -35.2 27.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -77.26 -30.62 54.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.483 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -78.45 -35.07 47.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.485 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.93 4.45 3.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.48 65.94 3.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 96' ' ' TRP . 59.7 mt -119.96 149.66 49.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.122 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -35.49 146.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 123.006 2.471 . . . . 0.0 112.468 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.401 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 8.8 p -151.51 154.85 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -146.96 139.04 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.595 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 32' ' ' ARG . 3.7 t -98.47 137.31 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.378 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.51 111.35 21.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.619 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.478 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 3' ' ' LEU . . . -100.53 36.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.823 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 3' ' ' LEU . 2.2 pp -39.61 120.81 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.251 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.8 m -116.36 156.19 27.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.013 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 p -85.41 149.48 25.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.229 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -139.09 164.2 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.061 0.458 . . . . 0.0 110.816 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -103.32 139.79 20.44 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.24 -16.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.559 2.173 . . . . 0.0 111.898 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' SER . 35.2 t60 -78.47 -35.27 46.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.944 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -75.66 -49.62 17.85 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.089 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 -43.29 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.338 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.98 -50.32 58.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 5.0 mt-10 -55.27 -30.8 60.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.455 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 61' ' ' ILE . 9.1 mt -75.3 -43.87 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.497 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.4 mt -48.27 -22.72 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' N ' ' C ' ' A' ' 14' ' ' LEU . . . -81.01 -26.67 36.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.157 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 7.4 mtt180 -85.46 -38.06 19.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.462 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.54 30.62 0.96 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -57.42 175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 110.519 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' NZ ' ' HB2' ' A' ' 57' ' ' HIS . 4.6 mttp -118.61 98.05 6.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.487 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -89.39 126.67 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.991 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.654 ' C ' ' CE1' ' A' ' 63' ' ' HIS . 6.9 mt -131.62 140.79 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.984 0.421 . . . . 0.0 111.421 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 24' ' ' ILE . 64.2 t0 -99.7 149.07 23.7 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.641 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -150.56 91.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.762 0.792 . . . . 0.0 110.582 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.511 ' CZ ' ' OD1' ' A' ' 23' ' ' ASP . 7.3 ptt-85 -169.04 -143.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.091 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.461 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -96.92 107.35 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.234 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -40.74 -26.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.457 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' ASP . 41.4 t0 -57.52 -38.07 74.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.09 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' OE1' ' OE1' ' A' ' 65' ' ' GLN . 10.9 mt-10 -80.68 -32.04 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.335 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.887 ' CD2' HD13 ' A' ' 40' ' ' LEU . 12.3 t80 -78.92 -32.0 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . 7.4 tp -60.27 -55.47 33.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.298 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 105' ' ' VAL . 16.0 mtp180 -55.0 -20.14 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.302 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.731 ' OE2' HG11 ' A' ' 103' ' ' VAL . 22.4 tt0 -163.29 120.7 1.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.232 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.696 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 15.0 p80 -138.24 160.85 38.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.591 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.6 mt -98.7 128.13 33.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.53 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.68 21.32 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.49 2.126 . . . . 0.0 111.91 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -141.96 26.49 1.87 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.34 33.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.793 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -87.64 145.68 26.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.514 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.887 HD13 ' CD2' ' A' ' 30' ' ' TYR . 62.7 tp -101.99 116.91 33.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.478 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.91 93.81 6.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.473 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' VAL . 52.6 Cg_exo -47.47 118.01 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.505 2.137 . . . . 0.0 111.875 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.886 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -38.26 -34.68 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.12 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 1.8 t -71.53 -29.77 65.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.357 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -73.28 -43.3 57.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.206 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.523 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 17.6 tp -75.82 -21.65 57.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.207 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -79.48 -39.72 31.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -92.79 -40.99 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 8.3 t -65.71 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.44 79.95 1.49 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.643 ' C ' ' H ' ' A' ' 53' ' ' ALA . 16.0 tp -118.28 91.43 40.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.785 0.326 . . . . 0.0 110.657 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 54' ' ' LYS . 27.4 Cg_exo -58.76 21.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.739 2.293 . . . . 0.0 112.168 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 51' ' ' LEU . . . -47.19 -21.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 81' ' ' ALA . 1.4 ttpm? -63.68 -27.17 69.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.414 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 55' ' ' LEU . 11.1 mp -76.86 -9.12 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.39 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -80.66 10.91 4.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 110.156 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.45 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 2.0 t60 -148.87 -146.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.421 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -150.15 -36.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.346 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.68 133.13 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.814 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.86 153.34 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.321 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 14' ' ' LEU . 4.5 mt -141.9 125.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.137 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.827 ' CE2' HD13 ' A' ' 77' ' ' LEU . 80.1 m-85 -107.7 149.23 28.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.956 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.654 ' CE1' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -138.68 133.43 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.794 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.593 ' SG ' ' CB ' ' A' ' 69' ' ' ARG . 1.4 t -116.73 153.77 31.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.489 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.519 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 6.7 pt20 -36.03 -33.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.872 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 64' ' ' CYS . . . -140.09 -37.42 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.915 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.71 -4.66 3.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -45.71 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.667 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.593 ' CB ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -59.26 -33.99 71.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.628 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.621 ' O ' ' N ' ' A' ' 74' ' ' ALA . 52.4 m -73.13 -46.22 52.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.722 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 p -62.94 -26.96 69.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.19 -27.72 24.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' CG ' HD13 ' A' ' 43' ' ' LEU . 23.2 t30 -102.57 -12.89 17.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.568 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -55.44 -35.26 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.657 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.3 -34.81 78.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.552 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -73.19 -34.21 65.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.544 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.827 HD13 ' CE2' ' A' ' 62' ' ' PHE . 28.0 mt -75.66 -56.06 5.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.409 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.04 -30.82 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.14 81.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.346 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 77' ' ' LEU . 89.3 mt -81.46 -30.52 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.563 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -55.69 -43.98 76.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 75.62 177.02 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.028 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.823 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 32.7 Cg_exo -54.55 65.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.089 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -128.89 -151.44 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.513 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.83 121.06 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.399 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.6 mp -125.56 126.88 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.426 ' HB3' HD12 ' A' ' 6' ' ' ILE . 43.0 m-85 -114.87 161.3 18.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.445 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 6' ' ' ILE . 9.1 mt -130.33 140.44 50.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.558 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -85.84 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.098 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 92' ' ' GLY . 1.5 tt0 -59.56 146.03 42.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.915 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.1 t0 69.19 -12.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.717 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 68.83 -158.31 52.98 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -30.58 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 110.576 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -31.1 67.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.388 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 99' ' ' ALA . . . -72.39 -59.38 4.56 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.667 ' CZ3' HD13 ' A' ' 101' ' ' LEU . 4.5 t-105 -48.38 -40.43 25.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.047 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -59.98 -47.08 87.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.461 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 100' ' ' GLY . 26.8 ttm180 -83.31 -17.82 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -60.22 -5.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.574 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 98' ' ' ARG . . . 88.39 33.96 9.93 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.667 HD13 ' CZ3' ' A' ' 96' ' ' TRP . 23.0 mt -125.79 144.01 47.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 148.37 42.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.586 2.191 . . . . 0.0 112.466 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.731 HG11 ' OE2' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -112.32 171.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.061 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.696 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -127.47 125.12 39.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.7 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 32' ' ' ARG . 21.2 t -97.46 137.72 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.127 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -71.4 108.54 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.202 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.622 -179.841 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 4' ' ' THR . . . -122.06 33.54 5.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.724 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -39.44 99.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 5' ' ' THR . 89.0 m -90.03 156.26 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.889 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 4' ' ' THR . 1.1 p -85.87 150.6 24.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.164 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -143.59 164.05 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.277 0.56 . . . . 0.0 111.052 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.538 ' N ' HG23 ' A' ' 6' ' ' ILE . 32.1 m -112.45 149.47 41.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.832 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -41.18 -22.59 0.14 Allowed 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.501 2.134 . . . . 0.0 111.856 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.466 ' N ' ' O ' ' A' ' 7' ' ' SER . 3.4 t-80 -67.21 -38.68 85.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.159 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.79 -54.79 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.434 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.58 -39.51 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HA ' HD12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -61.38 -44.61 96.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.81 -36.84 84.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 29.5 mt -72.79 -42.99 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.705 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.621 HD12 ' HA ' ' A' ' 12' ' ' GLN . 48.0 mt -50.54 -22.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.15 -20.32 38.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.123 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 14' ' ' LEU . 4.7 mtt180 -93.94 -51.28 4.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.46 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 57' ' ' HIS . . . 149.15 33.85 0.05 OUTLIER Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -62.68 179.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.227 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HB3' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -133.7 98.15 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.898 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 15' ' ' ILE . 1.6 mp -85.59 133.71 34.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.972 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.477 HD12 ' CE1' ' A' ' 62' ' ' PHE . 12.1 mt -132.34 142.58 42.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.96 142.13 35.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.432 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -147.21 88.42 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.799 0.809 . . . . 0.0 110.769 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.542 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 2.6 ptp180 -165.42 -144.45 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.619 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.459 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 38.1 t0 -97.17 107.39 19.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -37.81 -42.27 0.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.371 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.66 -38.61 2.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 109.979 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -80.09 -35.09 37.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.067 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.735 ' CD2' HD13 ' A' ' 40' ' ' LEU . 4.4 t80 -71.48 -26.98 62.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.3 tp -62.74 -50.42 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.849 ' O ' HG13 ' A' ' 105' ' ' VAL . 4.4 ptm180 -56.76 -27.12 58.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.372 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.524 ' OE2' HG21 ' A' ' 103' ' ' VAL . 31.8 tt0 -159.6 128.85 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.644 ' CD2' ' O ' ' A' ' 104' ' ' ALA . 13.2 p80 -145.61 155.35 42.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 110.767 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 37' ' ' GLU . 8.7 mm -91.9 121.56 66.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.5 23.79 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.278 1.986 . . . . 0.0 112.091 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 35' ' ' ILE . 26.0 mt-10 -146.71 30.6 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.545 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.86 157.89 43.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.556 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.37 153.08 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.602 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.735 HD13 ' CD2' ' A' ' 30' ' ' TYR . 57.7 tp -113.46 110.57 20.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.263 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.64 95.35 6.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.649 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 45' ' ' VAL . 71.2 Cg_exo -44.83 120.32 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.565 2.177 . . . . 0.0 112.079 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.939 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -43.12 -25.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.94 -30.63 39.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.393 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -81.79 -31.38 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.972 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.47 -20.18 57.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.819 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.65 -40.15 19.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.534 ' CG ' ' N ' ' A' ' 49' ' ' SER . 4.6 pt20 -87.86 -45.2 10.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.012 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.534 ' N ' ' CG ' ' A' ' 48' ' ' GLN . 5.6 t -66.55 -59.01 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.59 82.19 1.39 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 53' ' ' ALA . 13.4 tp -116.08 89.52 25.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.651 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.01 64.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.774 2.316 . . . . 0.0 112.045 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -50.13 -20.0 0.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.492 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.636 ' NZ ' ' HB3' ' A' ' 82' ' ' ALA . 19.7 tttm -57.6 -26.41 61.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.612 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -80.83 -13.98 58.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.062 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -90.15 13.25 15.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.033 0.444 . . . . 0.0 109.937 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.723 ' CG ' ' H ' ' A' ' 58' ' ' GLU . 13.7 t-80 179.3 -150.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.723 ' H ' ' CG ' ' A' ' 57' ' ' HIS . 54.7 tt0 -137.38 -41.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.946 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -111.95 132.98 54.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.53 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -132.41 150.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.001 0.429 . . . . 0.0 111.215 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 HD12 ' A' ' 14' ' ' LEU . 1.2 mt -133.58 129.69 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.967 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.72 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 97.9 m-85 -112.04 145.87 38.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.529 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -152.26 135.47 15.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.708 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.59 ' SG ' HD11 ' A' ' 24' ' ' ILE . 1.8 m -115.19 153.09 31.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.542 ' H ' ' NE ' ' A' ' 25' ' ' ARG . 38.1 tp60 -29.69 -47.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.662 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.87 -11.33 8.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.554 ' H ' ' HB2' ' A' ' 64' ' ' CYS . . . 91.57 2.66 69.81 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -64.56 -30.16 71.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.357 . . . . 0.0 110.523 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 9.7 mpt_? -81.38 -24.72 36.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.534 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -59.82 -55.4 34.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -27.59 67.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' OD2' ' A' ' 75' ' ' ASP . 6.5 m120 -86.69 -37.83 17.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.739 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 69' ' ' ARG . 3.7 t30 -84.9 -17.08 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -48.31 -26.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.169 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -80.78 -51.8 8.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -65.35 -26.22 67.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.502 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.72 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 48.1 mt -65.56 -61.16 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' ALA . . . -45.71 -53.31 9.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.3 68.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.29 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mm -71.39 -17.85 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.182 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -121.62 100.03 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.7 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . -44.02 178.93 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.448 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 29.2 Cg_exo -57.36 64.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.7 2.267 . . . . 0.0 112.34 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 82' ' ' ALA . . . -104.8 -149.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.253 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.576 ' OE1' ' O ' ' A' ' 84' ' ' ALA . 3.1 mm-40 -115.58 103.01 10.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.07 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.1 139.1 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CG ' HD12 ' A' ' 6' ' ' ILE . 54.4 m-85 -120.97 166.92 13.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.184 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 6' ' ' ILE . 17.1 mt -135.58 142.19 45.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 110.753 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.623 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -97.91 109.71 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.319 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 92' ' ' GLY . 3.7 tm-20 -60.12 143.51 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.755 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.22 -27.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.623 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 87.09 -155.6 27.61 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.8 tt -50.66 -32.45 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.292 . . . . 0.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.66 -37.34 8.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.427 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -57.24 7.26 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.626 ' CD1' ' C ' ' A' ' 96' ' ' TRP . 1.7 t-105 -45.45 -39.28 6.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 110.437 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -56.18 -62.35 1.77 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.885 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 100' ' ' GLY . 14.3 ptp180 -70.54 -29.6 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.3 -15.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.491 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 98' ' ' ARG . . . 93.51 38.12 5.38 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 96' ' ' TRP . 24.9 mt -125.13 141.05 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.539 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.53 145.98 34.15 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.525 2.15 . . . . 0.0 112.073 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.524 HG21 ' OE2' ' A' ' 33' ' ' GLU . 14.4 m -112.3 172.08 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.548 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.644 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -132.52 128.93 38.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 32' ' ' ARG . 4.8 t -96.77 136.1 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.436 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.543 ' N ' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -82.79 110.68 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.535 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 tttm . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.426 179.93 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.83 7.59 14.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.459 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 78' ' ' ALA . 1.4 pp -94.37 144.54 25.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.617 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 88' ' ' LEU . 71.5 m -118.87 151.98 37.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.544 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.31 149.18 33.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.662 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.82 HD12 ' CG ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -136.3 161.55 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 110.437 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 9' ' ' HIS . 96.0 p -98.17 135.85 21.19 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.533 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -40.85 -16.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.151 1.901 . . . . 0.0 111.565 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.598 ' N ' ' O ' ' A' ' 7' ' ' SER . 2.1 t60 -79.6 -30.79 41.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.896 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.8 OUTLIER -76.81 -52.07 10.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 110.241 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -47.36 -31.08 3.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.28 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.544 ' HA ' HD12 ' A' ' 15' ' ' ILE . 32.8 tt0 -68.66 -52.02 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.375 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.35 -37.64 70.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 65.2 mt -70.34 -40.98 73.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.552 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 12' ' ' GLN . 14.9 mt -48.4 -24.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.46 -23.61 32.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.02 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 14' ' ' LEU . 10.8 mmt180 -82.13 -44.94 15.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 143.5 -6.96 1.97 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -28.71 149.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.848 0.356 . . . . 0.0 110.653 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 39' ' ' ASP . 7.1 mtpp -104.13 98.91 8.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 21' ' ' LEU . 6.3 mp -83.24 124.32 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.969 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mt -122.96 136.67 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 111.475 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' ALA . 34.8 t70 -105.47 136.54 44.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.691 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 41' ' ' ALA . 1.1 pt -136.47 86.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.47 0.653 . . . . 0.0 110.877 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.579 ' NE ' ' H ' ' A' ' 65' ' ' GLN . 3.1 ptp180 -157.27 -146.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.956 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 27' ' ' ALA . 48.3 m-20 -102.98 114.82 29.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -38.16 -39.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.503 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -42.46 -33.25 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.341 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' ARG . 2.6 mt-10 -86.5 -33.6 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.125 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' O ' ' A' ' 33' ' ' GLU . 1.2 t80 -73.54 -40.55 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.796 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tp -55.88 -56.04 25.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.419 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 105' ' ' VAL . 10.5 ptp180 -49.19 -28.06 4.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 30' ' ' TYR . 1.4 tm-20 -169.24 136.66 1.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.116 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.647 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.1 p80 -150.38 176.54 10.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 110.744 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.67 ' C ' ' H ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -119.68 98.31 49.81 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.444 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 104' ' ' ALA . 31.9 Cg_exo -54.23 18.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.89 2.393 . . . . 0.0 113.005 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.67 ' H ' ' C ' ' A' ' 35' ' ' ILE . 1.9 pm0 -126.96 9.73 6.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.047 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.41 149.34 52.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.436 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -84.78 124.48 31.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.467 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 tp -84.47 119.95 25.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -148.88 89.65 4.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HB2' HG13 ' A' ' 45' ' ' VAL . 89.3 Cg_exo -40.46 146.78 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.068 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -72.61 -25.42 61.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.213 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -30.82 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.4 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 49' ' ' SER . 3.4 m -85.54 -30.11 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.576 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.87 ' C ' HD23 ' A' ' 46' ' ' LEU . 5.7 tt -60.5 -50.9 71.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.684 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.4 -52.88 62.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 48' ' ' GLN . 5.8 mt-30 -70.97 -44.98 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 41.7 t -61.68 -70.17 0.21 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.06 68.48 1.18 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.4 tp -118.21 86.19 26.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.512 ' C ' ' N ' ' A' ' 54' ' ' LYS . 14.5 Cg_exo -64.97 79.23 0.2 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.906 2.404 . . . . 0.0 112.336 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.72 -21.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.142 0.496 . . . . 0.0 109.676 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 82' ' ' ALA . 24.9 tttp -56.71 -15.35 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.114 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.49 -10.0 59.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.93 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 -118.3 17.53 13.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.252 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.38 -166.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.45 -31.54 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.18 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -112.12 133.03 54.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.702 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.58 138.84 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 111.07 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mt -116.91 133.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.236 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.576 ' CD1' HD13 ' A' ' 77' ' ' LEU . 95.1 m-85 -116.9 138.01 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.603 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 15.3 p80 -160.65 137.32 8.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.296 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -116.27 154.08 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.354 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.583 ' O ' HG22 ' A' ' 93' ' ' ILE . 1.9 tp-100 -27.4 -54.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.56 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -108.01 -3.44 18.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' A' ' 69' ' ' ARG . . . 79.46 -43.05 2.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 67' ' ' GLY . 13.6 mttt -31.56 -33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 110.552 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -63.32 -59.96 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.553 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.837 HG21 HD13 ' A' ' 88' ' ' LEU . 17.5 m -43.83 -49.57 8.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -27.16 63.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.95 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -86.69 -47.48 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.096 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.661 ' OD1' HD13 ' A' ' 43' ' ' LEU . 2.3 t30 -89.96 -10.41 45.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.998 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -48.84 -29.44 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.214 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -29.32 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.762 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.452 ' HB2' ' ND2' ' A' ' 73' ' ' ASN . 52.5 mmtt -83.95 -23.45 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.879 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 80' ' ' ILE . 11.7 mt -80.09 -57.59 3.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.849 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' A' ' 3' ' ' LEU . . . -39.98 -34.25 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.46 -29.23 46.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' LEU . 97.0 mt -86.37 -17.89 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB3' HD13 ' A' ' 86' ' ' ILE . . . -97.67 4.99 49.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.768 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 45.44 179.59 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.989 0.423 . . . . 0.0 110.538 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 23.1 Cg_exo -60.12 20.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.747 2.298 . . . . 0.0 112.164 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -66.11 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.586 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.66 94.12 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.816 HD13 ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -110.89 144.07 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.82 ' CG ' HD12 ' A' ' 6' ' ' ILE . 11.6 m-85 -120.56 171.02 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.691 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 70' ' ' THR . 18.6 tp -137.83 128.66 27.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.508 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 3.3 tt -87.28 97.41 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.563 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.496 ' C ' ' CG ' ' A' ' 91' ' ' ASP . 1.4 tt0 -46.16 139.53 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 74.15 -47.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 89' ' ' LEU . . . 105.98 -156.06 16.55 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 65' ' ' GLN . 7.6 tt -50.56 -20.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.829 0.347 . . . . 0.0 110.519 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.96 -33.91 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.465 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -83.37 -36.93 13.08 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.422 ' CE2' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -67.09 -29.38 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.31 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -43.27 19.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.493 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -77.04 -24.61 52.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.371 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 95' ' ' GLY . . . -53.36 -41.57 65.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.52 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.78 30.46 0.49 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.422 HD13 ' CE2' ' A' ' 96' ' ' TRP . 14.2 mt -118.86 141.93 30.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.72 169.83 21.44 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.355 2.037 . . . . 0.0 112.09 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.62 166.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.54 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 34' ' ' HIS . . . -121.57 117.09 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.298 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 32' ' ' ARG . 15.8 t -96.64 135.73 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.671 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.408 HD22 ' N ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -74.88 109.07 8.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.309 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.408 ' N ' HD22 ' A' ' 106' ' ' ASN . 21.0 ttpt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.648 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 174.85 82.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.575 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.541 HD12 HD11 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -130.38 125.67 35.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.634 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -113.98 138.52 50.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -77.88 145.17 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -131.81 163.21 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.385 0.612 . . . . 0.0 111.205 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' HIS . 12.4 t -105.06 142.35 24.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.656 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -41.64 -17.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.451 2.101 . . . . 0.0 112.302 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -81.42 -28.56 34.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -79.79 -52.15 8.28 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.345 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.05 -35.26 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.29 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -38.88 92.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' ASP . 21.0 mt-10 -70.66 -41.73 71.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 16.1 mt -66.98 -41.94 85.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.685 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.593 HD11 ' CD1' ' A' ' 21' ' ' LEU . 8.3 mt -48.36 -24.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.89 -23.27 36.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.396 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -86.36 -40.35 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.598 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 149.99 -10.69 0.9 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . . . -30.96 147.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HG3' ' CG ' ' A' ' 57' ' ' HIS . 11.4 mtpt -112.28 109.91 19.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.563 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.593 ' CD1' HD11 ' A' ' 15' ' ' ILE . 3.6 mt -94.37 131.9 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.089 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.607 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 12.4 mt -135.55 141.99 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -98.42 137.94 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.95 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 73' ' ' ASN . 1.3 pt -138.61 83.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 0.0 110.608 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HE ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -168.32 -149.1 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.425 ' H ' ' CD ' ' A' ' 25' ' ' ARG . 4.0 m-20 -89.01 114.14 25.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.351 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.593 ' O ' ' N ' ' A' ' 30' ' ' TYR . . . -43.34 -43.58 5.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.17 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -42.29 -21.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 109.763 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' ALA . 3.2 mm-40 -86.84 -38.45 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.859 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -81.6 -24.26 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.17 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -45.0 94.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -68.98 -21.93 64.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 103' ' ' VAL . 2.8 tt0 -164.71 126.45 2.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.375 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' N ' ' A' ' 106' ' ' ASN . 2.7 p80 -139.65 160.17 40.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.423 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 37' ' ' GLU . 10.0 mt -105.35 130.58 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.671 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.34 23.17 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.552 2.168 . . . . 0.0 111.876 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 35' ' ' ILE . 51.7 mm-40 -141.67 34.47 1.62 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.646 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.74 23.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.529 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 40' ' ' LEU . 2.0 t0 -90.32 155.48 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.684 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.649 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.5 tp -110.3 119.46 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.535 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.79 88.21 6.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.312 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 45' ' ' VAL . 88.4 Cg_exo -42.49 126.76 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.747 2.298 . . . . 0.0 112.688 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.019 ' O ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -41.99 -24.92 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.717 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' PRO . 5.6 t -79.18 -27.51 42.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.462 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 42' ' ' PRO . 33.4 m -84.74 -27.83 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.165 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.62 -43.41 69.36 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.704 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -32.27 51.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -87.41 -43.63 11.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.611 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -86.26 -72.83 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . 112.08 92.55 2.07 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.8 tp -118.59 83.57 22.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.446 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 54' ' ' LYS . 8.3 Cg_exo -68.79 62.22 1.26 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.885 2.39 . . . . 0.0 112.198 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' CB ' HD11 ' A' ' 22' ' ' ILE . . . -39.72 -27.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -51.22 -18.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.48 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.33 -13.56 54.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.985 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.508 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.5 mtp85 -109.16 18.34 20.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -179.52 -169.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.03 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.542 ' C ' ' OE1' ' A' ' 59' ' ' GLN . 4.2 tt0 -118.94 -30.57 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.542 ' OE1' ' C ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -112.06 133.76 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.6 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.892 ' N ' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -127.32 145.51 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.947 0.403 . . . . 0.0 111.107 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.421 HD11 ' HB1' ' A' ' 19' ' ' ALA . 7.7 mt -137.55 136.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.402 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 77' ' ' LEU . 67.8 m-85 -119.75 132.25 55.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.733 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 1.8 p80 -129.0 134.03 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -116.29 153.39 32.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.745 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' N ' ' SG ' ' A' ' 64' ' ' CYS . 60.1 tp60 -34.15 -36.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.481 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' A' ' 91' ' ' ASP . . . -125.61 -42.66 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.654 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 70' ' ' THR . . . 133.18 -32.0 2.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 67' ' ' GLY . 15.8 mmtm -38.67 -42.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.728 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -64.81 -31.92 73.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.13 -45.67 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.011 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.3 -23.14 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.852 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.33 -33.37 20.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.401 HD22 HD13 ' A' ' 24' ' ' ILE . 52.6 t30 -93.3 -17.0 24.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.803 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 70' ' ' THR . . . -51.4 -29.9 17.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -29.75 65.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.011 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -21.51 29.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.767 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.605 HD13 ' CD1' ' A' ' 62' ' ' PHE . 87.6 mt -80.92 -56.56 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.945 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 77' ' ' LEU . . . -39.27 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -80.18 -47.31 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.8 mt -80.84 -19.17 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.154 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 82' ' ' ALA . . . -95.98 5.71 50.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.941 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.815 ' HB1' ' HD2' ' A' ' 83' ' ' PRO . . . 44.47 -178.86 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 0.0 110.371 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.815 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 23.2 Cg_exo -60.45 21.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.732 2.288 . . . . 0.0 112.244 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 82' ' ' ALA . . . -68.2 179.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.333 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.27 112.69 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 mt -117.27 139.12 45.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.44 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.499 ' O ' HD23 ' A' ' 88' ' ' LEU . 70.0 m-85 -120.02 171.98 8.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.604 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 3' ' ' LEU . 7.1 mt -137.2 131.73 32.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.993 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -81.66 85.33 6.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.205 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.646 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 46.8 tt0 -57.48 121.03 9.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.62 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.646 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 19.1 t0 94.11 -26.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.423 ' H ' HD12 ' A' ' 89' ' ' LEU . . . 78.46 -153.32 38.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.2 tt -61.56 -21.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.484 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.15 -59.55 3.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.077 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.445 ' HA2' ' NH1' ' A' ' 98' ' ' ARG . . . -61.38 -40.35 98.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.533 ' CE2' ' CB ' ' A' ' 101' ' ' LEU . 16.7 t-105 -53.73 -35.44 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.361 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -80.68 -51.11 9.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.637 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.445 ' NH1' ' HA2' ' A' ' 95' ' ' GLY . 14.2 ttp-105 -51.48 -18.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.976 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.92 -21.12 15.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.775 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.62 72.68 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.533 ' CB ' ' CE2' ' A' ' 96' ' ' TRP . 15.1 mt -119.68 152.68 53.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.399 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' LEU . 96.3 Cg_exo -30.17 118.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 123.193 2.595 . . . . 0.0 112.446 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 33' ' ' GLU . 2.4 p -143.64 157.04 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.088 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 34' ' ' HIS . . . -143.48 130.03 20.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.076 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.416 ' C ' ' NE2' ' A' ' 34' ' ' HIS . 60.9 t -97.33 142.63 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.234 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.567 ' N ' ' NE2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -86.45 108.69 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.314 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.505 179.955 . . . . . . . . 0 0 . 1 stop_ save_